╨╧рб▒с > ■ б г ■ Щ Ъ Ы Ь Э Ю Я а ье┴ M °┐ ЭЁ bjbjт=т= "| АW АW °╪ l 4 Є Є Є Є ╘ ╞В $ 4 =R м ЎЙ V Lз Lз Lз Lз +и B mк ┤ !л \ P >P >P >P >P >P $ щS V x bP Х }л 'и +и }л }л bP =) Lз Lз █ ўQ =) =) =) }л ■t Lз Lз
and < signify increase(d) and decrease(d) or greater than- less than as appropriate
* Sorry about typos, etc. HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/?order=Ba" Brand Name1 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0070.html" APAP/Hydrocodone
Class: antitussive opioid analgesic; Schedule III
Action: acts on cough center in medulla; binds to opiate receptors in CNS to reduce pain
Dosage: Adult-PO 5-10mg q4h prn
Child-PO 1.25-5mg q4hprn or 0.2mg/kg q3-4h
SE: drowsiness, sedation, dizziness, light-headedness, nausea, anorexia, vomiting, and constipation, circulatory depression, respiratory depression.
Contra: addiction
Precautions: addictive personality, > intracranial P, acute MI, severe heart disease, respiratory depression, hepatic, renal
Interactions: >CNS depression: alcohol, opioids, sedative/hypnotics, phenothiazines, skeletal muscle relaxants, general anesthetics, tricyclics
Pharmacokinetic: Onset 10-20 min, duration 4-6h, T╜ 3╜-4╜h HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0070.html" Generic,
Vicodin, Lortab2 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3318.html" Atorvastatin
Class: antilipidemic
Action: inhibits HMG-CoA reductase enzyme, which reduces cholesterol synthesis
Dosage: PO 10mg qd, usual range 10-80, adjustments may be made in 2-4wk intervals, max 80/d
SE: abdominal cramps, constipation, diarrhea, flatus, heartburn, liver dysfunction, rhabdomyolysis
Contra: active liver disease
Precautions: past liver disease, alcoholism, severe acute infections, trauma, HypoTN, uncontrolled seizure disorders, severe metabolic disorders, electrolyte imbalance
Interactions: rhabdomyolysis: azole antifungals, cyclosporine, erythromycin, niacin, gemfibrozil, clofibrate; >serum digoxin; >levels oral contraceptives; >levels atorvastatin: erythromycin, itraconazole; >effects of warfarin (Coumadin); grapefruit juice
Pharmacokinetics: 98% protein bound, T╜ 14h HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3318.html" Lipitor3 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1612.html" Levothyroxine
Class: thyroid hormone
Action: >metabolic rate, controls protein synthesis, > cardiac output, renal bld flow, O2 consumption, body temp, bld volume, growth, development at cellular level, exact mechanism unknown
Dosage: severe hypothyroidism- Adult:PO 50mcg qd, increased by 50-100 mcg q 1-4 wk until desired response, maintenance dose 75-125 mcg qd; IM/IV 50-100mcg/d as a single dose or 50% of usual oral dosage. Child: >12yr PO 2-3mcg/kg/day, 6-12yr PO 4-5mcg/kg/day; 1-5yr PO 5-6 mcg/kg/day, 6-12mos PO 6-8 mcg/kg/day, up to 6mos PO 8-10 mcg/kg/day Ц all children's as single dose am; myxedema coma- Adult: IV 200-500 mcg, may increase by 100-300mcg after 24 hr; use oral med asap
SE: anxiety, insomnia, tremors, thyroid storm, tachycardia, palpitations, angina, dysrhythmias, cardiac arrest,
Contra: adrenal insufficiency, recent MI, thyrotoxicosis, hypersensitivity to beef, alcohol intolerance (injection only)
Precautions: elderly, angina pectoris, HTN, ischemia, cardiac disease, diabetes
Interactions: >risk cardiac insufficiency when used w/ epinephrine products; < absorption of levothyroxine: cholestryamine, colestipol, ferrous sulfate; > effects of anticoagulants, sympathomimetics, tricyclics; < effects of levothyroxine: estrogens; incompatible in syringe w/ all other drugs. Do not give w/ bugleween, possible < thyroid hormone levels with soy.
Pharmacokinetics: PO Onset 3-5 days, pk 1-3wks, duration 1-3wk; IV Onset 6-8hr, pk 24h duration unknown. T ╜ 6-7 days; distributed throughout body tissues HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1612.html" Synthroid4 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0333.html" Atenolol
Class: antiHTN, antianginal; beta blocker ( bЁ1 , bЁ2 h i g h d o s e s )
A c t i o n : b l o c k s s t i m u l a t i o n o f B a d r e n e r g i c r e c e p t o r w i t h i n v a s c u l a r s m o o t h m u s c l e ; p r o d u c e s n e g a t i v e c h r o n o t r o p i c a c t i v i t y ( a f f e c t i n g t h e t i m e o r r a t e , a s t h e r a t e o f c o n t r a c t i o n o f t h e h e a r t ) , n e g a t i v e i n o t r o p i c a c t i v i t y ( < r a t e o f S A n ode discharge, > recovery time), slows conduction of AV node, < HR, < O2 consumption in myocardium; also < renin-aldosterone-angiotensin system at hi doses, inhibits B2 receptors in bronchial system at higher doses.
Uses: mild to moderate HTN, prophylaxis of angina pectoris, suspected or known MI (IV)
Dosage: Adult: IV 5mg, repeat 10 min if initial dose well tolerated, then start PO dose 10 min after last IV dose. Adult: PO 50mg qd, increasingq 1-2wk to 100mg qd; may increase to 200mg qd for angina. Elderly: PO 25mg/day initially. Renal disease: Adult- PO CCr 15-35 ml/min, max 50mg/day; CCr <15 ml/min max, dose 50mg qod; hemodialysis 25-50 mg after dialysis. MI-Renal dose: Adult- IV 5mg, then 5mg over 10 min, then after 10 min, give PO dose.
SE: profound HypoTN, bradycardia, CHF, cold extremities, postural HypoTN, 2nd or 3rd degree heartblock, insomnia, fatigue, dizziness, mental changes, nausea, diarrhea, mesenteric arterial thrombosis, ischemic colitis, agranulocytosis, thrombocytopenia, purpura, bronchospasm
Contra: cardiogenic shock, 2nd or 3rd degree heart block, sinus bradycardia, cardiac failure
Precautions: major surgery, diabetes, renal, thyroid, CHF, COPD, asthma, well-compensated heart failure
Interactions: > HypoTN, bradycardia: reserpine, hydralazine, methyldopa, prazosin, antichlinergics, digoxin, diltiazem, verapamil, cardiac glycosides, antiHTN's; >hypoglycemic effect: insulin, oral antidiabetics; mutual inhibition: sympathomimetics(cough, cold preps)
Pharmacokinetics: IV onset rapid, pk 5 mins, duration UK; PO pk2-4 hr, onset 1 hr duration 24 hr; T╜ 6-9hr, excrete unchanged in urine, 5-15% protein bound. HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0333.html" Generic, Tenormin5 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0231.html" Amoxicillin
Class: antiinfective, antiulcer; aminopenicillin
Action: interferes with cell wall replication of susceptible organisms; the cell wall, rendered osmotically unstable, swells and bursts from osmotic pressure.
Uses: Tx skin, respiratory, GI, GU infections; otitis media, gonorrhea
Dosage: systemic infx: Adult-PO 750mg-1.5g qd in divided doses q8h; Child- PO 20-50 mg/kg/day in divided doses q8h; Renal disease: Adult- PO CCr 10-50ml/min dose q 12 h; CCr <10ml/min dose q24h; gonorrhea/UTI: Adult- PO 3g given w/ 1g probenecid as a single dose, followed by TPN or erythromycin therapy; chlamydia trachomatis: Adult- PO 500mg/day x 1wk; bacterial endocarditis prophylaxis: Child- PO 50mg/kg/h before and 25 mg/kg 6h after procedure; helicobacter pylori: Adult- 1000mg bid, given w/ lansoprazole 30mg bid, clarithromycin 500mg bid x 2 wk or 1000mg bid given w/ omeprazole 20mg bid, clarithromycin 500mg bid x wk, or 1000mg tid given w/ lansoprazole 30mg tid x 2wk
SE: bone marrow depression, granulocytopenia, nausea, vomiting, diarrhea, pseudomembranous colitis, seizures, anaphylaxis, respiratory distress, serum sickness, uticaria, rash
Precautions: hypersensitivity to chephalosporins, neonates, renal disease
Interactions: > amox level: probenecid, < effectiveness of oral contraceptives, > anticoagulant action: warfain (Coumadin), delayed or reduced absorption: Khat so separate by 2hr
Pharmacokinetics: PO pk 2h, duration 6-8h, T╜ 1-1 1/3 h HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0231.html" Generic, Amoxil, Trimox 6 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1197.html" Estrogens; Conjugated Tablets
Class: estrogen, hormone
Action: needed for adequate fx female reproductive sys; affects release of pituitary gonadotropins, inhibits ovulation, adequate Ca+ use in bone.
Uses: menopausal sx, inoperable breast cancer, prostatic cancer, abnormal uterine bleeding, hypogonadism, primary ovarian failure, prevention of osteoporosis
Dosage: Menopause: PO 0.3-1.25mg qd 3wk on, 1wk off; prevention of osteoporosis: PO 0.625mg qd or in cycle; atrophic vaginitis: Vag Cream 2-4g ml qd x 21 days, off for 7 days, repeat; prostatic cancer: PO 1.25-2.5mg tid; breast cancer: PO 10mg tid x 3mo or longer; abnormal uterine bleeding IV/IM 25mg, repeat in 6-12hr; castration/primary ovarian failure: PO 1.25mg qd 3 wk on, 1wk off; hypogonadism PO 2.5mg bid-tid x 20 days/mo
SE: seizures, thromboembolism, stroke, pulmonary embolism, MI, nausea, cholestatic jaundice, hepatic adenoma, gynecomastia, testicular atrophy, impotence, > risk breast cancer, endometrial cancer
Contra: breast cancer, thromboembolic disorders, reproductive cancer, genital bleeding, pregnancy, lactation
Precautions: HTN, asthma, blood dyscrasias, gallbladder disease, CHF, diabetes, bone disease, depression, migraines, convulsive disorders, hepatic, renal, family hx of cancer of breast or repro tract, smoking
Interactions: May need to increase thyroxine dose; >toxicity: cyclosporine, dantrolene, < action of anticoagulants, oral hypoglycemics, tamoxifen; < action of estrogens: anticonvulsants, barbiturates, phenylbutazone, rifampin; >action of corticosteroids; > estrogen level: grapefruit juice. HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1197.html" Premarin Tablets7 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1342.html" Furosemide Oral
Class: loop diuretic; sulfonamide derivative
Action: inhibits reabsorption of Na+ and chloride at proximal and distal tubule and in the loop of Henle.
Uses: pulmonary edema; edema in CHF, liver disease, nephritic syndrome, ascites, HTN
Dosage: Adult- PO 20-80 mg/day in am; may give another dose in 6hr up to 600mg/day; IM/IV 20-40mg, increased by 20mg q2hr until desired response. Child- PO/IM/IV 2mg/kg; may increase by 1-2mg/kg/q6-8hr up to 6mg/kg. Pulmonary edema- IV 40mg given over several min, repeated in 1 hr; increase to 80mg if needed. Hypertensive crisis/acute renal failure: IV 100-200mg over 1-2min. Antihypercalcemia: Adult- IM/IV 80-100mg q 1-4hr or PO 120mg qd or divided bid; Child- IM/IV 25-50mg, repeat q4hr if needed
SE: circulatory collapse, ototoxicity, hypokalemia, hypochloremic alkalosis, hypomagnesemia, hyperuricemia, hypocalcemia, hyponatremia, hyperglycemia, nausea, polyuria, renal failure, thrombocytopenia, agranulocytosis, leukopenia, neutropenia, anemia, rash, pruritis, Stevens-Johnson syndrome
Contra: hypersensitivity to sulfonamides, anuria, hypovolemia, infants, electrolyte depletion
Precautions: diabetes, dehydration, severe renal disease, cirrhosis, ascites
Interactions: > toxicity: lithium, nondepolarizing skeletal muscle relaxants, digitalis; > hypotensive action of antiHTN, nitrates; > ototoxicity: aminoglycosides, cisplatin, vancomycin
Pharmacokinetics: PO onset 1 hr pk 1-2hr, duration 6-8hr; absorbed 70%. IV onset 5min pk ╜ hr, duration 2hr (metab by liver 30%). Excreted in urine, some as unchanged drug, feces; T╜ 1hr HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1342.html" Generic, Lasix8 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3072.html" Amlodipine
Class: antianginal, antiHTN, Ca+ channel blocker
Action: inhibits Ca+ influx during depolarization, relaxes
Coronary muscle, dilates coronary arteries; Relaxing the muscles lining the arteries of the rest of the body lowers the blood pressure, which reduces the burden on the heart. Reducing burden lessens the heart muscle's demand for oxygen, and further helps to prevent angina
Dosage: Angina- PO 5-10mg qd; HTN PO 2.5-5mg qd initially,
Max 10mg/day SE: most common-headache and edema(swelling) of lower extremities. Less common- dizziness, flushing, fatigue, nausea, palpitations
Contra: sick sinus syndrome, 2nd-3rd degree heart block, HypoTN< 90mmHg systolic
Precautions:CHF, HypoTN, hepatic injury, renal, elderly
Interactions: high Na diet, grapefruit juice; >HypoTN: alcohol, fentanyl, quinidine, antiHTN, nitrates; neurotoxicity: lithium; < antiHTN effect: NSAIDS
Pharmacokinetics: Onset ?; pk 6-12h, T╜ 30-50h, >95% protein bound. HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3072.html" Norvasc9 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/T o p _ 2 0 0 / D r u g s / e 0 1 1 5 . h t m l " A l b u t e r o l A e r o s o l
C l a s s : a d r e n e r g i c bЁ2 a g o n i s t , s y m p a t h o m i m e e t i c , b r o n c h o d i l a t o r
A c t i o n : b r o n c h o d i l a t i o n b y a c t i o n o n bЁ2 ( p u l m o n a r y ) r e c e p t o r s b y i n c r e a s i n g l e v e l s o f c a m p , w h i c h r e l a x e s s m o o t h m u s c l e ; p r o d u c e s b r o n c h o d i l a t i o n , C NS, cardiac stimulation, as well as > diuresis and gastric acid secretion; longer acting than isoproterenol
Uses: prevention of exercise-induced asthma, acute bronchospasm, bronchitis, emphysema, bronchiectasis, or other reversible airway obstruction
Dosage: exercise-induced bronchospasm: Adult: INH (metered dose inhaler) 2 puffs 15mins before exercising. Other resp conditions: adult and child> 12 yr: INH 2 puffs q4hr; PO 2-4mg tid-qid, not to exceed 8mg; Volmax XR 8mg q12h; Repetabs4-8mg q12h; NEB/IPPB 2.5mg tid-qid. Geriatric: PO 2mg tid-qid, may increase gradually to 8mg tid-qid. Child 2-12yr: INH 0.1mg/kg tid (max2.5mg tid-qid); NEB/IPPB 0.1-0.15mg/kg/dose tid-qid or 1.25mg tid-qid for child 10-15kg or 2.5mg tid-qid15kg. Adult and child>4yr: INH CAP (Rotohaler inhalation) 200mcg cap inhaledq4-6hr; may use 15min before exercise
SE: tremors, anxiety, restlessness, bronchospasm
Contra: hypersensitivity to sympathomimetics, tachydysrhythmias, severe cardiac disease, heart block
Precautions: cardiac disorders, hyperthyroidism, diabetes, HTN, prostatic hypertrophy, narrow-angle glaucoma, seizures, exercise-induced bronchospasm (aerosol) in children <12yrs
Interactions: > action of aerosol bronchodilators, >action of albuterol: tricyclic antidepressants, MAOI's, other adrenergics; do not use together. May inhibit action of abluterol: other bЁ- b l o c k e r s . S e v e r e H y p o T N : o x y t o x i c s . T o x i c i t y : t h e o p h y l l i n e . E C G c h a n g e s / h y p o k a l e m i a : K + - l o s i n g d i r u r e t i c s . > s t i m u l a t i o n : e p h e d r a , c a f f e i n e ( c o l a n u t , g r e e n / b l a c k t e a , g u a r a n a , m a t e , c o f f e e , c h o c o l a t e ) .
P h a r m a c o k i n e t i c s : w e l l a b s o r b e d P O , e x t e n s i v e l y m e t a b olized in liver and tissues, crosses bld brain barrier. PO onset ╜ h, pk 2 ╜ hr, duration 4-6h, T ╜ 2 ╜ h. PO-XR onset ╜ h; pk 2-3h; duration 12h. INH: onset 5min, pk 1-1 ╜ h, duration 4-6h, T ╜ 4h HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0115.html" Generic10 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0140.html" Alprazolam
Class: antianxiety; benzodiazepine; schedule IV
Action: depresses subcortical levels of CNS, including limbic system, reticular formation
Uses: anxiety, panic disorders, anxiety with depressive sx
Dosage: anxiety disorder: PO 0.25-0.5mg tid, not to exceed 4mg/day in divided doses. Elderly: PO 0.125-0.25 mg bid; increase by 0.125 as needed. Panic disorder: PO 0.5 mg tid may increase, max 10mg/day. Premenstrual dysphoric disorders: PO 0.25mg bid-qid, starting on day 16-18 of menses, taper over 2-3 days when menses occurs. Social phobia: PO 2-8mg/day. Hepatic dose: reduce by 50%
SE: dizziness, drowsiness, orthostatic HypoTN, ECG changes, tachycardia, blurred vision
Contra: hypersensitivity to benzodiazepines, narrow-angle glaucoma, psychosis, addiction
Precautions: elderly, debilitated, hepatic
Interactions: < sedation: xanthines. < alprazolam action: cimetidene, disulfiram, erythromycin, fluoxetine, isoniazid, ketoconazole, metoprolol, propoxyphene, propanolol, valproic acid. > CNS depression: anticonvulsants, alcholol, antihistamines, sedative/hypnotics, valerian, chamomile, hops, skullcap, cat's claw, kava, Echinacea, golden-seal, licorice, St. John's Wort, wild cherry. < action of levodopa. > drug level with grapefruit juice.
Pharmacokinetics: PO onset 30min, pk 1-2 h, duration 4-6h, therapeutic response 2-3 days; excreted by kidneys, T ╜ 12-15h HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0140.html" Generic, Xanax11 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1456.html" Hydrochlorothiazide
Class: thiazide diuretic, antiHTN; sulfonamide derivative
Action: acts on distal tubule and ascending limb of loop of Henle by > excretion of water, Na+, chloride, K+
Uses: edema, HTN, diuresis, CHF, edema in corticosteriod, estrogen, NSAIDS, idiopathic lower extremity edema therapy
Dosage: Adult-PO 25-100 mg/day; Geriatric PO 12.5mg/day, initially; Child >6mo: PO up to 2mg/kg/day in divided doses; child <6mos PO up to 4mg/kg/day in divided doses
SE: urinary frequency, uremia, glucosuria, dizziness, fatigue, weakness, nausea, vomiting, anorexia, hepatitis, rash, hyperglycemia, hyperuricemia, aplastic anemia, hemolytic anemia, leukopenia, agranulcytosis, thrombocytopenia, neutropenia, hypokalemia
Contra: anuria, renal decompensation, hypomagnesemia
Precautions: hypokalemia, renal, hepatic, gout, COPD, LE, diabetes, hyperlipidemia, CCr<25ml/min
Interactions: > toxicity of lithium, nondepolarizing skeletal muscle relaxants, cardiac glucosides. < effects of antidiabetics. < absorption of thiazides: cholestyramine, colestipol. >risk of renal failure: NSAIDS. Hyperglycemia: glucocorticoids, amphotericin B. > effects: loop diuretics. K+ deficiency: aloe, buckthorn bark/bery, cascara sagrada bark, licorice root, senns pod/leaf. > effect: ginkgo
Pharmacokinetics: PO onset 2 h, pk 4h, duration 6-12h, T╜ 6-15h, excreted unchanged by kidneys HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1456.html" Generic, HydroDiuril12 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3087.html" Sertraline
Class: antidepressant; SSRI
Action: inhibits serotonin reuptake in CNS; >action of seotonin; does not affect dopamine, norepinephrine
Dosage: Adult-PO 50mg qd; may > to max of 200mg/day; do not change dose at intervals of <1/wk; administer qd in am or pm; or 100mg 3 x/wk (off-label). Geriatric: PO 25mg qd, >by 25mg q3days to desired dose. Child 6-12 yr: PO 25mg qd. Child 13-17yr PO 50mg qd.
Uses: major depression, OCD, PTSD, panic disorder
SE: insomnia, agitation, somnolence, dizziness, headache, tremor, fatigue, male sex dysfx, diarrhea, nausea, constipation, anorexia, dry mouth, vomiting, flatulence
Contra: pimozide
Precautions: elderly, hepatic, renal, epilepsy, recent MI
Interactions: > effects of: antidepressants (tricyclics), diazepam, tobutamide, warfarin, benzodiapzepines, sumatriptan. Fatal reactions: MAOI's. > sertraline levels: cimetidine, warfarin, other highly protein bound drugs. Altered lithium levels: lithium. Sertraline in contraindicated with pimozide. Potentiation of SSRI, serotonin syndrome: St. John's Wort, SAM-e; do not use together.
Pharmacokinetics: PO pk 4.5-8.4h; steady state 1 wk; 99%plasma protein bound, T ╜ 1-4days, extensively metabolized, metabolite excreted in urine, bile HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3087.html" Zoloft13 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3130.html" Paroxetine
Class: antidepressant; SSRI
Action: inhibits CNS neuron uptake of serotonin but not of norepinephrine or dopamine
Uses: major depressive disorder, OCD, panic disorder, generalized anxiety disorder
Dosage: PO 20mg qd inam; after 4 wk if no improvement may > by 10mg/day q wk to desired response, max 60mg/day or controlled releases 25mg/day weekly up to 62.5mg/day. Geriatric start at 10mg/day, max 40mg/day. Renal:10mg/day in am, may increase to max 50mg/day. OCD: PO 40mg/day, start w/ 20mg/day, > 10mg/day increments max 60mg/day. Panic disorder: PO 40mg/day start w/ 10mg/day > 10mg/day increments, max 60mg/day or controlled release 12.5 mg/day, max 75mg/day SE: upset stomach, drowsiness, weakness or tiredness, excitement or anxiety, insomnia, nightmares, dry mouth, changes in appetite or weight
Contra: MAOI's
Precautions: children, elderly, seizure hx, pts w/ hx of mania, renal, hepatic disease
Interactions: > bleeding w/ warfarin. No MAOI's, potentially fatal reaction. Cimetidine > paroxetine plasma levels. > agitation: L-tryptophan. Phnobarbital and phytoin SE's: highly protein bound drugs. Paroxetine may < digoxin levels. > theophylline levels: theophylline. Possible serotonin syndrome: SAM-e, St. John's Wort.
Pharmacokinetics: PO pk5.2h, unchanged drugs and metabolites excreted in feces and urine; T ╜ 21h; 95% protein bound. HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3130.html" Paxil14 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0081.html" APAP/Propoxyphene-N
Class: opiate analgesic; synthetic opiate
Action: depresses pain impulse transmission at the spinal cord level by interacting with opioid receptors
Uses: mild to moderate pain
Dosage: PO 65mg q4h prn (HCl); PO 100mg q4h prn (napsylate)
SE: drowsiness, dizziness, confusion, headache, sedation, seizures, hyperthermia(elderlyl), nausea, vomiting, anorexia, constipation, cramps, rash, dysrhythmias, respiratory depression
Contra: addiction
Precautions: addictive personality, > intracranial pressure, acute MI, severe heart disease, respiratory depression, hepatic, renal, <18 yrs., elderly
Interactions: possible fatal: MAOI's; > effects c other CNS depressants- alcohol, opioids, sedative/hypnotics, antipsychotics, skeletal muscle relaxants; > CNS depression c chamomile, hops, kava, skullcap, valerian
Pharmacokinetics: PO onset ╜- 1h, pk 2-2 ╜h, duration 4-6h. T 1/2 6-12h HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0081.html" Generic, Darvon15 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3066.html" Azithromycin
Class: antiinfective; macrolide
Action: binds to 50S ribosomal subunits of susceptible bacteria and suppresses protein synthesis; much greater spectrum of activity than erythromycin.\
Uses: mild to moderate infx; upper resp, lower resp, uncomplicated skin infx, urethritis & cervicitis d/t chalmydia trachomatis, acute otitis media, tonsillitis, commuhity acquired pneumonia, mycobacterium avium complex (MAC [HIV related])
Dosage: most infx: Adult ЦPO 500mg/day on day 1, then 250mg qd on days 2-5 for a total dose of 1.5g. Child2-15yr- PO 10mg/kg on day 1, then 5mg/kg x 4 days. Cervicitis, chlamydia, chancroid 1g single dose, gonorrhea 2g single dose. Pelvic inflammatory disease PO/IV 500mg IV q24hr x 2 doses, then 500mg PO q24hr x 7-10 days. MAC PO 600mg/day in combination w/ ethambutol. Pneumonia PO/IV 500mg/ IV q24h x 2 doses, then 500mg PO q 24h x 7-10days. Endocarditis prophylaxis Adult: PO 500mg 1 hr prior to procedure. Child Po 15mg/kg 1 h prior to procedure.
SE: nausea, vomiting, diarrhea, hepatotoxicity, cholestatic jaundice, pseudomembranous colitis, angioedema
Contra: hypersensitivity to azithromycin, erythromycin, or any macrolide
Precautions: hepatic, renal, cardiac disease; elderly, <6mos for otitis, <2yr for pharyngitis, tonsillitis
Interactions: toxicity: ergotamine. >effects of oral anticoagulants, digoxin, theophylline, methylprednisolone, cyclosporine, bromocriptine, disopyramide, triazolam, carbamazepine, phenytoin. < clearance of triazolam. Dysrhythmias: astemizole, pimozide Ц fatal reaction. < absorption of azithromycin: aluminum, magnesium antacids.
Pharmacokinetics: PO Pk 2-4h, duration 24h, IV pk end of infx, duration 24h; T ╜ 11-57h, excreted in bile, feces, urine primarily as unchanged drug HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3066.html" Zithromax Z-Pak16 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0698.html" Cephalexin
Class: antiinfective, 1st generation cephalosporin
Action: inhibits bacterial cell wall synthesis, rendering cell wall osmotically unstable, leading to cell death by binding to cell wall membrane.
Dosage: moderate infx: Adult: Po 250-500mg q6h, Child: Po 25-50mg/kg/day in 4 equal doses. Moderate skin infections: Adult ЦPO 500mg q12h. Endocarditis prophylaxis 2g 1 h before procedure. Severe infx: Adult PO 500mg Ц1g q6h; Child PO 50-100 mg/kg/day in 4 equal doses
SE: seizures (high doses), diarrhea, anorexia, pseudomembranous colitis, nephrotoxicity, renal failure, leukopenia, thrombocytopenia, agranulocytosis, neutropenia, lymphocytosis, eosinophilia, pancytopenia, hemolytic anemia, anaphylaxis, serum sickness
Contra: infants <1mo
Precautions: hypersensitivity to pcn's, renal
Interactions: > toxicity: aminoglycosides, loop diuretics, probenecid
Pharmacokinetics: pk 1 hr, duration 6-12h, T ╜ 30-72 min, 5-15% plasma protein bound HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0698.html" Generic, Keflex17 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3088.html" Simvastatin
Class: antilipidemic; HMG-CoA reductase inhibitor
Action: inhibits HMG-CoA reductase enzyme, which reduces cholesterol synthesis
Dosage: PO 5-10mg qd in pm initially; usual range 5-40mg/day qd in pm, not to exceed 80mg/day ; dosage adjustments may be made in 4wk intervals or more. Elderly/renal PO 5mg/day
SE: liver dysfx, myositis, rhabdomyolysis
Contra: active liver disease
Precautions: past liver disease, alcoholism, severe acute infx, trauma, HypoTN, uncontrolled seizure disorders, severe metabolic disorders, electrolyte imbalances
Interactions: > effects of warfarin. > myalgia, myositis: cyclosporine, gemfibrozil, niacin, erythromycin, clofibrate, clarithromycin, itraconazole, protease inhibitors. > serum level of digoxin
Pharmacokinetics: pk 1.5-2h, highly protein bound, excreted primarily in bile, feces (60%) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3088.html" Zocor18 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3230.html" Lansoprazole
Class: antiulcer, proton pump inhibitor; benzimidazole
Action: suppresses gastric secretion by inhibiting H/K+ ATPase enzyme system in gastric parietal cell; characterized as gastric acid pump inhibitor, since it blocks final step of acid production
Uses: GERD, pathologic hypersecretory conditions (Zollinger-Ellison syndrome, systemic mastocytosis, multiple endocrine ademosas); ulcers
Dosage: NG tube: use intact granules mixed in 40ml of apple juice and injected thru NG tube, then flush c apple juice. Duodenal ulcer: PO 15mg qd before eating for 4 wk then 15mg qd to maintain healing of ulcers; associated c helibacter pylori Ц 30mg + 500mg clarithromycin, 1g amoxicillan bid x14days or 30mg + 1g amoxicillan x 14d. Erosive esophagitis: PO 30mg qd before eating for up to 8wk, may use another 8 wk course if needed. Hypersecretory conditions: PO 60mg qd up to 90mg bid
SE: constipation, diarrhea, CVA, MI, shock, hematuria, hemolysis
Interactions: delayed absorption of lansoprazole: sucralfate. May be < absorption of ketoconazole, itraconazole, ampicilling, iron, digoxin
Pharmacokinetics: absorption after granules leave stomach- rapid; plasma T╜ 1.5h, 97%protein bound, clearance < in elderly, renal and hepatic impairment HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3230.html" Prevacid19 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1520.html" Ibuprofen
Class: NSAID, antipyretic, non-opioid analgesic; propionic acid derivative
Action: inhibits prostaglandin synthesis by < enzyme needed for biosynthesis; analgesic, anti-inflammatory, antipyretic
Uses: rheumatoid arthritis, osteoarthritis, primary dysmenorrhea, gout, dental pain, musculoskeletal disorder, fever
Dosage: Analgesic: PO 200-400mg q4-6h no to exceed 3.2g/day. Child: Po 4-10mg/kg/dose q6-8h. Antipyretic: child 6mo-12yr: PO 5mg/kg (temp <102.5F or 39.2C), 10mg/kg, (temp > 102.5), may repeat q4-6h, max 40mg/kg/day. Anitinflammatory: PO 300-800mg tid-qid, max 3.2g/d. Child PO 30-40 mg/kg/day in 3-4 divided doses, max 50mg/kg/day.
SE: headache, nausea, anorexia, hepatitis, GI bleeding, nephrotoxicity, blood dyscrasias, anaphylaxis
Contra: asthma, severe renal or hepatic
Precautions: bleeding disorders, GI disorders, cardiac disorders, elderly, CHF, CCr<25 ml/min
Interactions: < effect of: antiHTN, thiazides, furosemide. < ibuprofen action: aspirin. > risk of bleeding cefamandole, cefotetan, cefoperazone, valproic acid, thrombolytics, antiplatelets, warfarin. > possibility of blood dyscrasias: antineoplastics, radiation. > toxicity: digoxin, lithium, oral anticoagulants, cyclosporin, probenecid. > GI reactions: aspirin, corticosteroids, NSAIDS, alcohol. > hypoglycemia: oral antidiabetics, insulin. > risk of bleeding: arnica, chamomile, clove, dong quai, fenugreek, feverfew, garlic, ginger, ginkgo, ginseng (Panax)
Pharmacokinetics: well absorbed PO. Onset .5h, pk 1-2h, T╜ 2-4h, 90-99%plasma protein binding, does not enter breast milk HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1520.html" Generic, Advil,
Motrin20 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3427.html" Celecoxib (NSAID, antirheumatic; COX 2 inhibitor for arthritis, etc.) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3427.html" Celebrex21 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1465.html" HCTZ/Triamterene
Class: K+ sparing diuretic, pteridine derivative
Action: acts of distal tubule to inhibit reabsorption of Na+, chloride; > K+ retention
Uses: Edema, may be used c other diuretics; HTN
Dosage: PO 100mg bid pc, not to exceed 300mg/day. Geriatric: PO 50mg qd, max 100mg/day
SE: nausea, diarrhea, vomiting, liver disease, thrombocytopenia, megaloblastic anemia, azotemia, interstitial nephritis, > BUN, creatinine
Contra: anuria, severe renal or hepatic disease, hyperkalemia
Precautions: dehydration, hepatic, renal, CHF, cirrhosis
Interactions: nephrotxic: indomethacin, enhanced action of antiHTN- amantadine. > hyperkalemia: other K+ sparing diuretics, K+ products, ACE inhibitors, salt substitutes. < renal clearance of triamterene: cimetidene
Pharmacokinetics: PO onset 2 h, pk 6-8h, duration12-16h, T ╜ 3h HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1465.html" Generic, Dyrenium22 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1612.html" Levothyroxine (see #3) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1612.html" Levoxyl23 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3270.html" Ethinyl Estradiol/Norgestimate (oral contraceptive) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3270.html" Ortho Tri-Cyclen24 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3294.html" Fexofenadine (antihistamine for allergies) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3294.html" Allegra25 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e2109.html" Prednisone Oral (corticosteroid for inflammation,immunosuppression, neoplasm, MS, collagen disorders, dermatologic disorders) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e2109.html" Generic26 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1801.html" Metoprolol Succinate
Class: antiHTN, antianginal. bЁ1 - b l o c k e r
A c t i o n : l o w e r s b f b y b - b l o c k i n g e f f e c t s ; r e d u c e s e l e v a t e d r e n i n p l a s m a l e v e l s ; b l o c k s b 2 a d r e n e r g i c r e c e p t o r s i n b r o c h i a l , v a s c u l a r s m o o t h m u s c l e o n l y a t h i g h d o s e s
U s e s : m i l d t o m o d e r a t e H T N , a c u t e M I t o r e d u c e c a r d i o v a s c u l a r m o r t a l i t y , a n g i n a pectoris, NYHA class II, III heart failure
Dosage: HTN: PO 50mg bid, or 100mgqd; may give up to 200-450mg in divided doses. Ext Rel give qd. Geriatric: Po 25mg/day initially, > weekly as needed. MI early tx: IV Bolus 5mg q2min x 3, then 50mg PO 15 min after last dose and q6h x 48h; late tx PO maintenance 100 mg bid for 3 mos. Angina PO 100mg qd, > qwk prn or 100mg ext rel qd.
SE: bradycardia, CHF, palpitations, cardiac arrest, AV block, pulmonary edema, insomnia, dizziness, depression, nausea, vomiting, diarrhea, hiccups, agranulocytosis, eosinophilia, thrombocytopenia, purpura, bronchospasm
Contra: cardiogenic shcok, 2nd, 3rd degree heart blcok, sinus bradycardia, bronchial asthma
Precautions: major surgery, diabetes, renal, thyroid, COPD, heart failure, CAD, nonallergic bronchospasm, hepatic, CHF
Interactions: > HypoTN, bradycardia: reserpine, hydralazine, methyldopa, prazosin, amphetamines, ephedrine, epinephrine, norepinephrine, H2-antagonists. > hypoglycemic effects: insulin oral antidiabetics. Don't use c MAOI's. < antiHTN effect: indomethacin. < effects of dopamine, dobutamine, xanthines. Drug/food: absorption c food.
Pharmacokinetics: PO Pk 2-4h, duration 13-19h, T 1/2 3-4h HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1801.html" Toprol XL, Lopressor27 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0051.html" APAP/Codeine (opiate analgesic, antitussive for moderate-severe pain, cough) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0051.html" Generic28 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3408.html" Citalopram (antidepressant; SSRI for major depressive disorder) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3408.html" Celexa29 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1916.html" Omeprazole (antiulcer, proton pump inhibitor for GERD, ulcers, etc.) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1916.html" Prilosec30 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1320.html" Fluoxetine
Class: antidepressant, SSRI (selective serotonin reuptake inhibitor)
Action: inhibits CNS neuron uptake of serotonin but not of norepinephrine
Uses: major depressive disorder, OBD, bulimia, Sarafem: PMDD
Dosage: Depression: Adult PO 20mg qd in am; after 4wk if no clinical improvement is noted, dose may be > to 20mg bid in am, pm, not to exceed 80mg/day. Geriatric 10mg/day, > as needed. Child: 5-18yr PO 5-10mg/day, max 20mg/day. PMDD PO 10-20mg qd, may be taken qd week before menses.
SE: headache, nervousness, insomnia, drowsiness, anxiety, tremor, dizziness, fatigue, sedation, poor concentration, abnormal dreams, agitation, seizures, nausea, diarrhea, dry mouth, anorexia, dyspepsia, constipation, cramps, vomiting, taste changes, flatulence, < appetitie, sweating, rash, pruritis, resp infx, pharyngitis, nasal congestion, sinus headache, sinusitis, cough, dyspnea, bronchitis, hot flashes, palpitations, hemorrhage, tachycardisa, bradycardia, MI, thrombophlebitis, dysmenorrhea, < libido, urinary frequency, UTI, asthenia, viral infx, fever, allergy, chills
Precautions: diabetes
Interactions: No MAOI's with or 14 days prior. St. John's Wort: Do not use together.
> SE: highly protein bound drugs. > effect: haloperidol. < fluoxetine effect: cyproheptadine. > T ╜ of diazepam. > levels or toxicity of carbamazepine, lithium, digoxin, warfarin, pheytoin. > leels of tricyclics, phenothiazines. Paradoxical worsening of OCD: buspirone. > CNS depression: alcohol, antidepressants, opioids, sedatives. > action c kava.
Pharmacokinetics: PO pk 6-8h, terminal T ╜ 2-3days, steady state 28-35 days, 94% protein bound HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1320.html" Generic, Prozac31 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3435.html" Rofecoxib
Class: NSAID analgesic, COX-2 inhibitor
Action: may inhibit prostaglandin sythesis by decreasing enzyme needed for biosynthesis; analgesic, anti-inflammatory, antipyretic properties
Dosage: PO 12.5mg/day as a single dose; may > to 25mg if needed. Dysmenorrhea PO 50mg qd, use for < 5 days.
SE: Many common SE's were listed, here are a few: headache, abdominal pain, dyspepsia, diarrhea, nausea, heartburn and water retention, tachycardia, MI, dysrhythmias, GI bleeding, nephrotoxicity, dysuria, hematuria, oligouria, azotemia, blood dyscrasias
Interactions: < effect, > adverse reactions: aspirin, ACE inhibitors. > bleeding: aspirin, others NSAIDS, anticoagulants. < effect of diuretics. > toxicity: lithium, antineoplastics. > adverse reaction: glucocorticosteroids.
Pharmacokinetics: well absorbed, bound to plasma proteins HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3435.html" Vioxx32 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3145.html" Zolpidem
Class: sedative, hypnotic; nonbenzodiazepine. Controlled substance schedule IV.
Action: produces CNS depression at limbic, thalamic, hypothalamic levels of CNS; may be mediated by neurotransmitter GABA; results are sedation, hypnosis, skeletal muscle ralxant, anticonvulsant activity, anciolytic action
Uses: insomnia, short-term tx
Dosage: PO 10mg hs x 7-10days only; total dose should not exceed 10mg
SE: leukopenia, granulocytopenia
Precautions: anemia, hepatic, renal, suicidal, drug abuse, elderly, psychosis, child <18yr, seizure disorder
Interactions:> action of both drugs: alcohol, CNS depressants. > CNS depression: chamomile, hops, kava, skullcap, valerian.
Pharmacokinetics: PO onset 1.5h, t ╜ 2-3h HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3145.html" Ambien33 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3162.html" Cetirizine (antihistamine, 2nd generation peripherally selective for allergies) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3162.html" Zyrtec34 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1801.html" Metoprolol Tartrate (see #26) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1801.html" Generic,
Lorpressor35 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1662.html" Lorazepam
Class: sedative, hypnotic, antianxiety. Benzodiazepine. Controlled substance schedule IV.
Action: potentiates the actions of GABA, esp in system and reticular formation
Uses: anxiety, irritability in psychiatric or organic disorders, preop, insomnia, adjunct in endoscopic procedures
Dosage: Anxiety: Adult PO 2-6mg/day in divided doses, not to exceed 10mg/day. Geriatric: PO 0.5-1mg/day or 0.5-1mg hs. Child PO 0.05mg/kg/dose, q 4-8h. Insomnia: PO 2-4mg hs; only minimally effective after 2wk continuous therapy. Preop: Adult IM 50mcg/kg 2h prior to surgery; IV 44mcg/kg 15-20min prior to surgery. Child IV 0.05mg/kg. Status epilepticus: Neonate IV 0.05mg/kg. Child IV 0.1mg/kg up to 4mg/dose; rectal (off label) 0.05-0.1mg x 2; wait 7 min before giving 2nd dose.
SE: dizziness, drowsiness, orthostatic HTN, ECG changes, tachycardia, apnea, cardiac arrest (IV, rapid), blurred vision
Contra: narrow-angle glaucoma, psychosis, child <12yr, hx of drug abuse, COPD
Precautions: elderly, debilitated, hepatic, renal
Interactions:< effects of lorazepam: valproic acid. > effects of lorazepam? CNS depressants, alcohol, disulfiram, oral contraceptives. Herbal > CNS depression: chamomile, hops, kava, skullcap, valerian
Pharmacokinetics: PO onset.5h, pk 1-6h, duration 24-48hr. IM onset 15-30min, pk 1-1.5h, duration 24-48h. IV onset 5-15min, pk UK, duration 24-48h. HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1662.html" Generic, Ativan36 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3232.html" Alendronate (bone reabsorption inhibitor for osteoporosis) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3232.html" Fosamax37 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3204.html" Metformin
Class: antidiabetic
Action: inhibits hepatic glucose production and > sensitivity of peripheral tissue to insulin
Dosage: PO 500mg bid initially, then > to desired response 1-3g; dosage adjustments q2-3wk or 850mg qd c morning meal c dosage > every other wk, max 2500mg/day, ext rel max 2000mg/day.
SE: headache, weakness, dizziness, drowsiness, agitation, nausea, vomiting, diarrhea, thrombocytopenia, lactic acidosis
Contra: hepatic, creatinine > 1.5mg/ml(males) >1.4(females), CHF, alcoholism, cardiopulmonary disease, hx of lactic acidosis
Precautions: thyroid disease
Interactions: > metformin level: cimetidine, digoxin, morphine, procainamide, quindine, rantidine, triamterene, vancomycin. > hypoglycemia: cimetidine, ca+ channel blockers, corticosteroids, estroens, oral contraceptives, phenothiazines, sympathomimetics, diuretics, thyroid, isoniazid, phenytoin. Do not give c radiologic contrast media; may cause renal failure. Herbal: quinine: > metformin level. Hyperglycemia: glucosamine. Hypoglycemia: chromium, coenzyme Q-10, fenugreek.
Pharmacokinetics: T ╜ 1.5-5h, terminal 6-20h, pk 1-3h HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3204.html" Generic38 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3161.html" Loratadine (antihistamine 2nd generation for seasonal rhinitis) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3161.html" Claritin39 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0231.html" Amoxicillin (see amoxicillin #5) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0231.html" Trimox40 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3400.html" Sildenafil (erectile agent) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3400.html" Viagra41 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e2174.html" Ranitidine (H2-histamine receptor agonist for ulcer, GERD, etc.) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e2174.html" Generic, Zantac42 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0213.html" Amitriptyline (tricyclic antidepressant for major depression) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0213.html" Generic, Elavil43 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0232.html" Amoxicillin/Clavulanate HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0232.html" Augmentin44 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0550.html" Buproprion Sustained-Release
Class: antidepressant, smoking deterrent
Action: inhibits reuptake of dopamine, serotonin, norephinephrine
Dosage: PO 100mg bid initially, then > after 3 days to 100mg tid if needed; may increase after 1 mo to 150 mg tid; SR 150bid, initially 150mg am, > to 300 mg/day if initial dose is tolerated.
SE: headache, agitation, dizziness, akinesia, bradykinesia, confusion, seizures, insomnia, sedation, tremors, dysrhythmias, HTN, tachycardia, complete AV block, nausea, vomiting, dry mouth, constipation, menstrual irregularities, rash, sweating, blurred vision, auditory disturbance, weight loss or gain
Contra: eating disorders, seizure disorders
Precautions: renal, hepatic, recent MI, cranial trauma, seizure disorder
Interactions: > adverse reactions, seizures: levodopa, MAOI's, phenothiazines, antidepressants, benzodiazepines, alcohol, theophylline, systemic steroids. > bupropion toxicity: ritonavir. < bupropion effect: carbamazepine, cimetidine, Phenobarbital, phenytoin. > bupropion level: cimetidine. Herbal: > CNS depression: kava. May > anticholinergic effect: belladonna leaf/root.
Pharmacokinetics: onset 2-4wk, T 1/2 14h, metabolized by liver, steady state 1.5-5wk HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0550.html" Wellbutrin SR, Zyban45 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3175.html" Gabapentin (anticonvulsant) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3175.html" Neurontin46 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3239.html" Estrongens; conjugated/ Medroxyprogesterone (hormone for menopause) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3239.html" Prempro47 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1647.html" Lisinopril
Class: antiHTN, ACE inhibitor
Action: selectively suppresses renin-angiotensin aldosterone system; inhibits ACE, preventing conversion of angiotensin I to angiotensin II
Uses: mild to moderat HTN, adjunctive therapy of systolic CHF, acute MI
Dosage: HTN: PO 10-40mg qd; may > to 80mg qd if required. CHF: PO 5mg initially c diuretics/digitalis, range 5-20mg
SE: proteinuria, renal insufficiency, vertigo, stroke, fatigue, angioedema
Precautions: renal disease, hyperkalemia, renal artery stenosis
Interactions: > hypotensive effect: diuretics, other hypertensives, probenecid, phenothiazines, nitrates, acute alcohol ingestion. < effects of lisinopril: aspirin, indomethacin, NSAIDS. Hyperkalemia: K+salt subs, K+sparing diuretics, K+supplements, cyclosporine. Possible toxicity: lithium, digoxin. > hypersensitivity reactions: allopurinol. Drug/food: hi K+ diet(bananas, OJ, avocados, nuts, spinach) should be avoided, hyperkalemia may result.
Pharmacokinetics: onset 1h, pk6-8h, duration 24h HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1647.html" Generic, Prinivil, Zestril48 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3166.html" Venlafaxine Extended-Release (antidepressant) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3166.html" Effexor XR49 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1647.html" Lisinopril (see #47) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1647.html" Zestril50 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3064.html" Pravastatin (antilipidemic) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3064.html" Pravachol51 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3383.html" Montelukast (bronchodilator for chronic asthma) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3383.html" Singulair52 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0692.html" Esomeprazole (antiulcer, proton pump inhibitor) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0692.html" Nexium53 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e2289.html" Sulfamethoxazole/Trimethoprim (antiinfective for UTI, etc.) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e2289.html" Generic, Gantanol, Urobak54 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0845.html" Clonazepam
Class: anticonvulsant; benzodiazepine derivative
Action: inhibits spike, wave formation in absence seizures (petit mal), < amplitude, frequency, duration, spread of discharge in minor motor seizures.
Dosage: PO not to exceed 1.5mg/day in 3 divided doses; may be increased 0.5-1mg q3d until desired response, not to exceed 20mg/day; rectal 0.02mg/kg.
SE: thrombocytopenia, leukocytosis, eosinophilia, drowsiness, nausea, constipation, > salivation, nystagmus, diplopia, respiratory depression
Contraindications: acute narrow angle glaucoma
Precautions: open angle glaucoma, chronic reps disease, renal, hepatic
Interactions: > CNS depression: alcohol, barbiturates, opiates, antidpressants, other anticonvulsants, general anesthetics, hypnotics, sedatives. < clonazepam effects: carbamazepine, Phenobarbital, phenytoin. Herbal: > CNS depression: kava
Pharmacokinetics: PO Pk 1-2h, T ╜ 18-50h, duration 6-12h HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0845.html" Generic, Klonopin55 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3069.html" Quinapril (ACE inhibitor) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3069.html" Accupril56 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0823.html" Ciprofloxacin Class: broad spectrum antiinfective
Action: interferes c conversion of intermediate DNA fragments into hi-molecular-wt DNA in bacteria; DNA gyrase inhibitor
Dosage: UTI's: PO 250mg q12h; IV 200mg q12h. Complicated/severe UTI's: PO 500mg q12h, IV 400mg q12h. Respiratory, bone, skin, joint, infx: PO 500-750mg q12h; IV 400 mg q12h. Renal disease: CCr<50ml/min PO 250-500mg q12h; CCr 5-29ml/min PO 250-500q18h; IV 200-400mg q1824h
SE: headache, restlessness, seizures, nausea, diarrhea, vomiting, pseudomembranous colitis, rash, anaphylaxis, Stevens-Johnson syndrome
Precautions: renal, epilepsy
Interactions: < absorption of ciproflaxin: antacids containing magnesium, aluminum; zinc, iron, sucralfate, enteral feedings, Ca+. Nephrotoxic: cyclosporine. > serum levels of cipro: probenecid; monitor for toxicity. > levels of: theophylline, warfarin, monitor bld levels. Herbal possible toxicity: yerba mate. Drug/food: >effect of caffeine; < absortption: dairy products, food.
Pharmacokinetics: PO Pk 1h, T 1/2 3-4h HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0823.html" Cipro57 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e2367.html" Trazodone (antidepressant, misc.; triazolopyridine) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e2367.html" Generic, Desyrel, Trialodine58 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1864.html" Naproxen (NSAID for mild-moderate pain, arthritis, dysmenorrhea) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1864.html" Generic, Aleve, Anaprox59 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e2081.html" Potassium Chloride
Class: electrolyte, mineral replacement
Action: needed for adequate transmission of nerve impulses & cardiac ctx, renal fx, intracellular ion maintenance.
Dosage: PO 40-100mEq in divided doses tid-qid; IV 20mEq/hr when diluted to 40 mEq/1000ml, not to exceed 150 mEq/day. Child: PO 2-4mEq/kg/day
SE: cardiac depression, dysrhythmias, arrest, peaking T waves, lowered R and depressed RST, prolonged P-R interval, widened QRS complex, nausea, vomiting, cramps, diarrhea
Contra: severe renal or hemolytic disease, Addison's, hyperkalemia, acute dehydration, extensive tissue breakdown
Precautions: cardiac disease, K+ sparing diruretics, systemic acidosis
Interactions:Kyperkalemia: K+ phosphate IV and products containing Ca+ or magnesium; K+ sparing, diuretic, or other K+ products
Pharmacokinetics: PO excreted by kidneys and in feces, onset about 30 mins. IV immediate onset HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e2081.html" Generic60 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3011.html" Fluticasone (corticosteroid for asthma, allergic rhinitis) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3011.html" Flonase61 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0926.html" Cyclobenzaprine (skeletal muscle relaxant, central acting) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0926.html" Generic, Flexaril62 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e2081.html" Potassium Chloride (see #59) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e2081.html" Klor-Con63 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1138.html" Enalapril (ACE inhibitor for HTN, CHF, l eft ventricular dysfx) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1138.html" Generic, Vasotec64 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e2444.html" Warfarin
Class: anticoagulant
Action: interferes c bld clotting by indirect means; depresses hepatic synthesis of vit K-dependent coagulation factors.
Uses: Pulmonary emboli, DVT, MI, atrial dysrhythmias, postcardiac valve replacement
Dosage: PO/IV 2.5-10mg/day x 3 days, then titrated to prothrombin time or INR qd. Child 0.1 mg/kg/day titrated to INR
SE: diarrhea, hepatitis, hematuria, rash, fever, hemorrhage, agranulocytosis, leukopenia, eosinophilia
Contra: hemophilia, leukemia c bleeding, peptic ulcer, thrombocytopenic purpura, hpatic(severe), severe HTN, subacute bacterial endocarditis, acute nephritis, blood dyscrasias, eclampsia, preeclampsia
Precautions: alcoholism
Interactions: > action of warfarin: allopurinol, chloramphenicol, amiodarone, diflunisal, heparin, steroids, cimetidine, disulfiram, thyroid, glucagons, metronidazole, quinidine, sulindac, sufinpyrazone, sulfonamides, clofibrate, salicylates, ethacrynic acids, indomethacin, mefenamic acid, oxyphenbutazones, phenybutazone, cefamandole, chloral hydrate, cotrimoxazole, erythromycin, quinolone antiinfectives, isoniazid, thrombolytic agents, tricyclics. < action of warfarin: barbiturates, griseofulvin, ethchlorvynol, carbamazepine, rifampin, oral contraceptives, phenytoin, estrogens, vit K, cholestryamine, corticosteroids, mercaptopurine, sucralfate, vit K foods, vit supplements. > toxicity: oral sulfonylureas, phenytoin. Drug/food: grapefruit juice: may > action of oral warfarin. Herbal: > risk of bleeding: bromelain, cinchona, cayenne, feverfew, garlic, dan shen, ginkgo biloba, quinine, ginger, horse chestnut, papain, sweet clover, sweet vernal grass leaves, tonka bean seeds, vanilla leaf, woodruff. < anticoagulation: ginseng, alfalfa, beet root/greens, broccoli flower buds, brussel sprout buds, cabbage leaves, Chinese cabbage leaves, collard leaves, corn silk, stigmas, kale, lettuce, parsely, plantain, shepherd's purse, smart weekd plant, spinach, stinging nettle, turnip leaves, watercress. > metabolism of warfarin: crucifer.
Pharmacokinetics: PO onset12-24h, pk 1.5-3days, duration 3-5days, T ╜ 1.5-2.5days, 99% bound to plasma proteins. HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e2444.html" Generic, Coumadin65 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3313.html" Levofloxacin
Class: antiinfective; fluoroquinolone
Action: interferes c conversion of intermediate DNA fragments into high-molecular-wt DNA in bacteria
Uses: various; sinusitis, bronchitis, community pneumonia, uncomplicated skin infx, complicated UTI, pyelonephritis, etc.
Dosage: IV INF 500mg by slow inf over 1h q24h x 7-14d depending on infx; PO 500mg q24h x 7-14d depending on infx
SE: anaphylaxis, multisystem organ failure, headache, insomnia, seizures, hemolytic anemia, nausea, vomiting, pseudomembranous colitis, photosensitivity, Stevens-Johnson syndrome
Contra: photosensitivity
Interactions: nephrotoxic: cyclosporine. < absorption of levofloxacin: antacids containing aluminum, magnesium; sucralfate, zinc, iron, calcium. Altered bld glucose levels: antidiabetic agents. > CNS stimulation, seizures: NSAIDs, foscarnet. May < clearance of: theophylline, toxicity may result. > risk of bleeding: warfarin. Do not use c magnesium in the same IV line. > toxicity/levels of digoxin, cimetidine.
Pharmacokinetics: T ╜ 6-8h HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3313.html" Levaquin66 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1033.html" Diazepam (antianxiety, anticonvulsant, skeletal muscle relaxant, central acting; benzodiapepine for anxiety, alcohol withdrawal, seizure, preop, etc.) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1033.html" Generic, Valium67 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1301.html" Fluconazole (antifungal) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1301.html" Diflucan68 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1357.html" Glipizide Extended-Release (antidiabetic; 2nd generation sufonylurea) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1357.html" Glucotrol XL69 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3380.html" Clopidogrel (platelet agreegation inhibitor for reducing stroke/MI) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3380.html" Plavix70 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0231.html" Amoxicillin (see #5) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0231.html" Amoxil71 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3467.html" Pantoprazole
Class: proton pump inhibitor; benzimidazole
Action: suppresses gastric secretion by inhibiting H/K+ ATPase enzyme system in gastric parietal cell; characterized as gastric acid pump inhibitor, since it blocks final step of acid production
Uses: GERD, severe erosive esophagitis, pathologic hypersecretory conditions (Zollinger-Ellison syndrome)
Dosage: GERD PO 40mg qd x 8 wk, may repeat course. Erosive esophagitis: IV 40mg qd x 7-10d, PO 40mg qd x 8wk, may repeat. Hypersecretory conditions: IV 80mg q12h; max 240 mg/day.
SE: headache, diarrhea, abdominal pain, rash
Interactions: may > serum levels of pantoprazole: diazepam, phenytoin, flurazepam, triazolam, clarithromycin. Possible > bleeding: warfarin. May delay absorption: sucralfate.
Pharmacokinetics: pk 2.4h, duration>24h, T 1/2 1.5h, 97%protein binding, in elederly elimination rate < HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3467.html" Protonix72 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e2425.html" Verapamil SR (Ca+ channel blocker, antiHTN, antianginal) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_20 0 / D r u g s / e 2 4 2 5 . h t m l " G e n e r i c , C a l a n 7 3 H Y P E R L I N K " h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 5 0 3 . h t m l " F l u t i c a s o n e / S a l m e t e r o l ( c o r t i c o s t e r o i d / bЁ2 a d r e n e r g i c a g o n i s t , b r o n c h o d i l a t o r f o r a s t h m a , a l l e r g i c r h i n i t i s ) H Y P E R L I N K " h t t p : / / www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3503.html" Advair Diskus74 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0664.html" Carisoprodol (skeletal muscle relaxant, central acting for pain, stiffness) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0664.html" Generic, Soma, Vanadom75 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1368.html" Glyburide (antidiabetic; 2nd generation sulfonylurea for stable NIDDM) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1368.html" Generic, Diabeta; Glynase; Micronase76 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1113.html" Doxycycline (tetracycline family antiinfective) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1113.html" Generic77 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3032.html" Ramipril (ACE inhibitor for HTN, CHF post MI, reducing MI/stroke) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3032.html" Altace78 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3320.html" Valsartan (antiHTN; angiotensin II receptor antagonist for HTN) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3320.html" Diovan79 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3212.html" Amlodipine/Benazepril (Ca+channel blocker/ACE inhibitor combo for HTN) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3212.html" Lotrel80 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3106.html" Isosorbide Mononitrate (antianginal,vasodilator - chronic stable angina,CHF) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3106.html" Generic, Imdur, Monoket81 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3066.html" Azithromycin Suspension (see #15) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3066.html" Zithromax Suspension82 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e2444.html" Warfarin Tablets (see #64) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e2444.html" Coumadin Tablets83 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0072.html" APAP/Oxycodone
Class: opiate analgesic; schedule II
Action: inhibits ascending pain pathways in CNS, > pain threshold, alters pain perception
Dosage: PO 10-30mg q4h (5mgq6h for OxyIR, OxyFast- OxyFast Conc. Sol. Is extremely concentrated; do not use interchangeably). Child PO 0.05-0.15mg/kg/dose up to 5mg/dose q4-6h; not recommended in children.
SE: drowsiness, dizziness, confusion, headache, sedation, euphoria, nausea, vomiting, anorexia, constipation, cramps, rash, respiratory depression.
Contra: addiction (opiate)
Precautions: addictive personality, increased intracranial pressure, acute Mi, severe heart disease, respiratory depression, hepatic, renal, child < 18yr.
Interactions: > effect c other CNS depressants: alcohol, opioids, sedative/hypnotics, antipsychotics, skeletal muscle relaxants.
Pharmacokinetics: PO onset 15-30min, pk 1hr, duration4-6h, detoxed by liver. HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0072.html" Generic, Percocet84 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1061.html" Digoxin
Class: cardiac glycoside inotropic, antidysrhythic; digitalis prep
Action: inhibits the Na+-K+ ATPase, which makes more Ca+ available for contractile proteins, resulting in > cardiac output; > force of CTX (+ inotropic effect); < HR (chronotropic effect); < AV conduction speed
Uses: CHF, atrial fib, atrial flutter, atrial tachy, cardiogenic shock, paroxysmal atrial tachy, rapid digitalization in these disorders
Dosage: Adult IV digitalizing dose 0.6-1.0mg given as 50% of the dose initially, additional fractions given at 4-8h intervals; PO digitalizing dose 0.75-1.25mg given as 50% of the dose initially, additional fractions at 4-8h intervals; maintenance 0.063-0.5mg/day(tabs), or 0.350-0.5mg/day(gelatin cap). See drug guide for child.
SE: headache, dysrhythmias, HypoTN, AV block
Contra: ventricular fib, ventricular tach, carotid sinus syndrome, 2nd or 3rd degree heart block
Precautions: renal, acute MI, AV block, severe resp disease, hypothyroidism, elderly, sinus nodal disease, hypokalemia
Interactions: < dig absorption: antacids kaolin/pectin. Hypercalcemia, hypomagnesemia, digitalis toxicity: thiazides, parenteral Ca+. Hypokalemia, digitalis toxicity: diuretics, amphotericin B, carbenicillin, ticarcillin, corticosteroids. < dig level: thyroid agents, cholestryamine, colestipol, metoclopramide. > digoxin bld levels: propantheline, quinidine, verapamil, amiodarone, anticholinergics, diltiazem, nifedipine. > bradycardia: b-adrenergic blockers, antidysrythmics. Herbal: > action: aloe, buckthorn bark/berry, cascara sagrada bark, castor bean oil, May apple root, rhubarb root, senna pod/leaf, yellow dock root, oleander, pheasant's eye, purple foxglove, squill. Dysrhythmias: ephedra. Bradycardia: Indian snakeroot. Cardiac toxicity: hawthorn. Digoxin toxicity: licorice. < digoxin absorption: psyllium. > hypokalemia: cocoa seeds, coffee seeds, cola seeds, guarana seeds, horsetail, licorice, yerba mate.
Pharmacokinetics: PO onset.5-2h, pk 6-8h, duration 3-4days. IV onset 5-30min, pk 1-5h, duration variable. T 1/2 1.5 days. HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1061.html" Lanoxin85 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0115.html" Albuterol Nebulizer Solution (see albuterol #10) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0115.html" Generic86 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1791.html" Methylprednisolone Tablets (corticosteroid- inflammation, shock, adrenal insufficiency, collagen disorders, mgt of acute spinal cord injury) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1791.html" Generic, Solu-Medrol, others87 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3543.html" Desloratadine (2nd generation antihistamine (H1 receptor agonist)- allergies HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3543.html" Clarinex88 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0133.html" Allopurinol (antigout drug) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0133.html" Generic, Zyloprim89 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3053.html" Benazepril (ACE inhibitor for HTN) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3053.html" Lotensin90 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1828.html" Mometasone (corticosteroid for allergies) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1828.html" Nasonex91 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0846.html" Clonidine (antiHTN, centrally acting analgesic for mild-moderate HTN; pain in cancer patients) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0846.html" Generic, Catapres92 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3231.html" Losartan (antiHTN; angiotensin II receptor for HTN, nephropathy in type II diabetes) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3231.html" Cozaar93 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1971.html" Penicillin VK (broad-spectrum antiinfective) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1971.html" Generic94 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1188.html" Estradiol Oral (estrogen hormone for menopause, breast/prostate cancer) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1188.html" Generic95 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3437.html" Rosiglitazone
Class: antidiabetic, oral
Action: improves insulin resistance by hepatic glucose metabolism, insulin receptor kinase activity, insulin receptor phsophorylation
Uses: stable NIDDM, alone or in combo c sufonylureas, metformin, or insulin
Dosage: PO 4mg qd or in 2 divided doses, may > to 8mg qd or in 2 divided doses after 12wk
SE: no common SE's listed. Others: weight gain, accidental injury, URI, sinusitis, anemia, back pain, diarrhea, edema, fatigue, headache, hyper/hypoglycemia.
Contra: diabetic ketoacidosis
Precautions: thyroid disease, hepatic, renal
Interactions: May < effect of: oral contraceptives, alternative method advised. Herbal: hypoglycemia: chromium, coenzyme10, fenugreek. Poor glucose control: glucosamine.
Pharmacokinetics: maximal reduction in FBS after 6-12wk, protein binding 99.8%, elimination T ╜ 3-4h HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3437.html" Avandia96 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3441.html" Pioglitazone (thiazolidinedione antidiabetic for stable NIDDM) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3441.html" Actos97 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1647.html" Lisinopril (ACE inhibitor) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1647.html" Prinivil, Zestril98 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3165.html" Risperidone (antipsychotic for pychotic disorders) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3165.html" Risperdal99 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3240.html" Metformin Extended-Release (antidiabetic) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3240.html" Glucophage XR100 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3011.html" Fluticasone (corticosteroid for asthma, allergic rhinitis) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3011.html" Flovent101 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1712.html" Medroxyprogsterone Tablets (progesterone derivitive hormone for abnormal uterine bleeding, endometrial/renal cancer, contraceptive) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1712.html" Generic, Provera, DepoProvera102 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1331.html" Folic Acid (vit B9 certain anemias, liver disease, alcoholism, hemolysis, intestinal obstruction, pregnancy) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1331.html" Generic103 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3301.html" Olanzapine (antipsychotic, neuroleptic for schizophrenia, acute mania) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3301.html" Zyprexa104 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3442.html" Rabeprazole (antiulcer; proton pump inhibitor for GERD, ulcer, etc.) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3442.html" Aciphex105 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3388.html" Fexofenadine/Pseudoephedrine (antihistamine/adrenergic for allergy/congestion) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3388.html" Allegra-D106 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1061.html" Digoxin (see #84) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1061.html" Digitek107 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3007.html" Doxazosin (peripheral aЁ1 - a d r e n e r g i c b l o c k e r f o r H T N , u r i n a r y f l o w o b s t r u c t i o n , s x o f b e n i g n p r o s t a t i c h y p e r p l a s i a ) H Y P E R L I N K " h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 0 0 7 . h t m l " G e n e r i c , C a r d u r a 1 0 8 H Y P E R L I N K " h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u lt/Top_200/Drugs/e3370.html" Raloxifene (bone resorption inhibitor, selective estrogen receptor modulator for preventing osteoporosis) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3370.html" Evista109 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3299.html" Latanoprost (ophthalmic for open-angle glaucoma, ocular HTN) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3299.html" Xalatan110 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3520.html" HCTZ/Valsartan (antiHTN; angiotensin II receptor agonist for HTN) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3520.html" Diovan HCT111 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1932.html" Oxycodone (see #83) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1932.html" OxyContin, Percocet112 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1790.html" Methylphenidate (cerebral stimulant for ADHD, narcolepsy) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1790.html" Concerta, Ritalin113 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e2125.html" Promethazine Tabs (antihistamine for motion sickness, rhinitis, allergies, sedation, nausea, pre-/postop sedation) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e2125.html" Generic, Phenergan114 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1096.html" Divalproex (anticonvulsant for some seizures, manic episodes, prophylaxis of migraines) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1096.html" Depakote115 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3338.html" Tamsulosin (selective aЁ1 - a d r e n e r g i c b l o c k e r , s x b e n i g n p r o s t a t i c h y p e r p l a s i a ) H Y P E R L I N K " h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 3 3 8 . h t m l " F l o m a x 1 1 6 H Y P E R L I N K " h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 2 3 1 0 . h t m l " T e m a z e p a m ( s e d a t i ve-hypnotic; benzodiazepine for insomnia; schedule IV) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e2310.html" Generic, Restoril117 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3501.html" Glyburide/Metformin (antidiabetic for stable NIDDM) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3501.html" Glucovance118 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3255.html" Tramadol (central analgesic for moderate to severe pain) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3255.html" Ultram119 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3260.html" HCTZ/Losartan (antiHTN; angiotensin II receptor for HTN; see #92) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3260.html" Hyzaar, Cozaar120 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1513.html" Hydroxyzine
Class: antianxiety/antihistamine/sedative-hypnotic, antiemetic; piperazine derivative
Action: depresses subcortical levels of CNS, incl. limbic system, reticular formation; competes c H1-receptor sites
Dosage: PO 25-100mg tid-qid, max 600mg/day. Geriatric: PO 10mg tid-qid (pruritis). Child >6yr: 50-100 mg/day in divided doses. Child <6yr: 50mg/day in divided doses. Preop/postop: IM 25-100mg q4-6h. Child IM 0.5-1.1mg/dk q4-6h. Pruritis: PO 25mg tid-qid. Antiemetic: IM 25-100mg/dose q4-6h.
SE: dizziness, drowsiness, seizures
Contra: acute asthma, hypersensitivity to cetirizine
Precautions: elderly, debitlitated, hepatic, renal, narrow-angle glaucoma, COPD, prostatic hypertrophy
Interactions: > CNS depressant effect: barbiturates, opioids, analgesics, alcohol. > anticholinergic effects: phenothiazines, quinidine, disopyramide, antihistamines, antidepressants, atropine, haloperidol, henbane leaf, jimsonweed, scopolia. > action: chamomile, hops, kava, skullcap, valerian
Pharmacokinetics: PO onset 15-30min, duration 4-6h, T 1/2 3h HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1513.html" Generic, Atarax, Vistaril121 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1803.html" Metronidazole Tabs (antiinfective) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1803.html" Generic, Flagyl122 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1351.html" Gemfibrozil (antilipemic) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1351.html" Generic, Lopid123 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1708.html" Meclizine (antiemetic, antihistamine, anticholinergic for vertigo,motion sick) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1708.html" Generic124 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3214.html" Albuterol/Ipratropium (anticholinergic c beta2-adrenergic agonist to > bronchodilation for chronic bronchitis) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3214.html" Combivent125 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e2371.html" Triamcinolone Acetonide Topical (topical anesthetic for oral pain) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e2371.html" Generic126 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e2269.html" Spironolactone (K+ sparing diruetic for edema of CHF, HTN, moreЕ) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e2269.html" Generic, Aldactone127 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3279.html" Glimepiride (antidiabetic for stable NIDDM) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3279.html" Amaryl128 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3236.html" Loratadine/Pseudoephedrine (antihistamine/decongestant) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3236.html" Claritin D 24 Hr129 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1541.html" Insulin Isophane (Human) (NPH) (Intermediate acting) Class: antidiabetic, pancreatic hormone. Exogenous unmodified insulin.
Action: < blood sugar; by transport of insulin into cells and the conversion of glucose to glycogen, indirectly > blood pyruvate and lactate, < phosphate and K+; processed by recombinant DNA technologies
Dosage: SC dosage individualized b y b l o o d , u r i n e g l u c o s e ; u s u a l d o s e 7 - 2 6 U , m a y > b y 2 - 1 0 U / d a y i f n e e d e d
S E : l i p o d y s t r o p h y , h y p o g l u c e m i a , a n a p h l a x i s
I n t e r a c t i o n s : > h y p o g l y c e m i a : s a l i c y l a t e , a l c o h o l , bЁ b l o c k e r s , a n a b o l i c s t e r o i d s , f e n f l u r a m i n e , p h e n y l b u t a z o n e , s u l f i n p y r a z o n e , g u a n e t h i d i n e, oral hypoglucemics, MAOI's, tetracycline, aceitilla, adiantum agrimony, aloe gel, banana flowers/roots, banya stembark, bilberry, bitter melon, broom, bugleweed, burdock, carob, cumin, damiana, dandelion, eucalyptus, fenugreek, fo-ti, garlic, goat's ru, guar gum, horse chestnut, jambue, juniper, konjac, maitake, onion, psyllium, reishi. < hypoglycemia: thiazides, thyroid hormones, oral contraceptives, corticosteroids, estrogens, dobutamine, epinephrine, annatto, cocoa seed, coffee seeds, cola seeds, guarana, ma huang, mate, rosemary. < or > hypoglycemic effect: chromium.
Pharmacokinetics: onset 1-2h, pk4-12h, duration 18-24h HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1541.html" Humulin N130 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1798.html" Metoclopramide
Class: cholinergic; antiemetic
Action: enhances response to acetylcholine of tissue in upper GI tract, which causes ctx of gastric muscle; relaxes pyloric, duodenal segments; increases peristalsis without stimulating secretions, blocks dopamine in chemoreceptor trigger zone of CNS
Dosage: for nausea: IV 1-2mg/kg 30min before administration of chemotherapy, then q2h x 2 doses, the q3h x 3 doses. Child IV 0.1-0.2mg/kg/dose. For reflux: PO 10-15mg qid 30min ac.
SE: sedation, fatigue, restlessness, headache, sleeplessness, dystonia, suicided ideation, seizures, neutropenia, luekopenia, agranulocytosis
Contras: seizure disorder, pheochromocytoma, prolactin dependant breast cancer, GI obstruction
Interactions: < action of metoclopramide: anticholinergics, opiates. > sedation: alcohol, other CNS depressants. > risk of EPS: haloperidol, phenothiazines. Avoid c MAOI's.
Pharmacokinetics: IV onset 1-3min, duration 1-2h. PO onset .5-1h, duration 1-2h, IM onset 10-15min, duration 1-2h. T 1/2 4h. HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1798.html" Generic, Reglan131 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1612.html" Levothyroxine (see #3) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1612.html" Levothroid132 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3052.html" Fosinopril (antiHTN; ACE inhibitor) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3052.html" Monopril133 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1818.html" Minocycline (tetracycline type broad-spectrum antiinfective) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1818.html" Generic134 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3167.html" Bisoprolol/HCTZ (antiHTN; beta blocker for mild to moderate HTN) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3167.html" Generic, Zebeta135 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3194.html" Fenofibrate (antilipemic) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3194.html" Tricor136 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3240.html" Metformin (see #37) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3240.html" Glucophage137 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3265.html" Valacyclovir (antiviral) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3265.html" Valtrex138 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e2311.html" Terazosin (antiHTN) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e2311.html" Generic, Hytrin139 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1749.html" Metaxalone (muscle relaxant) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1749.html" Skelaxin140 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3162.html" Cetirizine syrup (antihistamine for rhinitis, allergy) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3162.html" Zyrtec Syrup141 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0876.html" Promethazine/Codeine (antihistamine; H1-receptor agonist for motion sickness, rhinitis, allergy, sedation, nausea, pre/postop sedation) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0876.html" Generic, Phenergan 142 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1246.html" Famotidine (H2-histamine receptor agonist for ulcer, GERD) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1246.html" Generic143 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3541.html" Valdecoxib (NSAID, COX-2) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3541.html" Bextra144 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0551.html" Buspirone (antianxiety, sedative) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0551.html" Generic, BuSpar145 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3090.html" Sumatriptan Oral (antimigraine) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3090.html" Imitrex Oral146 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e2135.html" Propranolol (antiHTN, antianginal, antidysrhythmic, beta blocker) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e2135.html" Generic147 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0838.html" Clindamycin Oral (antiinfective; lincomycin derivative) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0838.html" Generic, Cleocin148 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0021.html" APAP/Butalbital/Caffeine (Analgesic, non-narcotic; Barbiturate) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0021.html" Generic, Fioricet149 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1069.html" Diltiazem (Ca+ channel blocker for angina, HTN, etc.) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1069.html" Cartia XT, Cardizem150 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3110.html" Nitrofurantoin/Nitrofurantoin Macrocrystalline (urinary tract antiinfective) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult / T o p _ 2 0 0 / D r u g s / e 3 1 1 0 . h t m l " M a c r o b i d 1 5 1 H Y P E R L I N K " h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 1 5 6 . h t m l " S a l m e t e r o l ( b r o n c h o d i l a t o r ; bЁ2 - a d r e n e r g i c a g o n i s t f o r a s t h m a , C O P D ) H Y P E R L I N K " h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / Top_200/Drugs/e3156.html" Serevent152 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1220.html" Ethinyl Estradiol/Norethindrone (hormone, oral contraceptive) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1220.html" Ortho-Novum 7/7/7153 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0232.html" Amoxicillin/Clavulanate (pcn family antiiinfective) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0232.html" Generic154 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1069.html" Diltiazem CD (Ca+ channel blocker for angina, HTN, etc.) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1069.html" Generic, Cardizem155 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1357.html" Glipizide (antidiabetic; 2nd generation sulfonurea) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1357.html" Generic, Glucotrol156 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3356.html" Irbesartan (antiHTN) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3356.html" Avapro157 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0105.html" Acyclovir (antiviral for herpes, varicella infxs) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0105.html" Generic, Zovirax158 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3102.html" Cefprozil (antiinfective; 2nd generation cephalosporin) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3102.html" Cefzil159 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1886.html" Nifedipine ER (Ca+channel blocker, antianginal, antiHTN) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1886.html" Generic, Procardia160 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3289.html" Amphetamine/Dextroamphetamine (CNS stimulant for ADHD) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3289.html" Adderall XR160 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3359.html" Quetiapine (antipsychotic) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3359.html" Seroquel161 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0642.html" Captopril (antiHTN; ACE inhibitor) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0642.html" Generic, Capoten)162 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3236.html" Loratadine/Pseudoephedrine (2nd generation antihistamine/decongestant) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3236.html" Claritin D 12 Hr163 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3270.html" Ethinyl Estradiol/Norgestimate (hormones; oral contraceptive) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3270.html" Ortho-Cyclen164 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3255.html" Tramadol (see #118) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3255.html" Generic, Ultram165 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e2029.html" Phenytoin Class: anticonvulsant; antidysrhythmic
Action: inhibits spread of seizure activity in motor cortex by altering ion transport; > AV conduction
Dosage: PO 1g or 20mg/kg (ex rel) in 3-4 doses given q2h, or 400mg, then 300mg q2h x 2 doses, maintenance 300-400mg/day, max 600mg/day; IV 15-20mg/dg, max 25-50mg/min, then 100mg q6-8h. Child: PO 5mg/kg/day in 2-3 divided doses, maintenance 4-8mg/kg/day; IV 15-20mg/kg at 1-3 mg/kg/min.
SE: ventricular fib, hepatitis, nephritis, angranulocytosis, leukopenia, aplastic anemia, thrombocytopenia, megaloblastic anemia, lupus erythematosus, Stevens-Johnson syndrome
Contra: psychiatric condition, bradycardia, SA and AV block, Stokes-Adams syndrome, hepatic failure
Precautions: allergies, hepatic, renal, petit mal seizures
Interactions: < effects of phenytoin: alcohol (chronic), antihistamines, antacids, antineoplastics, CNS depressants, rifampin, folic acid. > effects of phenytoin: low plasma albumin levels. Herbal: > K+ loss, > antidysrhythmic action: aloe, buckthorn, cascara sagrada, senna
Pharmacokinetics: PO-ER: onset 2-24h, pk 4-12h, duration 12-36h. IV onset 1-2h, duration 12-24h. PO onset 2-24h, pk 1.5-2.5h, duration 6-12h. Highly protein bound, T ╜ 22h. HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e2029.html" Dilantin Kapseals166 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1219.html" Ethinyl Estradiol/Levonorgestrel (hormones; oral contraceptive) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1219.html" Trivora-28167 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0072.html" APAP/Oxycodone (see #83) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0072.html" Endocet168 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3270.html" Mestranol/Norethindrone (hormones; oral contraceptive) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3270.html" Necon 1/35169 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3528.html" APAP/Tramadol (see#118) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3528.html" Ultracet, Ultram170 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3309.html" Tolterodine Extended-Release (overactive bladder product; muscarinic receptor agonist) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3309.html" Detrol LA171 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1971.html" Penicillin VK (antiinfective) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1971.html" Veetids172 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1843.html" Mupirocin (topical antiinfective) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1843.html" Bactroban173 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e2371.html" Triamcinolone Acetonide (corticosteroid for severe inflammation, immunosupression, neoplasms, asthma, collagen/respiratory/dermatologic disorders) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e2371.html" Nasacort AQ174 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3236.html" Loratadine (antihistamine) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3236.html" Claritin RediTabs175 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1219.html" Ethinyl Estradiol/Levonorgestrel (hormone, oral contraceptive) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1219.html" Aviane176 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3267.html" Carvedilol (antiHTN; alpha/beta-adrenergic blocker for HTN, CHF) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3267.html" Coreg177 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1542.html" Insulin Isophane/Insulin Regular (Human) (see #129) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1542.html" Humulin 70/30178 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1069.html" Diltiazem (Ca+ channel blocker for angina, HTN, etc.) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1069.html" Tiazac, Cardizem179 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3201.html" Budesonide (glucocorticoid; rhinitis, asthma, Crohn's disease) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3201.html" Rhinocort Aqua180 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3293.html" Insulin Lispro (see #129) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3293.html" Humalog181 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1903.html" Nortriptyline (antidepressant, tricyclic) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1903.html" Generic, Aventyl, Pamelor182 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3274.html" Mirtazapine (antidepressant, tetracyclic) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3274.html" Remeron183 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0232.html" Amoxicillin/Clavulanate (antiinfective) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0232.html" Augmentin ES-600184 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e2326.html" Tetracycline Class: broad spectrum antiinfective
Action: inhibits protein synthesis and phosphoylation in microorganisms; bacteriostatic
Dosage: PO 250-500mg q6h. Child > 8y: PO 25-50mg/kg/day in divided doses q6h.
SE: eosinophilia, neutropenia, thrombocytopenia, leukocytosis, hemolytic anemia, nausea, vomiting, diarrhea, hepatotoxicity, increased BUN, rash, uticaria, photosensitivity, > pigmentation, exfoliative dermatitis, angioedema
Contra: children < 8yr
Precautions: renal, hepatic
Interactions:< effect of tetracycline: antacids, NaHCO3, dairy products, alkali products, iron, kaolin/pectin, cimetidine. > effect: warfarin, digoxin. < effect of pcn's, oral contraceptives. Nephrotoxicity: methoxyflurane
Pharmacokinetics: PO pk 2-3h, duration 6h, T ╜ 6-10h, 20-60% protein bound. HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e2326.html" Generic185 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3143.html" Desogestrel/Ethinyl Estradiol (hormones; oral contraceptive) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3143.html" Mircette186 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0466.html" Betamethasone/Clotrimazole (corticosteroid/antifungal) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0466.html" Generic187 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3312.html" Topiramate (anticonvulsant) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3312.html" Topamax188 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3387.html" Risedronate (bone reabsorption inhibitor for Paget's, osteoporosis) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3387.html" Actonel189 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e2306.html" Tamoxifen (antineoplastic for breast cancer) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e2306.html" Generic190 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0299.html" Aspirin; Enteric-Coated
Class: Nonopioid analgesic, NSAID, antipyretic, antiplatelet. Salicylate.
Action: blocks pain impulses in CNS, inhibition of prostaglandin synthesis; antipyretic action results from vasodilation of peripheral vessels, < platelet aggregation
Uses: mild to moderate pain or fever incl. rheumatoid arthritis, osteoarthritis, thromboembolic disorders; transient ischemic attacks, rheumatic fever, postMI, prophylaxis of MI, ischemic stroke, angina
Dosage: Arthritis, Adult: PO 2.6-5.2g/day in divided doses q4-6h. Child PO 90-130mg/kg/day in divided doses q4-6h. Pain, fever: Adult PO/Rect 325-650 mgq4h prn, not to exceed 4g/day. Child PO/Rect 40-100mg/kg/day in divided doses q 4-6h prn. Kawasaki disease: Child PO 80-120mg/kg/day in 4 divided doses, maintainance 3-8mg/kg/day as a single dose x 8 wk. Thromboembolic disorders Po 325-650mg/day or bid. Transient ischemic attacks PO 650mg qid or 325mg qid. Mi, stroke prophylaxis PO 81-650mg/day
SE: thrombocytopenia, agranulocytosis, leukopenia, neurtopenia, hemolytic anemia, seizures, coma, nausea, vomiting, GI bleeding, hepatits, rash, Reye's syndrome(children), anaphylaxis, laryngeal edema
Contra: tartrazine (FDC yellow dye #5), GI bleeding, bleeding disorders, children <12yr, children c flulike sx, vit K deficiency, peptic ulcer
Precautions: anemia, hepatic, renal, Hodgkin's disease, pre/post-op, gastritis, asthmatic ptsc nasal polyps or aspirin sensitivity
Interactions: < effects of aspirin: antacids (hi doses), steroids, urinary alkalizers, corticosteroids. > bleeding: alcohol, heparin, plicamycin, cefamandole, thrombolytics, ticlopidine, clopidogrel, triofiban, eptifibatide. > effects of warfarin, insulin, methotrexate, thrombolytic agents, pcn's, phenytoin, valproic acid, oral hypoglycemics, sulfonamides. > salicylate levels: urinary acidifiers, ammonium chloride, nizatidine. < effects of probenacid, sp i r o n o l a c t o n e , s u l f i n p y r a z o n e , s u l f o n y l a m i d e s , N S A I D S , bЁ- b l o c k e r s . G a s t r i c : s t e r o i d s , a n t i i n f l a m m a t o r i e s , N S A I D S . H e r b a l > r i s k o f b l e e d i n g : h o r s e c h e s t n u t , k e l p w a r e , a n i s e , a r n i c a , c h a m o m i l e c l o v e , f e n u g r e e k , f e v e r - f e w , g a r l i c , g i n g e r , g i n k g o , g i n s e n g ( p anax), licorice. Drug/food: foods acidifying urine may > aspirin level.
Pharmacokinetics: well absorbed PO, T╜ 1-3.5h up to 30h in lg dose; rectal products may be erratic. PO onset 15-30min, pk 1-2h, duration 4-6h. Rect onset slow, duration 4-6h. HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0299.html" Generic191 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3068.html" Clarithromycin Extended-Release (antiinfective, macrolide, aminoglycoside) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3068.html" Biaxin XL192 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3066.html" Azithromycin (antiinfective, aminoglycoside; see #15) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3066.html" Zithromax192 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3366.html" Cefdinir (3rd generation cephalosporin broad-spectrum abx) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3366.html" Omnicef193 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0446.html" Benzonatate (antitussive, nonopioid for nonproductive cough) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e0446.html" Generic, Tessalon Perles194 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1275.html" Ferrous Sulfate (hematinic, mineral replacement: iron) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1275.html" Generic195 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1458.html" HCTZ/Lisinopril (antiHTN) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1458.html" Zestoretic196 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3523.html" Drospirenone/Ethinyl Estradiol (hormone) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3523.html" Yasmin 28197 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3317.html" Olopatadine (ophthalmic antihistamine for allergic conjunctivitis) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3317.html" Patanol198 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1222.html" Ethinyl Estradiol/Norgestrel (hormone) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1222.html" Low-Ogestrel199 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1995.html" Phenazopyridine (nonopioid analgesic (urinary system) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e1995.html" Generic, Pyridium200 HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3068.html" Clarithromycin (antiinfective, macrolide) HYPERLINK "http://www.mosbysdrugconsult.com/DrugConsult/Top_200/Drugs/e3068.html" BiaxinExtra HYPERLINK "http://www.dolasetron.com/" Dolasetron
Class: antiemetic
Action: prevents nausea, vomiting aby blocking serotonin peripherally, centrally, and in the small intestine
Uses: nausea and vomiting caused by cancer chemotherapy, anesthesia, or surgery
Dosage: Adult PO 100mg 1hr prior to chemo. Adult and child 2-16yr: IV 1.8mg/kg as a single dose, ╜ hr prior to chemo. Pre/postop nausea: IV 12.5mg single dose, 15min before cessation of anesthesia, PO 100mg 2 hr before surgery.
SE: diarrhea, headache, bronchospasm, dysrhythmias
Interactions: Dysrhythmias: antidysrhythmics. > dolastetron levels: cimetidine. < dolasetron levels: rifampin.
Pharmacokinetics: UKAnzemetExtra HYPERLINK "http://www.mscontin.com/html/Our_products/Our_products.htm" Morphine
Class: opioid analgesic, Schedule II
Action: depresses pain impulse transmission at the spinal cord level by interacting c opioid receptors
Uses: severe pain
Dosage: SC/IM 4-15mg q4h prn; PO 10-30mg q4h prn; ext rel q8-12h; rect 10-20mg q4h prn; IB 4-10mg diluted in 4-5ml H20 for injection, over 5min.
SE: thrombocytopenia, bradycardia, shock, cardiac arrest, resp depression, resp arrest, apnea
Contra: addiction, hemorrhage, bronchial asthma, > intracranial pressure
Precautions: addictive personality, acute MI, severe heart disease, resp depression, hepatic, renal, child <18yr
Interactions: Unpredictable reaction, avoid use c MAOI's. > effects c other CNS depressants: alcohol, opiates, sedative/hypnotics, antipsychotics, muscle relaxants, < morphine action: rifampin. Herbal: > CNS depression: chamomile, hops, kava, skullcap, valerian. < morphine effects: excessive cranberry juice
Pharmacokinetics: PO onset variable, pk variable, duration variable. IM onset ╜ h, pk .5-1h, duration 3-7h, SC onset 15-20min, pk 50-90 min, duration 3-5h. IV Pk 20min. Rect pk 1/2 Ц1h, duration 4-5h. Intrathecal: onset rapid, duration up to 24h. T 1/2 1.5-2h.MS ContinExtra HYPERLINK "http://www.google.com/search?hl=en&ie=UTF-8&q=acetaminophen&spell=1" Acetaminophen
Class: nonopiod analgesic, antipyretic
Action: may block pain impulses peripherally that occur in response to inhibition of prostaglandin sythesis, not anti-inflammatory, antipyretic action from inhibition of prostaglandins in CNS (hypothalamic heat-regulating center)
Dosage: PO 325-650mg q4h prn, max 4g/day. Child PO 10-15mg/kg q4h
SE: leukopenia, neutropenia, hemolytic anemia (long-term use), thrombocytopenia, pancytopenia, hepatotoxic, hepatic seizure (OD), cyanosis, anemia, neutropenia, jaundice, pancytopenia, CNS stimulation, delirium followed by vascular collapse, convulsions, coma, death, renal failure (hi prolonged doses).
Contra: intolerance to tartrazine (yellow dye #5), alcohol, table sugar, saccharin, depending on product.
Precautions: anemia, hepatic, renal, chronic alcoholism
Interactions: < effect, > hepatotoxic: barbiturates, alcohol, carbamazepine, hydantoins, rifampin, rigabutin, isoniazid, diflusinal, sulfinpyrazone. Hypoprothrombinemia: warfarin, long-term use, hi doses of acetaminophen. Bone marrow supporession: zidovudine. < absorption: colestipol, cholestryamine. Renal adverse reactions: NSAIDS, salicylates.
Pharmacokinetics: well absorbed PO, rectal varies, metabolites may be toxic if OD occurs; T ╜ 1-4hTylenolExtra HYPERLINK "http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202318.html" Ketorolac
Class: nonsteroidal anti-inflammatory/nonopioid analgesic
Action: inhibits prostaglandin sythesis by < an enzyme needed for biosythesis
Uses: mild to moderate pain; seasonal allergic conjuncitivits (ophthalmic version)
Dosage: PO 20mg then 10mg q4-6h prn, max 40mg/day
SE: drowsiness, GI bleeding, perforation, nephrotoxicity: disuria, hematuria, oliguria, azotemia, blood dyscrasias
Contra: asthma, severe renal or hepatic, ulcer, CV bleeding
Precautions: bleeding disorders, GI disorders, cardiac disorders, CCr<25 ml/min
Interactions: > toxicity: methotrexate, lithium, cyclosporine. > risk of bleeding: anticoagulants, cefamandole, cefoperazone, cefotetan, clopidogrel, eptifibatide, plicamycin, salicylates, ticlopidine, tirofiban, thrombolytics, valproic acid. < effects: antiHTN's, diuretics. > renal impairment: ACE inhibitors. > levels of ketorolac: aspirin, probenecid. > GI effects: steroids, alcohol, aspirin, NSAIDs, K+ products. Herbal: risk of bleeding: anise, arnica, chamomile, clove, dong quai, feverfew, garlic, ginger, ginkgo, ginseng (panax)
Pharmacokinetics: PO pk 2-3h, duration 4-6h. IM pk 50min, T 1/2 6h, <50% metabolized by liver, excreted by kidneysToradolExtra HYPERLINK "http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a601209.html" Ondansetron
Class: antiemetic
Action: prevents nausea, vomiting by blocking serotonin peripherally, centrally, and in the small intestine
Uses: prevention of nausea and vomiting from chemo and post-op
Dosage: Chemo: Adult and child 4-18yrs: IV 0.15 mh/kg infused over 15mins, 30 min before start of chemo; 0.15mg/kg given 4h and 8h after first dose or 32mg as a single dose; dilute in 50ml of D5 or 0.9% NaCl before giving; rectal use (off label) 16mg qd 2h prior to chemo. Post-op: IV/IM 4mg undiluted over > 30sec prior to induction of anesthesia.
SE: diarrhea, constipation, headache, dizziness, drowsiness, fatigue, EPS, bronchospasm (rare), musculoskeletal pain, wound problems, shivering, fever, hypoxia, urinary retention.
Interactions: none listed!
Pharmacokinetics: IV mean elimination T ╜ 3.5-4.7h, plasma protein binding 70%-76%ZofranExtra HYPERLINK "http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202278.html" Haloperidol
Class: antipsychotic, neuroleptic
Action: depresses cerebral cortex, hypothalamus, limbic system, which control activity and aggression; blocks neurotransmission produced by dopamine at synapse; exhibits strong alpha-adrenergic, antichilinergic blocking action; mechanism for antipsychotic effects unclear
Uses: psychotic, control of tics (Tourette's), short-term tx of hyper kids showing excessive motor activity, prolonged parenteral therapy in chronic schizophrenia, nausea in chemo, hiccups, emergency sedation of severely agitated or delirious pts.
Dosage: PO 0.5-5mg bid or tid initially depending on severity of condition; dose is > to desired dose, max 100mg/day. IM 2-5mg q4-8h or bid-tid.
SE: laryngospasm, resp depression, EPS: pseudoparkinsonism, akathisia, dystonia, tardive dyskinesia, drowsiness, headache, seizures, neuroleptic malignant syndrome, rash, dry mouth, nausea, vomiting, anorexia, constipation, ileus, hepatitis, orthostatic hypotension, cardiac arrest, tachy
Contra: blood discrasias, coma, child <3yr, brain damage, bond marrow depression, alcohol and barbiturate withdrawal, Parkinson's, angina, epilepsy, urinary retention, narrow angle glaucoma
Precautions: seizure disorders, HTN, hepatic, cardiac
Interactions: oversedation: other CNS depressants, alcohol, barbiturate anesthetics. Toxicity: epinephrine, lithium, < effects of lithium, levodopa. > effects of both drugs: beta blockers, alcohol. > anticholinergic effects: anticholinergics. < effects of haloperidol: phonobarbital, carbamazepine. Herbal: > action: chamomile, hops, kava, skullcap, valerian. Antagonist action: jimsonweed, scopolia.
Pharmacokinetics: PO onset erratic, pk 2-6h, T ╜ 24h. IM: onset 15-30min, pk 15-20min, T ╜ 21h. HaldolExtra HYPERLINK "http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202372.html" Midazolam
Class: sedative, hypnotic, antianxiety; benzodiazepine, short-acting
Action: depresses subcortical levels in CNS; may act on limbic system, reticular formation; may potentiate GABA by binding to specific benzodiazepine receptors
Uses: Pre-op sedation, general anesthesia induction, sedation for diagnostic endoscopy, intubation
Dosage: Pre-op: Adult IM 0.07-0.08 mg/kg 1/2 Ц1h before general anesthesia. Child: IM 0.1-0.15 mg/kg, may give up to 0.5 mg/kg if needed.
SE: retrograde amnesia, apnea, bronchospasm, laryngospasm, resp depression, cardiac arrest, nausea, vomiting
Contra: shock, coma, alcohol intoxication, acute narrow angle glaucoma
Precautions: COPD, CHF, chronic renal failure, chills, debilitated
Interactions: prolonged resp depression: other CNS depressants, alcohol, barbiturates, opiates, verapamil, ritonavir, indinavir, fluvoxamine. May alter midazolam metabolism: erythromycin, theophylline. Extended T 1/2 : oral contraceptives. Drug/food: > midazolam effect: grapefruit juice. Herbal: risk of CNS depression: chamomile, hops, kava, skullcap, valerian.
Pharmacokinetics: IM onset 15min, pk 1/2 Ц1h. IV onset 3-5min, onset of anesthesia 1.5-2.5min, protein binding97%, T ╜ 1.2-12.3h. Crosses blood brain bar r i e r . V e r s e d E x t r a D o p a m i n e
C l a s s : a d r e n e r g i c ; c a t e c h o l a m i n e
A c t i o n : c a u s e s > c a r d i a c o u t p u t ; a c t s o n bЁ1 a n d aЁ-Ёr e c e p t o r s , c a u s i n g v a s o c o n s t r i c t i o n i n b l d v e s s e l s ; l o w d o s e c a u s e s r e n a l a n d m e s e n t e r i c v a s o d i l a t i o n ; bЁ1 s t i m u l a t i o n p r o d u c e s i n o t r o p i c e f f e c t s with >cardiac output
Uses: shock; increased perfusion; hypotension
Dosage: shock: IV INF 2-5 mcg/kg/min, not to exceed 50mcg/kg/min, titrate to pts response. Child IV 5-20 mcg/kg/min adjust depending on response.
SE: headache, papitations, tachy, HTN, ectopic beats, angina, wide QRS, nausea, vomiting, diarrhea, gangrene
Contra: ventricular fib, tachydysrhythmias, pheochromocytoma
Precautions: arterial embolism, peripheral vascular disease
Interactions: Do not use within 2 wks of MAOI's, phenytoin; hypoten s i v e c r i s i s m a y r e s u l t . D y s r h y t h m i a s : g e n e r a l a n e s t h e t i c s . S e v e r e H T N : e r g o t s . < a c t i o n o f d o p a m i n e : bЁ b l o c k e r s , aЁ b l o c k e r s .
P h a r m a c o k i n e t i c s : I V o n s e t 5 m i n , d u r a t i o n < 1 0 m i n ; T ╜ 2 m i n I n t r o p i n E x t r a D o b u t a m i n e
C l a s s : a d r e n e r g i c d i r e c t - a c t i n g bЁ1 - a g o n i s t , c a r d i a c s t i m u l a n t
A c t i o n : c a u s e s > c o n t r a c t i l i t y , > c o r o n a r y b l d f l o w a n d H R b y a c t i n g o n bЁ1 - r e c e p t o r s i n h e a r t ; m i n o r aЁ a n d bЁ2 e f f e c t s .
U s e s : c a r d i a c d e c o m p e n s a t i o n d u e t o o r g a n i c h e a r t d i s e a s e o r c a r d i a c s u r g e r y
D o s a g e : I V I N F 2 . 5 - 1 0 m c g / k g / m i n ; m a y > to 40mcg/kg/min if needed. Child: IV INF: 5-20 mcg/kg/min over 10min for cardiac cath
SE: anxiety
Contra: iodiopathic hypertrophic subaortic stenosis
Precautions: HTN
Interactions: Severe HTN: guanethidine.. Dysrhythmias: general anesthetics, bretylium. < action of dobutamine: other beta blockers. Dysrhythmias: bretylium, general anesthetics. > pressor effect and dysrhythmias: tricyclics, MAOI's, oxytocics
Pharmacokinetics: IV onset 1-2min, pk 10min, T ╜ 2minDobutrexExtraEsmolol
Class: bЁ- a d r e n e r g i c b l o c k e r ( a n t i d y s r h y t h m i c I I )
A c t i o n : c o m p e t i t i v e l y b l o c k s s t i m u l a t i o n o f bЁ1 - a d r e n e r g i c r e c e p t o r s i n t h e m y o c a r d i u m ; p r o d u c e s n e g a t i v e c h r o n o t r o p i c , i n o t r o p i c a c t i v i t y ( < r a t e o f S A n o d e d i s c h a r g e , > i n c r e a s e r e c o v e r y t i m e ) , s l o w s c o n d u c t i o n o f A V n o d e , < H R , < O 2 c o n s u m p t i o n i n m y o c a r d i u m ; a l s o < r e n i n - a l d o s t e r o n e - a n g i o t e n s i n s y s t e m a t h i d o s e s ; i n h i b i t s bЁ2 r e c e p t o r s i n b r o n c h i a l s y s t e m a t h i g h e r d o s e s .
U s e s : s u p r a v e n t r i c u l a r t a c h y c a r d i a , n o n c o m p e n s a t o r y s i n u s t a c h y , H T N c r i s i s , i n t r a o p e r a t i v e and postoperative tachycardia and HTN
Dosage: IV loading dose 500mcg/kg/min over 1 min; maintenance 50mcg/kg/min for 4min; if no response in 5min, give 2nd loading dose; then > inf to 100mcg/kg/min for 4 min; if no response, repeat loading dose, then increase maintenance inf by 50mcg/kg/min (max of 200mcg/kg/min), titrate to pt response. Child 50mcg/kg/min may > q10min (max 200mcg/kg/min)
SE: induration, inflammation at site, seizures,CHF, bronchospasm, nausea
Contra: 2nd or 3rd degree heart block, cariogeni c s h o c k , C H F , c a r d i a c f a i l u r e
P r e c a u t i o n s : h y p o t e n s i o n , p e r i p h e r a l v a s c u l a r d i s e a s e , d i a b e t e s , h y p o g l y c e m i a , t h y r o t o x i c o s i s , r e n a l
I n t e r a c t i o n s : > d i g o x i n l e v e l s : d i g o x i n , > aЁ- a d r e n e r g i c s t i m u l a t i o n : e p h e d r i n e , e p i n e p h r i n e , a m p h e t a m i n e , n o r e p i n e p h r i n e , p h enylephrine, pseudoephedrine. < action of thyroid hormones. < action of esmolol: thyroid hormone. Avoid c MAOI's. Herbal: K+ deficiency: aloe, buckthorn bark/berry, cascara sagrada bark, senna pod/leaf
Pharmacokinetics: onset very rapid, duration short, T ╜ 9min, metabolized by hydrolysis of the ester linkageBreviblocExtraPropranolol
C l a s s : a n t i H T N , bЁ- a d r e n e r g i c b l o c k e r
A c t i o n : n o n s e l e c t i v e b - b l o c k e r w i t h n e g a t i v e i n o t r o p i c , c h r o n o t r o p i c , d r o m o t r o p i c p r o p e r t i e s
U s e s : c h r o n i c s t a b l e a n g i n a , H T N , s u p r a v e n t r i c u l a r d y s r h y t h m i a s , m i g r a i n e , p r o p h y l a x i s , M I , p h e o c h r o m o c y t o m a , e s s e n t i a l tremor, cyanotic spells re: to hypertrophic subaortic stenosis, tetralogy of Fallot, dysrhythmias assoc c thyrotoxicosis, alcohol w/d
Dosage: dysrhythmias: PO 10-30mg tid-qid. IV BOL 0.5-3mg give 1mg/min; may repeat in 2 min, may repeat q4h thereafter. HTN: PO 40mg bid or 80mg qd (ext rel) initially, usual dose 120-240mg/day bid-tid. Angina PO 80-320bid-qid or 80mg qd (ext rel).
SE: bronchospasm, bradycardia, CHF, pul edema, dysrhythmias, agranulocytosis, thrombocytopenia, laryngospasm
Contra: cardiac failure, cardiogenic shock, 2nd or 3rd degree heart block, bronchospastic disease, sinus bradycardia, CHF
Precautions: diabetes, renal, hyperthyroidism, COPD, hepatic, myasthenia gravis, peripheral vascular disease, HypoTN, CHF
Interactions: AV block: digitalis, Ca+channel blockers. > neg inotropic effects: verapamil, disopyramide. > effects of reserpine, digitalis, neuromuscular blocking agents. < beta blocking effects: norepinephrine, isoproterenol, barbiturates, rifampin, dopamine, dobutamine, smoking. > beta blocking effect: ciimetidine. > hypotension: quinidine, haloperidol, hydralazine. < propranolol effects: thyroid agents.
Pharmacokinetics: PO onset 30min, pk 1-1.5h, duration 6-12h. PO-ER pk 6h, duration 24h. IV onset 2min, pk 15min, duration 3-6h, 90%PB, T ╜ 3-5h, XR T ╜ 8-11h.InderalExtraHeparin
Class: anticoagulant, antithrombotic
Action: prevents conversion of fibrin and prothrombin to thrombin by enhancing inhibitory effects of antithrombin III
Uses: DVT, pulmonary emboli, MI, open heart surgery, atrial fib c embolization, as anticoagulant in transfusion and dialysis procedures, to maintain patency of indwelling venipuncture devices.
Dosage: DVT: IV PUSH 5000-7000 U q4h then titrated to PTT or ACT level. Heparin flush: adult and child IV 10-100U
SE: fever, diarrhea, hepatitis, hematuria, hemorrhage, thrombocytopenia, anemia, anaphylaxis, rash
Contra: hemophilia, leukemia c bleeding, ulcer, thrombocytopenic purpura, severe hepatic or renal, bld dyscrasias, severe HTN, subacute bacterial endocarditis, acute nephritis
Precautions: alcoholism
Interactions: < action of corticosteroids. > action of diazepam. < action of heparin: digitalis, tetracyclines, antihistamines. > action of heparin: oral anticoagulants, salicylates, dextran, steroids, NSAIDs. Herbal: > risk of bleeding: arnica, anise, bromelian, chamomile, cinchona bark, clove, dong quai, feverfew, garlic, ginger, ginseng (panax)
Pharmacokinetics: well absorbed SC. IV pk 5min, duration 2-6h. SC onset 20-60min, duration 8-12h. T 1/2 1.5h, 95%PB, does not cross placenta or alter breast milk, removed from system by lymph and spleenExtraEnoxaparin
Class: anticoagulant, antithrombotic
Action: prevents conversion of fibrin and prothrombin to thrombin by enhancing inhibitory effects of antithrombin III
Uses: prevention of DVT, pulmonary emboli in hip and knee replacements
Dosage: Hip/knee replacement: SC 30mg bid given 12-24h postop for 7-10d.
SE: hypochromic anemia, thrombocytopenia, cardiac toxicity
Contra: hypersensitivity to this drug, heparin or pork; hemophilia, leukemia c bleeding, ulcer, thrombocytopenis purpura, heparin induced thrombocytopenia.
Precautions: alcoholism, severe renal or hepatic, bld dyscrasias, severe HTN, subacute bacterial endocarditis, acute nephritis
Interactions: > action of enoxaparin: anticoagulants, salicylates, NSAIDs, antiplatelets. > hypoprothrombinemia: plicamycin, valproic acid. Do not mix c other drugs or infusion fluids. Herbal: > risk of bleeding: bromelian, cinchona bark.
Pharmacokinetics: SC 90% absorbed, max antithrombin activity (3-5hr), elimination T ╜ 4.5hLovenoxExtraLevophed (adrenergic; catcholamine for acute hypotension, shock)
Norepi-nephrineExtraPhenylephrine (adrenergic, direct-acting; hypotension, paroxysmal supraventricular tachycardia, shock, maintain BP for spinal anesthesia)Neosyn-ephrineExtraEpinephrine (bronchodilator nonselective adrenergic agonist, vasopressor; catcholamine for acute asthma attack, hemostasis, bronchospasm, anaphylaxis, allergic reactions, cardiac arrest, adjunct in anesthesia, shock)EpiPen, Primatine MistExtraAmiodarone (antidysrhythmic for severe ventricular tachy, supraventricular tachy, atrial fib, ventricular fib not controlled by first-line agents, cardiac arrest)Cordarone, PaceroneExtraNicardipine (Ca+channel blocker, antianginal, antihypertensive)CardeneExtraPropofol (general anesthetic for induction or maintenance of anesthesia; sedation in mechanically ventilated pts)Diprivan, DisoprofolExtra
Class:
Action:
Uses:
Dosage:
SE:
Contra:
Precautions:
Interactions:
Pharmacokinetics:Extra
Class:
Action:
Uses:
Dosage:
SE:
Contra:
Precautions:
Interactions:
Pharmacokinetics:Extra
Class:
Action:
Uses:
Dosage:
SE:
Contra:
Precautions:
Interactions:
Pharmacokinetics:Extra
Class:
Action:
Uses:
Dosage:
SE:
Contra:
Precautions:
Interactions:
Pharmacokinetics:Extra
Class:
Action:
Uses:
Dosage:
SE:
Contra:
Precautions:
Interactions:
Pharmacokinetics:Extra
Class:
Action:
Uses:
Dosage:
SE:
Contra:
Precautions:
Interactions:
Pharmacokinetics:Extra
Class:
Action:
Uses:
Dosage:
SE:
Contra:
Precautions:
Interactions:
Pharmacokinetics:
" # $ % p q v w В Г Д Е ╤ ╥ у ф ц ы
Q R S И Й ┬ o ┐ ╟ ╓ ╫ ▐ ▀ Ї Їя▀Ї▀╤┐╤▀п▀Ї▀╤▀ЇгЪНЪ}НrНЪ ЪfЪfЪW j >*CJ OJ QJ UaJ 6БCJ OJ QJ ]БaJ 0J CJ OJ QJ aJ Бj CJ OJ QJ UaJ j CJ OJ QJ UaJ CJ OJ QJ aJ 5БCJ OJ QJ \БaJ 5БB*CJ OJ QJ \БaJ ph "5Б>*B*CJ OJ QJ \БaJ ph 0J 5БCJ OJ QJ \БaJ j 5БCJ OJ QJ U\БaJ CJ aJ 5БCJ OJ QJ \БaJ " " # $ Д х ц э ┬ o ш Ў Ё ъ gФ Ў ъ ъ ъ ъ a ъ $If В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ╠╠╠ ╠╠╠ ╠╠╠ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ $If $If $$If a$ ЭЁ ■ ▀ B C D b c d x y $ % j
l
н
о
п
√
№
їу╘╔╘ї└╘їо╘╔╘└в└ХЕyЕkЕ[VM CJ OJ QJ aJ CJ aJ 5БB*CJ OJ QJ \БaJ ph 0J 5БCJ OJ QJ \БaJ 5БCJ OJ QJ \БaJ j 5БCJ OJ QJ U\БaJ B*CJ OJ QJ aJ ph 6БCJ OJ QJ ]БaJ "Бjj >*CJ OJ QJ UaJ CJ OJ QJ aJ 0J CJ OJ QJ aJ j >*CJ OJ QJ UaJ "БjM >*CJ OJ QJ UaJ >*CJ OJ QJ aJ ш G Е ┬
=
Ф
о
r д ∙ ∙ ∙ ∙ ∙ ∙ ∙ ∙ vx m ∙ ∙ $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ╠╠╠ ╠╠╠ ╠╠╠ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ $If
_ ` p q r y г м ¤ H L V н █ ▄ х я № l
z
К
Л
№
6 7 8 Л М У Ф е ж з и й к ¤ ■
! Єх▄х╤х▄├╕├╕├╕├╕нЯн├╕Н~Н~Н~Н~Єх▄х╤х▄Єy▄Єх▄х╤х▄├╕ CJ aJ B*CJ OJ QJ ^J aJ ph #5БB*CJ OJ QJ \Б^J aJ ph 6БCJ OJ QJ ]Б^J aJ CJ OJ QJ ^J aJ CJ OJ QJ ^J aJ 5БCJ OJ QJ \Б^J aJ 0J CJ OJ QJ aJ CJ OJ QJ aJ j CJ OJ QJ UaJ B*CJ OJ QJ aJ ph /д ¤ H ▌ я l
№
7 Ц ж з й ∙ ∙ ∙ ∙ ∙ ∙ ∙ ∙ ∙ ∙ v\ m $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ $If й ! p ╠ / L Ї є } ~ А ∙ ∙ ∙ ∙ ∙ ∙ ∙ ∙ ∙ ∙ vр m $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ $If ! ) p x ╠ ╨
. / 7 L Y є є s t { | } ~ А Б ╘ ╒ т у ф ы √ ╕ └ ╒ # A 2 ? Т Ц ЄчЄчЄч┘ч┘чЄч╟╕╟╕╟╕иЫТЫЗЫzuТzЫТЫЗЫТЄчЄчЄ┘ч┘ч┘чЄCJ aJ B*CJ OJ QJ aJ ph 0J CJ OJ QJ aJ CJ OJ QJ aJ j CJ OJ QJ UaJ 5БB*CJ OJ QJ \БaJ ph B*CJ OJ QJ ^J aJ ph #5БB*CJ OJ QJ \Б^J aJ ph 6БCJ OJ QJ ]Б^J aJ CJ OJ QJ ^J aJ 5БCJ OJ QJ \Б^J aJ .А ф √ ╕ Т | ╠ : ╒ 5 6 8 ∙ ∙ ∙ ∙ ∙ ∙ ∙ ∙ ∙ ∙ vи! m $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ $If Ц ▓ ┴ Ё | Й ╠ ╪ : L ╘ ╒ ╓ ) * 3 4 5 6 7 8 9 М Н Х Ц Ч Ю ж з
$ 6 їчїчї┘ї╟╕╟╕╟╕лЮХЮКЮлЕХлЮХЮКЮХ┘ї┘їznїznї┘ї CJ H*OJ QJ ^J aJ CJ OJ QJ ^J aJ CJ aJ 0J CJ OJ QJ aJ CJ OJ QJ aJ j CJ OJ QJ UaJ B*CJ OJ QJ aJ ph B*CJ OJ QJ ^J aJ ph #5БB*CJ OJ QJ \Б^J aJ ph 5БCJ OJ QJ \Б^J aJ 6БCJ OJ QJ ]Б^J aJ CJ OJ QJ ^J aJ )8 Ч & ╪ / є c ╦ ╫! u" ▌" ▐" ∙ ∙ ∙ ∙ ∙ ∙ ∙ ∙ ∙ ∙ ∙ v В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ $If ж з и / 7 · ( w Г Ю л є ў > @ E G Ы
" $ ) + c p ╦ ╫ ╫! щ! t" u" v" ╔" ╩" Ёх┘х╦х╜х╜х╜х╜х╦╜х▒х▒х╜х╦х▒х▒хЯРЯРЯРГvmv CJ OJ QJ aJ j CJ OJ QJ UaJ B*CJ OJ QJ aJ ph B*CJ OJ QJ ^J aJ ph #5БB*CJ OJ QJ \Б^J aJ ph CJ H*OJ QJ ^J aJ 6БCJ OJ QJ ]Б^J aJ 5БCJ OJ QJ \Б^J aJ CJ H*OJ QJ ^J aJ CJ OJ QJ ^J aJ B*CJ OJ QJ ^J aJ ph '╩" ╤" ╥" ▄" ▌" ▐" ▀" р" с" 4# 5# @# A# B# I# s# {# $ $ [$ c$ p$ ╧$ ▄$ % +% М% б% ╛% р% & 1& ' ' 0' N' f' r' }' ' г' ┤' ┴' ¤'
( ▒( ├( щ( ъ( ы( >) ?) F) їш▀╥═▀╥ш▀шїш▀┐┤┐┤┐┤┐ж┤ж┤ж┤ж┤ж┤ж┤┐ж┤ж┤ж┤ж┤ФЕФЕФЕ╥ш▀шї B*CJ OJ QJ ^J aJ ph #5БB*CJ OJ QJ \Б^J aJ ph 6БCJ OJ QJ ]Б^J aJ CJ OJ QJ ^J aJ 5БCJ OJ QJ \Б^J aJ CJ aJ B*CJ OJ QJ aJ ph CJ OJ QJ aJ j CJ OJ QJ UaJ 0J CJ OJ QJ aJ 4▐" р" B# s# $ [$ ' ┤' ■' ▒( ъ( ^) _) Ў Ё Ё Ё Ё Ё Ё Ё Ё Ё Ё mЁ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ $If $$If a$ F) G) ]) ^) _) `) a) b) ╡) ╢) ╙) ╘) ╒) ▄) я) ў) Б* Е* + '+ 0+ 2+ T+ n+ Л+ Э+ ╫+ ч+ №+ , (, A, `, В, г, п, ╬, ╥, ┌, ▄, - - :- i- Т- Ъ- - . ╨. ▄. Є/ є/ Ї/ Єщ▄╫щ▄ЄщЄ╠Єщ╛│╛│╛│╛е╛│е│е│е│е│е│е│е│╛е│е│е│е╛│УДУД▄Є B*CJ OJ QJ ^J aJ ph #5БB*CJ OJ QJ \Б^J aJ ph 6БCJ OJ QJ ]Б^J aJ CJ OJ QJ ^J aJ 5БCJ OJ QJ \Б^J aJ 0J CJ OJ QJ aJ CJ aJ B*CJ OJ QJ aJ ph CJ OJ QJ aJ j CJ OJ QJ UaJ 4_) a) ╒) я) Б* + ╬, Т- - ╨. є/ Z0 [0 Ў Ё Ё Ё Ё Ё Ё Ё Ё Ё Ё mф В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ $If $$If a$ Ї/ G0 H0 X0 Y0 Z0 [0 \0 ]0 ^0 ▒0 ▓0 ┴0 ┬0 ├0 ╩0 я0 °0 Z1 ^1 п1 ╖1 Й2 Ш2 и3 м3 ═3 Q4 ^4 `4 в4 ┤4 ═4 ╒4 +5 85 x5 Д5 26 D6 э6 ю6 я6 B7 C7 J7 K7 R7 S7 T7 U7 V7 W7 ўъ▀ъ╥═ў╥ъўъ▀ъў┐┤┐┤┐┤┐┤ж┤┐ж┤ж┤ж┤ж┐┤ФЕФЕФЕ╥ъўъ▀ъў╥═ў╥ъ B*CJ OJ QJ ^J aJ ph #5БB*CJ OJ QJ \Б^J aJ ph 6БCJ OJ QJ ]Б^J aJ CJ OJ QJ ^J aJ 5БCJ OJ QJ \Б^J aJ CJ aJ B*CJ OJ QJ aJ ph 0J CJ OJ QJ aJ j CJ OJ QJ UaJ CJ OJ QJ aJ 4[0 ]0 ├0 Ё0 Z1 п1 и3 ═4 +5 x5 26 ю6 S7 Ў Ё Ё Ё Ё Ё Ё Ё Ё Ё Ё Ё $If $$If a$ S7 T7 V7 ╖7 ш7 #8 49 o9 9 P: И: !; e; |└ s m m m m m m m m m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ W7 к7 л7 ╡7 ╢7 ╖7 ╝7 ш7 ю7 O8 49 :9 |9 ~9 А9 9 : : : !: #: P: [: И: Ц: !; 1; d; e; f; ╣; ║; ┴; ┬; ├; ─; ┼; ╞; ╟; 4< 6< X< Z< \< j< А< В< ўъ▀ъў╤╞╤╞╖╤╞╤╞╖е╖Ф╖Ф╖е╖е╖е╖Зъўъ▀ъЗВўЗъўъ▀ъў╤╞w CJ OJ QJ ^J aJ CJ aJ B*CJ OJ QJ aJ ph B*CJ H*OJ QJ ^J aJ ph #5БB*CJ OJ QJ \Б^J aJ ph B*CJ OJ QJ ^J aJ ph CJ OJ QJ ^J aJ 5БCJ OJ QJ \Б^J aJ 0J CJ OJ QJ aJ j CJ OJ QJ UaJ CJ OJ QJ aJ .e; ├; ─; ╞; \< ┌< l> √> OA АA хA ШB ЦE ∙ vр" m ∙ ∙ ∙ ∙ ∙ ∙ ∙ ∙ ∙ $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ $If В< Ж< ┌< ъ< $= &= *= l> p> √> ? OA SA sA A АA ИA хA ЄA ШB дB D D ЦE ║E ╚F ╔F ╩F G G %G &G 'G (G *G +G ,G єш┌ш╧єш┌ш┌ш┌ш┴ш┌шпапаСапаДwnwcwД^nДw CJ aJ 0J CJ OJ QJ aJ CJ OJ QJ aJ j CJ OJ QJ UaJ B*CJ OJ QJ aJ ph B*CJ OJ QJ ^J aJ ph B*CJ OJ QJ ^J aJ ph #5БB*CJ OJ QJ \Б^J aJ ph 6БCJ OJ QJ ]Б^J aJ CJ OJ QJ ^J aJ 5БCJ OJ QJ \Б^J aJ CJ OJ QJ ^J aJ CJ H*OJ QJ ^J aJ $ЦE ╔F 'G (G +G МG ╝G H QH ╘I ,J ЕJ ░J ∙ ∙ vЬ m ∙ ∙ ∙ ∙ ∙ ∙ ∙ ∙ $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ $If ,G G АG КG ЛG МG УG ╝G ─G H H QH YH kH уH єH I =I ЫI иI ╘I ╪I J J J J ,J 4J ЕJ ТJ ░J ╝J nL АL шL щL ъL =M >M EM FM MM NM OM QM RM SM жM зM ║M ╗M ╝M ├M ўъ▀ъў╤╞╤╞╤╞╤╕╞╕╞╕╞╕╞╤╞╕╞╕╞╤╞жЧжЧжЧКъўъ▀ъўКЕўКъўъ▀ъў╤ CJ aJ B*CJ OJ QJ aJ ph B*CJ OJ QJ ^J aJ ph #5БB*CJ OJ QJ \Б^J aJ ph 6БCJ OJ QJ ]Б^J aJ CJ OJ QJ ^J aJ 5БCJ OJ QJ \Б^J aJ 0J CJ OJ QJ aJ j CJ OJ QJ UaJ CJ OJ QJ aJ 4░J nL щL NM OM RM ╝M ЎM dN ┘N АO ~P │P ∙ ∙ ∙ vФ m ∙ ∙ ∙ ∙ ∙ ∙ ∙ $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ $If ├M ЎM ■M bN jN ┘N сN АO ДO ЧO йO хO юO P pP ~P ЕP │P └P Q Q иR ║R S S S \S ]S dS eS rS sS tS vS wS xS ╦S ╠S ╓S ╫S ╪S ▀S ЇS №S ^T fT dU hU ЦU ЪU ;V AV CV їчїчїчїчї┘ї┘ї┘їчї╟╕╟╕╟╕лЮХЮКЮХлЕХлЮХЮКЮХчїчїчїчїчїчї CJ aJ 0J CJ OJ QJ aJ CJ OJ QJ aJ j CJ OJ QJ UaJ B*CJ OJ QJ aJ ph B*CJ OJ QJ ^J aJ ph #5БB*CJ OJ QJ \Б^J aJ ph 6БCJ OJ QJ ]Б^J aJ 5БCJ OJ QJ \Б^J aJ CJ OJ QJ ^J aJ 4│P Q иR S sS tS wS ╪S ЇS ^T dU ЦU ;V ∙ ∙ ∙ ∙ v, m ∙ ∙ ∙ ∙ ∙ ∙ $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ $If CV KV LV YV ЖV ТV V W
X X аX бX вX їX ЎX №X ¤X ■X X Y Y Y VY WY aY bY cY jY Y ЗY ╒Y ┘Y (Z 0Z √[ [ Ж\ З\ Р\ Ч\ Ёх╙Ё╙Ё┴Ё╙Ё┤зЮзУз┤ОЮ┤зЮзУзЮАхАхАхАхАqdАх CJ OJ QJ aJ mH sH CJ OJ QJ ^J aJ mH sH 5БCJ OJ QJ \Б^J aJ CJ aJ 0J CJ OJ QJ aJ CJ OJ QJ aJ j CJ OJ QJ UaJ B*CJ OJ QJ aJ ph #6БB*CJ OJ QJ ]Б^J aJ ph #5БB*CJ OJ QJ \Б^J aJ ph CJ OJ QJ ^J aJ B*CJ OJ QJ ^J aJ ph ';V LV ЖV
X бX ■X X Y cY Y ╒Y (Z И\ ∙ ∙ ∙ ∙ ∙ v| m ∙ ∙ ∙ ∙ ∙ $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ $If И\ Ч\ ю\ J^ ┴^ _ _ !_ Л_ ╡_ ` <` x` ∙ ∙ ∙ ∙ ∙ v m ∙ ∙ ∙ ∙ ∙ $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ $If Ч\ д\ ю\ ·\ J^ \^ └^ ┴^ ┬^ _ _ _ _ _ _ _ !_ "_ u_ v_ Й_ К_ Л_ Т_ ┤_ ╛_ ` &` ;` D` x` |` ▓` ╥` a 0a 1a 8a Ca Pa ┌a цa ▒b ├b ∙b ·b √b Nc Oc Vc Wc _c `c э▐э▐э▐╤─╗─░─╤л╗╤─╗─░─╗ЭТЭТЭТЭТЭТДТДТЭТэ▐э▐э▐╤─╗─░─╗╤6БCJ OJ QJ ]Б^J aJ CJ OJ QJ ^J aJ 5БCJ OJ QJ \Б^J aJ CJ aJ 0J CJ OJ QJ aJ CJ OJ QJ aJ j CJ OJ QJ UaJ B*CJ OJ QJ aJ ph B*CJ OJ QJ ^J aJ ph #5БB*CJ OJ QJ \Б^J aJ ph 4x` 1a Ca ┌a ▒b ·b `c ac dc ╟c чc d oe ∙ ∙ ∙ ∙ ∙ ∙ v| m ∙ ∙ ∙ ∙ $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ $If `c ac cc dc ec ╕c ╣c ┼c ╞c ╟c ╬c чc яc d Гd oe we ╙e Щg Эg ╔g ▌g ▀g ўg ∙g h h h Mh Zh ╕h ─h Фi ╟i j j Шj Щj Ъj эj юj ¤j ■j j k k √Єх╪Є╪═╪Є┐┤┐┤┐┤┐ж┤┐┤ж┤ж┤ж┤┐┤ФЕФЕsЕФЕх╪Є╪═╪х√Є #6БB*CJ OJ QJ ]Б^J aJ ph B*CJ OJ QJ ^J aJ ph #5БB*CJ OJ QJ \Б^J aJ ph 6БCJ OJ QJ ]Б^J aJ CJ OJ QJ ^J aJ 5БCJ OJ QJ \Б^J aJ 0J CJ OJ QJ aJ j CJ OJ QJ UaJ B*CJ OJ QJ aJ ph CJ OJ QJ aJ CJ aJ -oe Щg h Mh ╕h j Щj j k k dk Чk )l ∙ ∙ ∙ ∙ ∙ ∙ ∙ vф m ∙ ∙ ∙ $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ $If k k k Wk Xk bk ck dk kk zk {k }k Цk Чk Яk )l 1l 7m ;m Cm fm ~m Аm Эm Яm 4n б [б hб ╚б ╘б Eв Wв nв oв pв ├в ─в ╩в ╦в ╠в ═в ╧в ╨в ╤в $г %г /г 0г Bг Dг uг vг wг ╩г ╦г ╤г ╥г ╙г ╘г ╓г ╫г ╪г +д ,д ?д @д ўъ▀ъў╤╞╤╞╤╞╤╞╤╞┤е┤е┤еШъўъ▀ъШУўШъўъ▀ъўЙўШъўъ▀ъШУўШъўъ▀ъCJ H*OJ QJ aJ CJ aJ B*CJ OJ QJ aJ ph B*CJ OJ QJ ^J aJ ph #5БB*CJ OJ QJ \Б^J aJ ph CJ OJ QJ ^J aJ 5БCJ OJ QJ \Б^J aJ 0J CJ OJ QJ aJ j CJ OJ QJ UaJ CJ OJ QJ aJ 6╠в ═в ╨в vг ╙г | s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ ╙г ╘г ╫г Kд кд ╡д |И s m m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ @д Jд Kд Lд Яд ад зд ид ┤д ╡д ╢д ╕д ╣д ║д
е е е е е е sе |е ├е ╟е 6ж >ж и и и и Fи Ги Ти Щи ри эи й й ▄й юй nк oк pк ├к ─к ╦к ╠к ╘к ўъ▌ў▌╥▌ўъ═ўъ▌ў▌╥▌ў┐┤┐┤┐┤┐┤и┤┐┤Ъ┤┐┤ИyИyИyъ▌ў▌╥▌ў B*CJ OJ QJ ^J aJ ph #5БB*CJ OJ QJ \Б^J aJ ph 6БCJ OJ QJ ]Б^J aJ CJ H*OJ QJ ^J aJ CJ OJ QJ ^J aJ 5БCJ OJ QJ \Б^J aJ CJ aJ 0J CJ OJ QJ aJ j CJ OJ QJ UaJ B*CJ OJ QJ aJ ph CJ OJ QJ aJ /╡д ╢д ╣д е tе ├е 6ж и Ти ри й ▄й oк |А s m m m m m m m m m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ oк ╒к ╓к ┘к jл ╚л ∙ v╠ m ∙ ∙ $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ $If ╘к ╒к ╓к ╪к ┘к ┌к -л .л 9л :л iл jл kл ╛л ┐л ╞л ╟л ╚л ╔л ╦л ╠л ═л м !м *м +м ,м 3м @м Hм Ям зм Yн ]н пн ┐н ┴н ╨н ╤н ┘н Nо [о kо wо M░ _░ В░ Г░ Д░ ╫░ ╪░ ▀░ р░ ЄэфЄ╫ф╫╠╫фЄ╫ф╫╠╫ЄэфЄ╫ф╫╠╫ф╛│╛│╛│╛│е│е│╛│УДУДУДЄ╫ф╫╠╫ B*CJ OJ QJ ^J aJ ph #5БB*CJ OJ QJ \Б^J aJ ph 6БCJ OJ QJ ]Б^J aJ CJ OJ QJ ^J aJ 5БCJ OJ QJ \Б^J aJ 0J CJ OJ QJ aJ j CJ OJ QJ UaJ CJ OJ QJ aJ CJ aJ B*CJ OJ QJ aJ ph 4╚л ╔л ╠л ,м @м Ям Yн ╤н Nо kо M░ Г░ с░ |d s m m m m m m m m m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ р░ с░ т░ ф░ х░ ц░ 9▒ :▒ D▒ E▒ V▒ X▒ z▒ {▒ |▒ ╧▒ ╨▒ ╪▒ ┘▒ ┌▒ █▒ ▌▒ ▐▒ ▀▒ 2▓ 3▓ >▓ ?▓ T▓ U▓ V▓ й▓ к▓ ░▓ ▒▓ ▓▓ │▓ ╡▓ ╢▓ ╖▓
│ │ │ │ '│ (│ )│ |│ }│ Г│ Д│ Е│ Ж│ И│ Й│ К│ ▌│ ▐│ ш│ щ│ ь│ э│ ┤ ┤ !┤ t┤ u┤ |┤ }┤ Е┤ Ж┤ З┤ Й┤ ЄэфЄ╫ф╫╠╫ф┬фЄ╫ф╫╠╫ЄэфЄ╫ф╫╠╫фЄ╫ф╫╠╫ЄэфЄ╫ф╫╠╫фЄ╫ф╫╠╫ЄэфЄ╫ф╫╠╫ф╕фЄ╫ф╫╠╫фЄэф CJ H*OJ QJ aJ CJ H*OJ QJ aJ 0J CJ OJ QJ aJ j CJ OJ QJ UaJ CJ OJ QJ aJ CJ aJ B*CJ OJ QJ aJ ph Hс░ т░ х░ {▒ ┌▒ |ф s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ ┌▒ █▒ ▐▒ U▓ ▓▓ |` s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ ▓▓ │▓ ╢▓ (│ Е│ |L s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ Е│ Ж│ Й│ ┤ Ж┤ | s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ Ж┤ З┤ К┤ ╡ Д╡ |° s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ Й┤ К┤ Л┤ ▐┤ ▀┤ ь┤ э┤ ╡ ╡ ╡ r╡ s╡ z╡ {╡ Г╡ Д╡ Е╡ З╡ И╡ Й╡ ▄╡ ▌╡ Ї╡ ї╡ Ў╡ ў╡ J╢ K╢ T╢ U╢ V╢ W╢ Y╢ Z╢ [╢ о╢ п╢ ╦╢ ╠╢ ╬╢ ╒╢ ў╢ ╢ 8╖ A╖ ∙╖ ¤╖ @╕ H╕ З╕ Ш╕ )╣ 1╣ U╣ b╣ Єх▄х╤х▄Єх▄х╤х▄Є╠▄Єх▄х╤хЄх▄х╤хЄ╠▄Єх▄х╤х▄╛│╛│╛│╛│е│е│╛│У #5БB*CJ OJ QJ \Б^J aJ ph 6БCJ OJ QJ ]Б^J aJ CJ OJ QJ ^J aJ 5БCJ OJ QJ \Б^J aJ CJ aJ 0J CJ OJ QJ aJ CJ OJ QJ aJ j CJ OJ QJ UaJ B*CJ OJ QJ aJ ph 6Д╡ Е╡ И╡ Ў╡ V╢ |H s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ V╢ W╢ Z╢ ╬╢ ў╢ 9╖ ∙╖ )╣ U╣ Ю╣ ╗ n╗ ┘╗ | s m m m m m m m m m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ b╣ Э╣ к╣ ╗ +╗ m╗ n╗ o╗ ┬╗ ├╗ ╨╗ ╤╗ ╪╗ ┘╗ ┌╗ ▄╗ ▌╗ ▐╗ 1╝ 2╝ <╝ =╝ N╝ O╝ P╝ г╝ д╝ н╝ о╝ п╝ ░╝ ▓╝ │╝ ┤╝ ╜ ╜ 3╜ 4╜ ╚╜ ╔╜ ╩╜ ╛ ╛ %╛ &╛ '╛ (╛ *╛ +╛ ,╛ ╛ А╛ К╛ Л╛ М╛ У╛ к╛ ▓╛ Ё▐Ё▐Ё╤─╗─░─╗╤л╗╤─╗─░─╗╤─╗─░─╤л╗╤─╗─░─╗╤─╗─░─╤л╗╤─╗─░─╗ЭТЭ CJ OJ QJ ^J aJ 5БCJ OJ QJ \Б^J aJ CJ aJ 0J CJ OJ QJ aJ CJ OJ QJ aJ j CJ OJ QJ UaJ B*CJ OJ QJ aJ ph #5БB*CJ OJ QJ \Б^J aJ ph B*CJ OJ QJ ^J aJ ph 9┘╗ ┌╗ ▌╗ O╝ п╝ |X s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ п╝ ░╝ │╝ ╔╜ '╛ |р s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ '╛ (╛ +╛ М╛ к╛ 6┐ ~┐ Є┐ =└ }└ =┬ n┬ ▀┬ |р s m m m m m m m m m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ ▓╛ 6┐ <┐ ~┐ Ж┐ К┐ Л┐ ╖┐ ╕┐ Є┐ Ў┐ └ !└ '└ 2└ <└ =└ J└ }└ Й└ Л└ Я└ ┴ ┴ 8┴ D┴ Е┴ Ц┴ к┴ ╞┴ ╒┴ ▐┴ =┬ O┬ m┬ n┬ o┬ ┬┬ ├┬ ╩┬ ╦┬ ▐┬ ▀┬ р┬ т┬ у┬ їчїчїчїчїч┘ї┘ї┘ї╟╕╟╕ж╕ж╕ж╕ж╕ж╕ж╕╟╕ЩМГМxМГЩsГЩ CJ aJ 0J CJ OJ QJ aJ CJ OJ QJ aJ j CJ OJ QJ UaJ B*CJ OJ QJ aJ ph #6БB*CJ OJ QJ ]Б^J aJ ph B*CJ OJ QJ ^J aJ ph #5БB*CJ OJ QJ \Б^J aJ ph 6БCJ OJ QJ ]Б^J aJ 5БCJ OJ QJ \Б^J aJ CJ OJ QJ ^J aJ -▀┬ р┬ у┬ g├ ╚├ |д s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ у┬ ф┬ 7├ 8├ T├ U├ f├ g├ h├ ╗├ ╝├ ╞├ ╟├ ╚├ ╔├ ╦├ ╠├ ═├ ─ !─ +─ ,─ 6─ 7─ 8─ Л─ М─ У─ Ф─ Х─ Ц─ Ш─ Щ─ Ъ─ э─ ю─ ∙─ ·─
┼ ┼ ┼ _┼ `┼ i┼ j┼ k┼ l┼ n┼ o┼ p┼ ├┼ ─┼ ╧┼ ╨┼ Ї┼ ї┼ Ў┼ I╞ J╞ S╞ T╞ U╞ V╞ X╞ Y╞ Z╞ н╞ о╞ ║╞ ╗╞ ▐╞ ▀╞ р╞ 3╟ 4╟ :╟ ;╟ <╟ =╟ ?╟ @╟ ЄщЄ▐Єщ╤ЄщЄ▐Є╤╠щ╤ЄщЄ▐Єщ╤ЄщЄ▐Є╤╠щ╤ЄщЄ▐Єщ╤ЄщЄ▐Є╤╠щ╤ЄщЄ▐Єщ╤ЄщЄ▐Є╤╠щ╤ЄщЄ▐Єщ╤ЄщЄ▐Є╤╠щ╤ CJ aJ B*CJ OJ QJ aJ ph 0J CJ OJ QJ aJ CJ OJ QJ aJ j CJ OJ QJ UaJ P╚├ ╔├ ╠├ 7─ Х─ |4 s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ Х─ Ц─ Щ─ ┼ k┼ |X s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ k┼ l┼ o┼ ї┼ U╞ |и s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ U╞ V╞ Y╞ ▀╞ <╟ |Ь s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ <╟ =╟ @╟ ╥╟ B╚ | s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ @╟ A╟ Ф╟ Х╟ ▓╟ │╟ ╤╟ ╥╟ ╙╟ &╚ '╚ .╚ /╚ A╚ B╚ C╚ E╚ F╚ G╚ Ъ╚ Ы╚ е╚ ж╚ и╚ п╚ ┘╚ с╚ p╔ x╔ ╩
╩ 7╩ }╩ Ф╩ е╩ ├╩ ╨╩
╦ ╦ √╦
╠ 3╠ 4╠ 5╠ И╠ Й╠ Р╠ С╠ Ы╠ Ь╠ Э╠ Я╠ а╠ ЄщЄ▐Єщ╤ЄщЄ▐Єщ╤╠щ╤ЄщЄ▐Єщ╛│╛│╛│╛е│е╛│УДУДУД╤ЄщЄ▐Єщ╤╠щ╤ B*CJ OJ QJ ^J aJ ph #5БB*CJ OJ QJ \Б^J aJ ph 6БCJ OJ QJ ]Б^J aJ CJ OJ QJ ^J aJ 5БCJ OJ QJ \Б^J aJ CJ aJ B*CJ OJ QJ aJ ph 0J CJ OJ QJ aJ CJ OJ QJ aJ j CJ OJ QJ UaJ 4B╚ C╚ F╚ и╚ ┘╚ p╔ ╩ Ф╩ ├╩
╦ √╦ 4╠ Ь╠ |h s m m m m m m m m m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ Ь╠ Э╠ а╠ ═ o═ |L s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ а╠ б╠ Ї╠ ї╠ ■╠ ╠ ═ ═ ═ d═ e═ m═ n═ o═ p═ r═ s═ t═ ╟═ ╚═ ╒═ ╓═ ╫═ ▐═ √═ ╬ t╬ |╬ Ж╧ К╧ в╧ к╧ ╚╧ р╧ ш╧
╨ ╨ ╨ +╨ 7╨ м╤ ╛╤ ╥╤ ╙╤ ╘╤ '╥ (╥ -╥ .╥ /╥ 0╥ 2╥ 3╥ ЄщЄ▐Єщ╤ЄщЄ▐Є╤╠щ╤ЄщЄ▐Єщ╛│╛│╛│╛│е│е│е│УДУДУД╤ЄщЄ▐Є╤╠щ╤ B*CJ OJ QJ ^J aJ ph #5БB*CJ OJ QJ \Б^J aJ ph 6БCJ OJ QJ ]Б^J aJ CJ OJ QJ ^J aJ 5БCJ OJ QJ \Б^J aJ CJ aJ B*CJ OJ QJ aJ ph 0J CJ OJ QJ aJ CJ OJ QJ aJ j CJ OJ QJ UaJ 4o═ p═ s═ √═ t╬ Ж╧ ╨ +╨ м╤ ╙╤ /╥ | s m m m m m m m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ
/╥ 0╥ 3╥ ╜╥ 0╙ | s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ 3╥ 4╥ З╥ И╥ С╥ Т╥ ╝╥ ╜╥ ╛╥ ╙ ╙ ╙ ╙ /╙ 0╙ 1╙ 3╙ 4╙ 5╙ И╙ Й╙ С╙ Т╙ ╩╙ ╦╙ ╠╙ ╘ ╘ '╘ (╘ 8╘ 9╘ :╘ <╘ =╘ >╘ С╘ Т╘ д╘ е╘ ж╘ н╘ ╬╘ ╓╘ A╒ I╒ ╬╒ ╥╒ U╓ z╓ В╓ ь╓ ∙╓ ЄщЄ▐Єщ╤ЄщЄ▐Єщ╤╠щ╤ЄщЄ▐Єщ╤ЄщЄ▐Єщ╤╠щ╤ЄщЄ▐Єщ╛│╛│╛│╛е│╛│У #5БB*CJ OJ QJ \Б^J aJ ph 6БCJ OJ QJ ]Б^J aJ CJ OJ QJ ^J aJ 5БCJ OJ QJ \Б^J aJ CJ aJ B*CJ OJ QJ aJ ph 0J CJ OJ QJ aJ CJ OJ QJ aJ j CJ OJ QJ UaJ 40╙ 1╙ 4╙ ╦╙ 9╘ |$ s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ 9╘ :╘ =╘ ж╘ ╬╘ A╒ ╬╒ z╓ ь╓ 3╫ │╫ ╪ q╪ |р s m m m m m m m m m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ ∙╓ 3╫ ?╫ │╫ ┼╫ ╪ ╪ ╪ g╪ h╪ o╪ p╪ q╪ r╪ t╪ u╪ v╪ ╔╪ ╩╪ ╒╪ ╓╪ ┘ ┘ ┘ Z┘ [┘ b┘ c┘ d┘ e┘ g┘ h┘ i┘ ╝┘ ╜┘ ╠┘ ═┘ °┘ ∙┘ ·┘ M┌ N┌ U┌ V┌ `┌ a┌ b┌ d┌ e┌ f┌ ╣┌ ║┌ ╠┌ ═┌ ╫┌ ╪┌ ┘┌ ,█ -█ 5█ 6█ 7█ 8█ :█ ;█ <█ П█ Р█ Ё▐Ё▐Ё╤─╗─░─╤л╗╤─╗─░─╗╤─╗─░─╤л╗╤─╗─░─╗╤─╗─░─╗╤л╗╤─╗─░─╗╤─╗─░─╤л╗╤─╗─ CJ aJ 0J CJ OJ QJ aJ CJ OJ QJ aJ j CJ OJ QJ UaJ B*CJ OJ QJ aJ ph #5БB*CJ OJ QJ \Б^J aJ ph B*CJ OJ QJ ^J aJ ph Cq╪ r╪ u╪ ┘ d┘ |╠ s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ d┘ e┘ h┘ ∙┘ a┌ |Ї s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ a┌ b┌ e┌ ╪┌ 7█ |X s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ 7█ 8█ ;█ ╤█ 8▄ | s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ Р█ Щ█ Ъ█ ╨█ ╤█ ╥█ %▄ &▄ -▄ .▄ 7▄ 8▄ 9▄ ;▄ <▄ =▄ Р▄ С▄ Щ▄ Ъ▄ Ы▄ в▄ ░▄ ╕▄ )▌ /▌ }▌ Е▌ є▌ ў▌ ▐
▐ ▐ ▐ $▐ .▐ 0▐ ?▐ A▐ K▐ M▐ Y▐ Z▐ b▐ #▀ 0▀ ;▀ G▀ I▀ їш▀╥ш▀шїш▀╥═▀╥ш▀шїш▀┐┤┐┤┐┤┐┤┐┤ж┤ж┤ж┤ж┤ж┤ж┤┐┤ФЕФЕ B*CJ OJ QJ ^J aJ ph #5БB*CJ OJ QJ \Б^J aJ ph 6БCJ OJ QJ ]Б^J aJ CJ OJ QJ ^J aJ 5БCJ OJ QJ \Б^J aJ CJ aJ B*CJ OJ QJ aJ ph CJ OJ QJ aJ j CJ OJ QJ UaJ 0J CJ OJ QJ aJ 08▄ 9▄ <▄ Ы▄ ░▄ )▌ }▌ є▌ Z▐ #▀ ;▀ Аф ёф |Д$ s m m m m m m m m m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ I▀ ^▀ с с щс єс т т Qт lт 2у Dу \ф uф Аф Тф Ёф ёф Єф Eх Fх Mх Nх Xх Yх Zх \х ]х ^х ▒х ▓х ╛х ┐х ┴х ╚х чх ях Lц Pц ╞ц ╬ц 7ч ;ч Бч Тч э▐э▐э▐э▐э▐э▐э▐╠▐┐▓й▓Ю▓й┐Щй┐▓й▓Ю▓йЛАЛАЛАЛАЛАr 6БCJ OJ QJ ]Б^J aJ CJ OJ QJ ^J aJ 5БCJ OJ QJ \Б^J aJ CJ aJ 0J CJ OJ QJ aJ CJ OJ QJ aJ j CJ OJ QJ UaJ B*CJ OJ QJ aJ ph #5БB*CJ OJ QJ \Б^J aJ ph B*CJ OJ QJ ^J aJ ph #6БB*CJ OJ QJ ]Б^J aJ ph ,ёф Yх Zх ]х ┴х чх Lц ╞ц 7ч ъч ш зщ ┬щ ∙ v m ∙ ∙ ∙ ∙ ∙ ∙ ∙ ∙ ∙ $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ $If Тч еч ╜ч ╤ч щч ъч ёч ш ш ш ш -ш Iш Цш ░ш ╚ш ┘ш █ш уш 1щ Cщ Pщ {щ зщ ╣щ ┴щ ┬щ ├щ ъ ъ ъ ъ !ъ "ъ $ъ %ъ &ъ yъ zъ Въ Гъ ы ы ы fы gы їчїчї┘ї╟╕ж╕ж╕ж╕ж╕ж╕ж╕ж╕╟╕ЩМГМxМЩsГЩМГМxМГЩМГМ CJ aJ 0J CJ OJ QJ aJ CJ OJ QJ aJ j CJ OJ QJ UaJ B*CJ OJ QJ aJ ph #6БB*CJ OJ QJ ]Б^J aJ ph B*CJ OJ QJ ^J aJ ph #5БB*CJ OJ QJ \Б^J aJ ph 5БCJ OJ QJ \Б^J aJ 6БCJ OJ QJ ]Б^J aJ CJ OJ QJ ^J aJ -┬щ !ъ "ъ %ъ ы xы ∙ v\ m ∙ ∙ $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ $If gы nы oы wы xы yы {ы |ы }ы ╨ы ╤ы ▄ы ▌ы ыы ьы эы @ь Aь Iь Jь Kь Lь Nь Oь Pь гь дь ╛ь ┐ь ╨ь ╥ь ъь ыь ьь ?э @э Lэ Mэ Nэ Oэ Qэ Rэ Sэ жэ зэ ▓э │э ыэ ьэ ээ @ю Aю Gю Hю Iю Jю Lю Mю Nю бю вю ню ою ╖ю ╕ю ╣ю я
я я я я я я я я mя nя zя їш▀╥═▀╥ш▀шїш▀╥ш▀шїш╥═▀╥ш▀шїш▀├▀╥ш▀шїш╥═▀╥ш▀шїш▀╥ш▀шїш╥═▀╥ш▀шїш▀╥ш▀шїш╥═▀╥ш▀шї CJ H*OJ QJ aJ CJ aJ B*CJ OJ QJ aJ ph CJ OJ QJ aJ j CJ OJ QJ UaJ 0J CJ OJ QJ aJ Mxы yы |ы ьы Kь |L s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ Kь Lь Oь ыь Nэ | s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ Nэ Oэ Rэ ьэ Iю |ь s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ Iю Jю Mю ╕ю я |0 s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ я я я |я ия kЁ ╒Ё Йё ╢ё gЄ ╧Є .є |d s m m m m m m m m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ zя {я |я Гя ия ░я kЁ oЁ ╒Ё ▌Ё Йё Нё ╢ё ┬ё gЄ yЄ ╬Є ╧Є ╨Є #є $є ,є -є .є /є 1є 2є 3є Жє Зє Ує Фє └є ┴є ┬є *Ї ,Ї :Ї <Ї JЇ LЇ NЇ RЇ TЇ VЇ №Ї ■Ї *ї ,ї Nї Pї Єщ█╨█╨█╨█╨█╨╛п╛пвЄщЄЧЄвТщвЄщЄЧЄщвЄщЄЧЄщвТщвЄщЄЧЄщЙ CJ OJ QJ aJ CJ aJ 0J CJ OJ QJ aJ B*CJ OJ QJ aJ ph B*CJ OJ QJ ^J aJ ph #5БB*CJ OJ QJ \Б^J aJ ph CJ OJ QJ ^J aJ 5БCJ OJ QJ \Б^J aJ CJ OJ QJ aJ j CJ OJ QJ UaJ 2.є /є 2є ┴є LЇ |р s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ LЇ NЇ TЇ ╪ї PЎ |и s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ Pї Rї ╓ї ╪ї ┌ї @Ў AЎ NЎ OЎ PЎ QЎ SЎ TЎ UЎ иЎ йЎ ╡Ў ╢Ў їЎ ЎЎ ўЎ Jў Kў Rў Sў bў cў dў fў gў hў ╗ў ╝ў ┼ў ╞ў ╫ў ┘ў ° ° ° X° Y° `° a° b° c° ~° ° А° В° Г° Д° ╫° ╪° у° ф° ∙ ∙
∙ ]∙ ^∙ e∙ f∙ g∙ h∙ j∙ k∙ l∙ ┐∙ └∙ ╚∙ їь▀╥ь╥╟╥▀┬ь▀╥ь╥╟╥ь▀╥ь╥╟╥ь▀┬ь▀╥ь╥╟╥ь╕ь▀╥ь╥╟╥ь ▒▀┬ь▀╥ь╥╟╥ь▀╥ь╥╟╥▀┬ь▀╥ь╥╟ CJ OJ QJ CJ H*OJ QJ aJ CJ aJ 0J CJ OJ QJ aJ j CJ OJ QJ UaJ B*CJ OJ QJ aJ ph CJ OJ QJ aJ CJ H*OJ QJ aJ FPЎ QЎ TЎ ЎЎ cў |L s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ cў dў gў ° ° |p s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ ° А° Г° ∙ g∙ |а s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ g∙ h∙ k∙ · `· |ф s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ ╚∙ ╔∙ · · · W· X· ^· _· `· a· c· d· e· ╕· ╣· ┬· ├· ∙· ·· √· N√ O√ U√ V√ W√ X√ Z√ [√ \√ п√ ░√ ┼√ ╞√ ў√ °√ ∙√ L№ M№ S№ T№ U№ V№ X№ Y№ Z№ н№ о№ ─№ ┼№ √№ №№ ¤№ P¤ Q¤ X¤ Y¤ i¤ j¤ k¤ m¤ n¤ o¤ ┬¤ ├¤ ┌¤ █¤ х¤ ц¤ ч¤ :■ ;■ O■ P■ Q■ R■ T■ U■ V■ й■ к■ Єщ▄ЄщЄ╤Є▄╠щ▄ЄщЄ╤Єщ▄ЄщЄ╤Є▄╠щ▄ЄщЄ╤Єщ▄ЄщЄ╤Є▄╠щ▄ЄщЄ╤Єщ▄ЄщЄ╤Єщ▄╠щ▄ЄщЄ╤Єщ▄ЄщЄ╤Є▄╠щ▄ЄщЄ CJ aJ 0J CJ OJ QJ aJ B*CJ OJ QJ aJ ph CJ OJ QJ aJ j CJ OJ QJ UaJ P`· a· d· ·· W√ |▄ s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ W√ X√ [√ °√ U№ |° s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ U№ V№ Y№ №№ j¤ |T s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ j¤ k¤ n¤ ц¤ Q■ |Ь s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ Q■ R■ U■ ╞■ - |p s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ к■ ║■ ╗■ ┼■ ╞■ ╟■ + , - . 0 1 2 Е Ж Ф Х Ц Э ╗ ├ у ч _ u w Т Я - 9 н └ · √ № O P W X b c d f g h ╗ ╝ ├ їш▀╥ш▀шїш╥═▀╥ш▀шїш▀┐┤┐┤┐┤┐┤ж┤┐┤ФЕФЕФЕ╥ш▀шїш▀╥═▀╥ш▀шї B*CJ OJ QJ ^J aJ ph #5БB*CJ OJ QJ \Б^J aJ ph 6БCJ OJ QJ ]Б^J aJ CJ OJ QJ ^J aJ 5БCJ OJ QJ \Б^J aJ CJ aJ B*CJ OJ QJ aJ ph CJ OJ QJ aJ j CJ OJ QJ UaJ 0J CJ OJ QJ aJ 4- . 1 Ц ╗ у w Т - о √ c |╪ s m m m m m m m m m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ c d g ┼ █ d п ▄ = ┤ U ╧ |(# s m m m m m m m m m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ ├ ─ ┼ ╠ █ с d l п │ ╜ ╔ ╙ █ ▄ ф " ' ) = J ┤ └ U g ╬ ╧ ╨ # $ + , - . 0 1 2 Е Ж в г ╖ ╕ ╣
Єщ█╨█╨█╨█╨█╨┬╨┬╨█╨╢╨╢╨дХдХдХИЄщЄ}ЄИxщИЄщЄ}ЄщИЄщ CJ aJ 0J CJ OJ QJ aJ B*CJ OJ QJ aJ ph B*CJ OJ QJ ^J aJ ph #5БB*CJ OJ QJ \Б^J aJ ph CJ H*OJ QJ ^J aJ 6БCJ OJ QJ ]Б^J aJ CJ OJ QJ ^J aJ 5БCJ OJ QJ \Б^J aJ CJ OJ QJ aJ j CJ OJ QJ UaJ /╧ - . 1 ╕
∙ vд m ∙ ∙ $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ $If
n
o
Й
К
№
¤
■
Q R Y Z o p q s t u ╚ ╔ ╓ ╫ ┌ ▄ ° ∙ k l t u v w y z { ╬ ╧ ┌ █ ы ь э @ A H I S T U W X Y м н ╖ ╕ ╨ ╤ ╥ % & . ЄчЄ┌╒╠┌Є╠ЄчЄ╠┌Є╠ЄчЄ╠┌╒╠┌Є╠ЄчЄ╠┬╠╕╠┌Є╠ЄчЄ┌╒╠┌Є╠ЄчЄ╠┌Є╠ЄчЄ╠┌╒╠┌Є╠ЄчЄ╠┌Є╠Єч CJ H*OJ QJ aJ CJ H*OJ QJ aJ CJ OJ QJ aJ CJ aJ B*CJ OJ QJ aJ ph 0J CJ OJ QJ aJ j CJ OJ QJ UaJ H
¤
p |h s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ p q t v | s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ v w z ь T |x s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ T U X ╤ 0 |p s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ . / 0 1 3 4 5 И Й У Ф │ ┤ ╡ j k t u ╩ ╦ ╠ ' ( 2 3 4 6 7 8 Л М Ф Х с т у 6 7 = > ? @ B C D Ч Ш е ж ┼ ╞ ╟ " # $ % ' ( ) | } Л М ┼ ╞ ╟ Єхр╫хЄ╫Є╠Є╫хЄ╫Є╠Єхр╫хЄ╫Є╠Є╫хЄ╫Є╠Є╫хр╫хЄ╫Є╠Є╫хЄ╫Є╠Єхр╫хЄ╫Є╠Є╫хЄ╫Є╠Єхр╫хЄ╫Є╠Є╫хЄ╫Є 0J CJ OJ QJ aJ CJ OJ QJ aJ CJ aJ B*CJ OJ QJ aJ ph j CJ OJ QJ UaJ P0 1 4 ┤ |И s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ ╦ 3 |Д s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ 3 4 7 т ? |0 s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ ? @ C ╞ $ |Ф s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ $ % ( ╞ $ | s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ " # $ % ' ( ) | } К Л М У ж о , 2 x А ╥ ╓ ь э Ї ї p x О Ы ╗ ╟ ╔ ╪ D X g y ╦ ╠ ═ ! ( ) * + - . їш█╓═█ш═шїш═┐┤┐┤┐┤┐┤┐┤┐┤┐┤┐┤вУвУБУБУБУвУ█ш═шїш█╓═█ #6БB*CJ OJ QJ ]Б^J aJ ph B*CJ OJ QJ ^J aJ ph #5БB*CJ OJ QJ \Б^J aJ ph CJ OJ QJ ^J aJ 5БCJ OJ QJ \Б^J aJ CJ OJ QJ aJ CJ aJ B*CJ OJ QJ aJ ph j CJ OJ QJ UaJ 0J CJ OJ QJ aJ 2$ % ( М ж , x ╥ p О ╗ g ╠ | s m m m m m m m m m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ ╠ * + . ├ ∙ v╘ m ∙ ∙ $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ $If . / В Г П Р ┬ ├ ─ " # $ w x В Г У Ф Х ш щ ё Є √ № ¤ T U ` a И Й К ▌ ▐ ч ш щ ъ ь э ю A B \ ] l m n ┴ ┬ ╧ ╨ ╤ ╥ ╒ ╓ ╫ * + 6 7 f g h ╗ ╝ ├ ─ ┼ ╞ ╔ ЄщЄ▐Єщ╤ЄщЄ▐Є╤╠щ╤ЄщЄ▐Єщ╤ЄщЄ▐Єщ╤╠щ╤ЄщЄ▐Єщ╤ЄщЄ▐Є╤╠щ╤ЄщЄ▐Єщ╤ЄщЄ▐Є╤╠щ╤ЄщЄ▐Єщ╤ЄщЄ▐Є╤╠щ CJ aJ B*CJ OJ QJ aJ ph 0J CJ OJ QJ aJ CJ OJ QJ aJ j CJ OJ QJ UaJ P # Ф № |t s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ № ¤ Й щ |┤ s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ щ ъ э m ╤ |а s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ ╤ ╥ ╓ g ┼ |╨ s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ ┼ ╞ ╩ д |L s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ ╔ ╩ ╦ 9 : г д е ° ∙ q r | } Д Ж р с 4! 5! ! ?! B! C! D! Ч! Ш! в! г! ▀! р! с! 4" 5" <" =" >" ?" B" C" D" Ч" Ш" г" д" ▌" ▐" ▀" 2# 3# :# ;# <# =# @# A# B# Х# Ц# ▓# │# х# ц# ч# :$ Єх▄х╤х▄Єх▄х╤х▄Є╠▄Єх▄х╤х▄┬Єх▄х╤хЄ╠▄Єх▄х╤х▄Єх▄х╤хЄ╠▄Єх▄х╤х▄Єх▄х╤хЄ╠▄Єх▄х╤х▄Єх▄ CJ H*OJ QJ aJ CJ aJ 0J CJ OJ QJ aJ CJ OJ QJ aJ j CJ OJ QJ UaJ B*CJ OJ QJ aJ ph L р >! |Ш s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ >! ?! C! р! >" | s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ >" ?" C" ▐" <# |° s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ <# =# A# ц# F$ |( s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ :$ ;$ D$ E$ F$ G$ J$ K$ L$ Я$ а$ з$ и$ ▓$ │$ ┤$ % % % % % % % % % j% k% t% u% & & & ╕& ║& ╝& b' d' r' t' Ж' И' К' Р' Т' Ф' ( ( (( )( И( Й( К( ▌( ▐( ф( х( ц( ч( ъ( ы( ь( ?) @) K) L) }) ~) ) ╥) ╙) ┌) █) ▄) ▌) ЄчЄ┌╒╠┌Є╠ЄчЄ╠┌Є╠ЄчЄ┌╒╠┌Є╠ЄчЄ╠├╣╠┌Є╠ЄчЄ╠┌╒╠┌Є╠ЄчЄ╠┌Є╠ЄчЄ┌╒╠┌Є╠ЄчЄ╠┌Є╠ЄчЄ┌╒ CJ H*OJ QJ aJ CJ OJ QJ aJ CJ OJ QJ aJ CJ aJ B*CJ OJ QJ aJ ph 0J CJ OJ QJ aJ j CJ OJ QJ UaJ IF$ G$ K$ │$ % |, s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ % % % ║& И' |╘ s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ И' К' Т' Й( ц( |И s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ ц( ч( ы( ~) ▄) |╪ s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ ▄) ▌) с) y* ┌* |° s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ ▌) р) с) т) 5* 6* D* E* x* y* z* ═* ╬* ╪* ┘* ┌* █* ▐* ▀* р* 3+ 4+ =+ >+ H+ I+ J+ Э+ Ю+ з+ и+ ▓+ │+ ┤+ ╖+ ╕+ ╣+ ,
, , , G, H, I, Ь, Э, е, ж, п, ░, ▒, ┤, ╡, ╢, -
- - - }- ~- - ╥- ╙- ┌- █- ц- ч- ш- ы- ь- э- @. A. K. L. Щ. Ъ. Ы. ю. я. ў. °. ўъ▌ў▌╥▌ўъ▌ў▌╥▌ъ═ўъ▌ў▌╥▌ўъ▌ў▌╥▌ўъ═ўъ▌ў▌╥▌ўъ▌ў▌╥▌ўъ═ўъ▌ў▌╥▌ўъ▌ў▌╥▌ўъ═ўъ▌ў▌╥▌ўъ▌ў▌╥▌ CJ aJ 0J CJ OJ QJ aJ j CJ OJ QJ UaJ B*CJ OJ QJ aJ ph CJ OJ QJ aJ Q┌* █* ▀* I+ │+ |d s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ │+ ┤+ ╕+ H, ░, |Ї s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ ░, ▒, ╡, ~- ч- |▄ s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ ч- ш- ь- Ъ. ∙. |H s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ °. ∙. ·. ¤. ■. . R/ S/ ]/ ^/ 0 0 0 l0 n0 p0 1 1 $1 &1 (1 *1 01 21 41 ┌1 ▄1 ю1 Ё1 62 72 82 Л2 М2 У2 Ф2 Ю2 Я2 а2 г2 д2 е2 °2 ∙2 3
3 -3 .3 /3 В3 Г3 Н3 О3 П3 Р3 У3 Ф3 Х3 ш3 щ3 ё3 Є3 "4 #4 $4 w4 x4 ~4 4 А4 Б4 Д4 Е4 Ж4 ЄэфЄ╫ф╫╠╫ф├╣фЄ╫ф╫╠╫ЄэфЄ╫ф╫╠╫фЄ╫ф╫╠╫фЄэфЄ╫ф╫╠╫фЄ╫ф╫╠╫ЄэфЄ╫ф╫╠╫фЄ╫ф╫╠╫ЄэфЄ╫ CJ H*OJ QJ aJ CJ OJ QJ aJ 0J CJ OJ QJ aJ j CJ OJ QJ UaJ CJ OJ QJ aJ CJ aJ B*CJ OJ QJ aJ ph I∙. ·. ■. n0 (1 | s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ (1 *1 21 72 Я2 |, s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ Я2 а2 д2 .3 П3 |└ s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ П3 Р3 Ф3 #4 А4 |─ s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ А4 Б4 Е4 5 В5 | s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ Ж4 ┘4 ┌4 ч4 ш4 5 5 5 q5 r5 x5 y5 Б5 В5 Г5 Ж5 З5 И5 █5 ▄5 ч5 ш5 щ5 Ё5 >6 G6 в6 г6 │6 ╗6 ╪7 ▄7 є7 √7 №7 8 18 >8 Ш8 д8 └9 ╥9 №9 ¤9 ■9 Q: R: Y: ўъ▀ъў╥ъўъ▀ъў╥═ў╥ъўъ▀ъў┐┤┐┤и┤┐┤┐┤Ъ┤┐┤ИyИyИy╥ъўъ▀ B*CJ OJ QJ ^J aJ ph #5БB*CJ OJ QJ \Б^J aJ ph 6БCJ OJ QJ ]Б^J aJ CJ H*OJ QJ ^J aJ CJ OJ QJ ^J aJ 5БCJ OJ QJ \Б^J aJ CJ aJ B*CJ OJ QJ aJ ph 0J CJ OJ QJ aJ j CJ OJ QJ UaJ CJ OJ QJ aJ /В5 Г5 З5 щ5 ?6 │6 ╪7 №7 18 Ш8 └9 ¤9 m: |м s m m m m m m m m m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ Y: Z: l: m: n: q: r: s: ╞: ╟: ┘: ┌: ъ: ы: ь: ?; @; G; H; P; Q; R; U; V; W; к; л; ╢; ╖; ┼; ╞; ╟; < < "< #< *< +< ,< /< 0< 1< Д< Е< О< П< ╘< ╒< ╓< )= *= 1= 2= 3= 4= 7= 8= 9= М= Н= в= г= ¤= ■= = R> S> \> ]> ^> _> b> c> d> ╖> ╕> ╫> ╪> √> №> ¤> Єщ▄╫щ▄ЄщЄ╠Єщ▄ЄщЄ╠Єщ▄╫щ▄ЄщЄ╠Єщ▄ЄщЄ╠Єщ▄╫щ▄ЄщЄ╠Єщ▄ЄщЄ╠Є▄╫щ▄ЄщЄ╠Єщ▄ЄщЄ╠Є▄╫щ▄ЄщЄ╠Єщ▄Є 0J CJ OJ QJ aJ CJ aJ B*CJ OJ QJ aJ ph CJ OJ QJ aJ j CJ OJ QJ UaJ Pm: n: r: ы: Q; |Р s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ Q; R; V; ╞; +< |h s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ +< ,< 0< ╒< 3= | s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ 3= 4= 8= ■= ^> |м s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ ^> _> c> №> Z? |Ё s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ ¤> P? Q? X? Y? Z? [? ^? _? `? │? ┤? ┬? ├? Ў? ў? °? K@ L@ S@ T@ _@ `@ a@ d@ e@ f@ ╣@ ║@ ┼@ ╞@ ц@ ч@ ш@ ;A B ?B BB CB DB ЧB ШB ░B ▒B ╬B ╒B C C сC щC ТD ЪD ╘D ўъ▀ъ╥═ў╥ъўъ▀ъў╥ъўъ▀ъў╥═ў╥ъўъ▀ъў╥ъўъ▀ъ╥═ў╥ъўъ▀ъў╥ъўъ▀ъ╥═ў╥ъўъ▀ъў┐┤┐┤┐┤┐┤ CJ OJ QJ ^J aJ 5БCJ OJ QJ \Б^J aJ CJ aJ B*CJ OJ QJ aJ ph 0J CJ OJ QJ aJ j CJ OJ QJ UaJ CJ OJ QJ aJ GZ? [? _? ў? `@ | s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ `@ a@ e@ ч@ DA |Р s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ DA EA IA ╫A >B |ш s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ >B ?B CB C сC ТD ъD GH ~H ▐H |А s m m m m m m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ ╘D шD ъD E PE RE GH YH }H ~H H ╥H ╙H ▄H ▌H ▐H ▀H тH уH фH 7I 8I FI GI II PI hI pI cJ kJ K K aK зK ░K L L ╖L ╔L 3M 4M 5M ИM ЙM РM СM ЩM Єч╒╞╖╞╒╞кЭФЭЙЭкДФкЭФЭЙЭФvчvчvчvчЄvч╒╞╒╞кЭФЭЙЭФ 5БCJ OJ QJ \Б^J aJ CJ aJ 0J CJ OJ QJ aJ CJ OJ QJ aJ j CJ OJ QJ UaJ B*CJ OJ QJ aJ ph B*CJ OJ QJ ^J aJ ph B*CJ OJ QJ ^J aJ ph #5БB*CJ OJ QJ \Б^J aJ ph CJ OJ QJ ^J aJ 6БCJ OJ QJ ]Б^J aJ .▐H ▀H уH II hI cJ K зK L ╖L 4M ЪM |Ё s m m m m m m m m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ ЩM ЪM ЫM ЮM ЯM аM єM ЇM N N N N
N `N aN kN lN mN nN qN rN sN ╞N ╟N ╤N ╥N ыN ьN эN @O AO IO JO KO LO OO PO QO дO еO ░O ▒O тO уO фO 7P 8P ?P @P AP BP EP FP GP ЪP ЫP кP лP ▄P ▌P ▐P 1Q 2Q 9Q :Q BQ CQ DQ GQ HQ IQ ЬQ ЭQ иQ йQ ╖Q ╕Q ╣Q R
R R ЄэфЄ╫ф╫╠╫фЄ╫ф╫╠╫ЄэфЄ╫ф╫╠╫фЄ╫ф╫╠╫ЄэфЄ╫ф╫╠╫фЄ╫ф╫╠╫ЄэфЄ╫ф╫╠╫фЄ╫ф╫╠╫фЄэфЄ╫ф╫╠╫фЄ╫ф╫╠ 0J CJ OJ QJ aJ j CJ OJ QJ UaJ CJ OJ QJ aJ CJ aJ B*CJ OJ QJ aJ ph PЪM ЫM ЯM N mN |L s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ mN nN rN ьN KO |x s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ KO LO PO уO AP |╪ s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ AP BP FP ▌P CQ | s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ CQ DQ HQ ╕Q R |H s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ R R R R R R R nR oR xR yR ГR ДR ЕR ╪R ┘R уR фR хR цR щR ъR ыR >S ?S KS LS XS YS ZS нS оS ╡S ╢S ╖S ╕S ╗S ╝S ╜S T T T T %T &T 'T zT {T ВT ГT ЛT МT НT РT СT ТT хT цT ЁT ёT U U U YU ZU bU cU dU eU hU iU jU ╜U ╛U ╬U ╧U їU ЎU ўU JV KV Єхр╫хЄ╫Є╠Є╫хЄ╫Є╠Єхр╫хЄ╫Є╠Є╫хЄ╫Є╠Єхр╫хЄ╫Є╠Є╫хЄ╫Є╠Є╫хр╫хЄ╫Є╠Є╫хЄ╫Є╠Єхр╫хЄ╫Є╠Є╫хЄ╫Є 0J CJ OJ QJ aJ CJ OJ QJ aJ CJ aJ B*CJ OJ QJ aJ ph j CJ OJ QJ UaJ PR R R ДR хR |@ s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ хR цR ъR YS ╖S |H s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ ╖S ╕S ╝S &T МT |T s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ МT НT СT U dU |` s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ dU eU iU ЎU YV |╘ s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ KV WV XV YV ZV ]V ^V _V ▓V │V ╟V ╚V ;W Z EZ FZ NZ OZ PZ SZ TZ UZ иZ йZ ╣Z ║Z ╔Z ╩Z ╦Z [ їш█╓═█ш═шїш═█ш═шїш═█╓═█ш═шїш═█ш═шїш█╓═█ш═шїш═█ш═шїш█╓═█ш═шїш═█ш═шїш═█╓═█ш═шїш═█ш═ CJ OJ QJ aJ CJ aJ B*CJ OJ QJ aJ ph j CJ OJ QJ UaJ 0J CJ OJ QJ aJ QYV ZV ^V a @a Кa Мa Оa b b #b $b %b &b )b *b +b ~b b Юb Яb ╜b ╛b ┐b c c $c %c &c 'c *c +c ,c c Аc Чc Шc ┤c ╡c ╢c d
d d d d d d d d ld md yd zd жd зd иd √d №d e e Єх▄х╤хЄ╠▄Єх▄х╤х▄├╣▄Єх▄х╤хЄ╠▄Єх▄х╤х▄Єх▄х╤хЄ╠▄Єх▄х╤х▄Єх▄х╤хЄ╠▄Єх▄х╤х▄Єх▄х╤х CJ H*OJ QJ aJ CJ OJ QJ aJ CJ aJ 0J CJ OJ QJ aJ CJ OJ QJ aJ j CJ OJ QJ UaJ B*CJ OJ QJ aJ ph IN` P` X` Мa %b |° s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ %b &b *b ╛b &c | s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ &c 'c +c ╡c d |┤ s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ d d d зd e |Ё s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ e e e e e e e he ie re se Дe Жe Эe Юe Яe Єe єe ·e √e f f f f f
f `f af kf lf vf wf xf ╦f ╠f ╥f ╙f ╘f ╒f ╪f ┘f ┌f -g .g 7g 8g `g ag bg ╡g ╢g ╜g ╛g ╟g ╚g ╔g ╠g ═g ╬g !h "h +h ,h >h @h Zh [h \h пh ░h ╢h ╖h ╕h ╣h ╝h ╜h ╛h i ўъхўъ╪ў╪═╪ў├ўъ╪ў╪═╪ўъхўъ╪ў╪═╪ўъ╪ў╪═╪ъхўъ╪ў╪═╪ўъ╪ў╪═╪ўъхўъ╪ў╪═╪ў├ўъ╪ў╪═╪ъхўъ╪ў CJ H*OJ QJ aJ 0J CJ OJ QJ aJ j CJ OJ QJ UaJ CJ aJ B*CJ OJ QJ aJ ph CJ OJ QJ aJ Me e e Юe f |р s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ f f f wf ╘f |4 s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ ╘f ╒f ┘f ag ╚g |╨ s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ ╚g ╔g ═g [h ╕h |└ s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ ╕h ╣h ╜h Li ╡i |Ї s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ i i i i Ki Li Mi аi бi иi йi ┤i ╡i ╢i ╣i ║i ╗i j j ,j -j Fj Gj Hj Ыj Ьj зj иj йj кj нj оj пj k k
k k k k k sk tk |k }k ~k k Вk Гk Дk ╫k ╪k сk тk √k №k ¤k Pl Ql Xl Yl cl dl el hl il jl ╜l ╛l ╪l ┘l ▄l ▐l m m m Zm [m ЄчЄ▐╤Є▐ЄчЄ▐╤╠▐╤Є▐ЄчЄ▐╤Є▐ЄчЄ╤╠▐╤Є▐ЄчЄ▐╤Є▐ЄчЄ╤╠▐╤Є▐ЄчЄ▐╤Є▐ЄчЄ▐╤╠▐╤Є▐ЄчЄ▐┬▐╤Є▐Є CJ H*OJ QJ aJ CJ aJ B*CJ OJ QJ aJ ph CJ OJ QJ aJ 0J CJ OJ QJ aJ j CJ OJ QJ UaJ L╡i ╢i ║i Gj йj |╨ s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ йj кj оj k ~k |T s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ ~k k Гk №k dl |Ш s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ dl el il m mm |$ s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ [m km lm mm nm qm rm sm ╞m ╟m хm цm n n n Zn [n gn hn in jn mn nn on ┬n ├n ╦n ╠n ╫n ╪n ┘n ,o -o 4o 5o =o >o ?o Bo Co Do Чo Шo бo вo гo кo ╠o ╘o 3p ;p Sq Wq r r r gr tr їш█╓═█ш═шїш═█ш═шїш█╓═█ш═шїш═█ш═шїш═█╓═█ш═шїш═┐┤┐┤┐┤┐ж┤┐┤Ф #5БB*CJ OJ QJ \Б^J aJ ph 6БCJ OJ QJ ]Б^J aJ CJ OJ QJ ^J aJ 5БCJ OJ QJ \Б^J aJ CJ OJ QJ aJ CJ aJ B*CJ OJ QJ aJ ph j CJ OJ QJ UaJ 0J CJ OJ QJ aJ 9mm nm rm n in |Ё s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ in jn nn ╪n >o |T s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ >o ?o Co ╠o 3p Sq r gr вr ╡s ct ╦t |4 s m m m m m m m m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ tr вr оr ░r ╚r -s Cs `s Мs ╡s ╟s bt ct dt ╖t ╕t ╔t ╩t ╦t ╠t ╧t ╨t ╤t $u %u Eu Fu eu fu gu ║u ╗u ┼u ╞u ╟u ╚u ╦u ╠u ═u v !v /v 0v :v ;v О СО ТО йО кО лО ▓О їО ¤О ЬП аП gР oР [Т _Т ╝Т ╧Т фТ ьТ #У $У +У │У └У 6Ф BФ DФ ЄщЄ▐Є╤╠щ╤ЄщЄ▐Єщ╤ЄщЄ▐Є╤╠щ╤ЄщЄ▐Єщ╛│╛│╛│╛│╛е│е│е│╛│УДУД B*CJ OJ QJ ^J aJ ph #5БB*CJ OJ QJ \Б^J aJ ph 6БCJ OJ QJ ]Б^J aJ CJ OJ QJ ^J aJ 5БCJ OJ QJ \Б^J aJ CJ aJ B*CJ OJ QJ aJ ph 0J CJ OJ QJ aJ CJ OJ QJ aJ j CJ OJ QJ UaJ 4RН SН WН ┌Н 8О |Ш s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ 8О 9О =О лО їО ЬП gР [Т $У │У 6Ф IШ ∙Ш ||( s m m m m m m m m m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ DФ XФ ЮФ иФ Х $Х ЭХ ░Х цХ єХ nЦ pЦ ИЦ ЦЦ шЦ ЇЦ ЎЦ Ч Ш Ш IШ [Ш °Ш ∙Ш ·Ш MЩ NЩ UЩ VЩ WЩ XЩ [Щ \Щ ]Щ ░Щ ▒Щ ╨Щ ╤Щ №Щ ¤Щ ■Щ QЪ RЪ [Ъ \Ъ ]Ъ ^Ъ aЪ bЪ cЪ ╢Ъ ╖Ъ ├Ъ ─Ъ эЪ э▐э▐э▐э▐э▐╧▐э▐э▐э▐э▐╜▐░гЪгПг░КЪ░гЪгПгЪ░гЪгПг░КЪ░гЪгПгЪ CJ aJ 0J CJ OJ QJ aJ CJ OJ QJ aJ j CJ OJ QJ UaJ B*CJ OJ QJ aJ ph #5БB*CJ OJ QJ \Б^J aJ ph B*CJ OJ QJ ^J aJ ph B*CJ OJ QJ ^J aJ ph #6БB*CJ OJ QJ ]Б^J aJ ph 6∙Ш WЩ XЩ \Щ ¤Щ ]Ъ ∙ v m ∙ ∙ $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ $If ]Ъ ^Ъ bЪ юЪ NЫ |─ s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ эЪ юЪ яЪ BЫ CЫ LЫ MЫ NЫ OЫ RЫ SЫ TЫ зЫ иЫ ░Ы ▒Ы ┤Ы ╢Ы уЫ фЫ хЫ 8Ь 9Ь @Ь AЬ BЬ CЬ FЬ GЬ HЬ ЫЬ ЬЬ зЬ иЬ ┘Ь ┌Ь █Ь .Э /Э 6Э 7Э HЭ IЭ JЭ MЭ NЭ OЭ вЭ гЭ ▓Э │Э ┌Э █Э ▄Э /Ю 0Ю 7Ю 8Ю 9Ю :Ю =Ю >Ю ?Ю ТЮ УЮ вЮ гЮ нЮ оЮ пЮ Я Я
Я Я Я Я Я Єх▄х╤хЄ╠▄Єх▄х╤х▄┬▄Єх▄х╤хЄ╠▄Єх▄х╤х▄Єх▄х╤х▄Є╠▄Єх▄х╤х▄Єх▄х╤хЄ╠▄Єх▄х╤х▄Єх▄х╤хЄ╠▄ CJ H*OJ QJ aJ CJ aJ 0J CJ OJ QJ aJ CJ OJ QJ aJ j CJ OJ QJ UaJ B*CJ OJ QJ aJ ph LNЫ OЫ SЫ фЫ BЬ |╨ s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ BЬ CЬ GЬ ┌Ь IЭ | s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ IЭ JЭ NЭ █Э 9Ю |└ s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ 9Ю :Ю >Ю оЮ Я |X s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ Я Я Я ╓Я 6а |Ь s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ Я Я Я hЯ iЯ ЗЯ ИЯ ╒Я ╓Я ╫Я *а +а 4а 5а 6а 7а :а ;а <а Па Ра Ыа Ьа ╙а ╘а ╒а (б )б 0б 1б 2б 3б 6б 7б 8б Лб Мб иб йб │б ┤б ╡б в в в в в в в в в pв qв Ав Бв зв ив йв №в ¤в г г г г г г г г iг jг xг yг Фг Хг Цг щг ъг Ёг ёг Єг єг Єх▄х╤х▄Єх▄х╤хЄ╠▄Єх▄х╤х▄Єх▄х╤хЄ╠▄Єх▄х╤х▄Єх▄х╤хЄ╠▄Єх▄х╤х▄Єх▄х╤х▄Є╠▄Єх▄х╤х▄Єх▄х╤хЄ╠ CJ aJ 0J CJ OJ QJ aJ CJ OJ QJ aJ j CJ OJ QJ UaJ B*CJ OJ QJ aJ ph P6а 7а ;а ╘а 2б |Ё s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ 2б 3б 7б ┤б в |Ф s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ в в в ив г |ф s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ г г г Хг Єг |И s m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ Єг єг ∙г 0д Bд пд д фе ж Иж Эж еж жж |╠
s m m m m m m m m m |╕ $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ єг ∙г ·г "д #д $д .д /д 0д 7д Bд Jд пд │д ╡д ■д д е vе Зе фе ше №е ж ж #ж %ж 1ж Fж Zж iж |ж Иж Ъж Ьж еж жж мж ўъў┌ъ╧ъў┴╢┴╢┴╢н╢┴╢Я╢┴╢Я╢Н~l~l~l~Н~ўgў CJ aJ #6БB*CJ OJ QJ ]Б^J aJ ph B*CJ OJ QJ ^J aJ ph #5БB*CJ OJ QJ \Б^J aJ ph 6БCJ OJ QJ ]Б^J aJ CJ OJ QJ ^J CJ OJ QJ ^J aJ 5БCJ OJ QJ \Б^J aJ 0J CJ OJ QJ aJ Бj┘ CJ OJ QJ UaJ j CJ OJ QJ UaJ CJ OJ QJ aJ %жж мж з &з Нз Яз 2и Ри ┘и Jй Бк Йл Ул Ў Ё Ё Ё Ё Ё Ё Ё Ё Ё Ё Ё $If $$If a$ мж нж їж Ўж ўж ж з з з &з .з Нз Сз Яз зз 2и 6и Zи \и jи lи Пи Ри Ши ┘и ци Jй Vй Xй yй Дй жй яй к
к &к Sк eк Бк Ук Ил Ёх╙Ё╞Ёх╕н╕н╕н╕н╕ЯнЯнЯн╕нН~Н~l~l~l~l~l~Н~ #6БB*CJ OJ QJ ]Б^J aJ ph B*CJ OJ QJ ^J aJ ph #5БB*CJ OJ QJ \Б^J aJ ph 6БCJ OJ QJ ]Б^J aJ CJ OJ QJ ^J aJ 5БCJ OJ QJ \Б^J aJ 0J CJ OJ QJ ^J aJ #БjА CJ OJ QJ U^J aJ CJ OJ QJ ^J aJ j CJ OJ QJ U^J aJ (Ил Ул Фл Ъл Ыл ьл эл юл √л №л ■л м %м -м н н Mн Qн }о ~о Жо що Ўо !п -п А░ Т░ т░ ы░ ь░ Є░ є░ ўЄўс╒┴с┤сжШНШНШНШНШНm^m^m^ўЄўT j 5БCJ U\Б B*CJ OJ QJ ^J aJ ph #5БB*CJ OJ QJ \Б^J aJ ph 6БCJ OJ QJ ]Б^J aJ CJ OJ QJ ^J aJ 5БCJ OJ QJ \Б^J aJ 5БCJ OJ QJ \Б^J aJ 0J CJ OJ QJ ^J aJ &Бjg >*CJ OJ QJ U^J aJ >*CJ OJ QJ ^J aJ j >*CJ OJ QJ U^J aJ CJ aJ CJ OJ QJ aJ Ул Фл Ъл ■л %м н Mн ~о що !п А░ у░ ы░ |` s m m m m m m m m m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ ы░ ь░ Є░ K▒ Е▒ ╙▒ &▓ X▓ ╦▓ │ W│ v╡ | s m g g g g g g g g $If $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ є░ >▒ ?▒ @▒ I▒ J▒ K▒ R▒ Е▒ Н▒ ╙▒ ╫▒ &▓ .▓ X▓ \▓ h▓ ╩▓ ╦▓ ╥▓ │ │ W│ c│ g│ o│ Ч│ й│ L┤ V┤ n┤ А┤ У┤ й┤ ┐┤ ╦┤ №┤ ╡ v╡ И╡ щ╡ Є╡ є╡ ∙╡ ·эу█у╪╩┐╩┐╩┐╩┐╩┐▒┐╩┐ЯРЯР~Р~Р~Р~Р~Р~Р~РЯРupu CJ aJ CJ OJ QJ aJ #6БB*CJ OJ QJ ]Б^J aJ ph B*CJ OJ QJ ^J aJ ph #5БB*CJ OJ QJ \Б^J aJ ph 6БCJ OJ QJ ]Б^J aJ CJ OJ QJ ^J aJ 5БCJ OJ QJ \Б^J aJ CJ 0J 5БCJ \Б j 5БCJ U\ББj` 5БCJ U\Б
5БCJ \Б+v╡ ъ╡ Є╡ є╡ ∙╡ Y╢ k╢ ╫╢ ╖ s╕ '╣ B╣ Х╣ ∙ ∙ vи m ∙ ∙ ∙ ∙ ∙ ∙ ∙ ∙ $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ $If ∙╡ ·╡ J╢ K╢ L╢ W╢ X╢ Y╢ `╢ k╢ s╢ ╫╢ █╢ ╖ ╖ #╖ %╖ =╖ >╖ '╕ .╕ s╕ w╕ ╛╕ ╩╕ '╣ 3╣ B╣ T╣ Ф╣ Ь╣ Э╣ г╣ д╣ я╣ Ё╣ ё╣ Ёх╙Ё╞Ёх╕н╕н╕н╕н╕Я╕нЯн╕нЯнН~Н~upuЁх^Ё #БjD CJ OJ QJ U^J aJ CJ aJ CJ OJ QJ aJ B*CJ OJ QJ ^J aJ ph #5БB*CJ OJ QJ \Б^J aJ ph 6БCJ OJ QJ ]Б^J aJ CJ OJ QJ ^J aJ 5БCJ OJ QJ \Б^J aJ 0J CJ OJ QJ ^J aJ #БjM CJ OJ QJ U^J aJ CJ OJ QJ ^J aJ j CJ OJ QJ U^J aJ $Х╣ Ь╣ Э╣ г╣ ■╣ ║ 0╗ (╝ ╣╝ ┌╜ Ш╛ ╬╛ d└ ∙ v╚ m ∙ ∙ ∙ ∙ ∙ ∙ ∙ ∙ ∙ $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ $If ё╣ №╣ ¤╣ ■╣ ║ ║ (║ 0╗ 4╗ (╝ 0╝ ╣╝ ╜╝ 4╜ ]╜ Щ╜ й╜ ─╜ ┘╜ ┌╜ т╜ Ч╛ Ш╛ е╛ ╬╛ ┌╛ ш╛ $┐ ,┐ D┐ P┐ e┐ |┐ Х┐ п┐ ─┐ ▌┐ ¤┐ └ ;└ L└ d└ v└ ╞└ ╬└ єф┘╦└╦└╦└╦└╦└▓└▓└▓└╦└╦аСаССССССССаСv CJ OJ QJ aJ #6БB*CJ OJ QJ ]Б^J aJ ph B*CJ OJ QJ ^J aJ ph #5БB*CJ OJ QJ \Б^J aJ ph 6БCJ OJ QJ ]Б^J aJ CJ OJ QJ ^J aJ 5БCJ OJ QJ \Б^J aJ CJ OJ QJ ^J aJ j CJ OJ QJ U^J aJ 0J CJ OJ QJ ^J aJ ,d└ ╟└ ╬└ ╧└ ╒└ .┴ s┴ ┬ v┬ ├ o├ ╢├ ∙├ ∙ ∙ v m ∙ ∙ ∙ ∙ ∙ ∙ ∙ ∙ $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ $If ╬└ ╧└ ╒└ ╓└ !┴ "┴ #┴ ,┴ -┴ .┴ 5┴ s┴ {┴ ┬ ┬ v┬ ~┬ ├ ├ ├ ├ o├ w├ ╢├ ├├ ∙├ ─ f┼ x┼ ╞ ╞ ╞ ╞ *╞ :╞ <╞ J╞ ~╞ О╞ ╨╞ ╥╞ √Єу╪╞у╣у╪лалалалалалалаОООаЄ√Є{ лалаp CJ OJ QJ ^J aJ 5Б\Б B*CJ OJ QJ ^J aJ ph #5БB*CJ OJ QJ \Б^J aJ ph CJ OJ QJ ^J aJ 5БCJ OJ QJ \Б^J aJ 0J CJ OJ QJ ^J aJ #Бj1 CJ OJ QJ U^J aJ CJ OJ QJ ^J aJ j CJ OJ QJ U^J aJ CJ OJ QJ aJ CJ aJ (∙├ f┼ ╞ ╞ ╞ *╞ <╞ ~╞ ╚ E╚ ╪╚ E╔ ∙ ∙ ∙ vр m g ∙ ∙ ∙ ∙ ∙ $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ $If ╥╞ ╘╞ ▐╞ т╞ ░╟ ▓╟ ╢╟ ╚ ╚ E╚ M╚ ╪╚ ▄╚ <╔ D╔ E╔ L╔ В╔ П╔ ╛╔ ╩╔ ╨╩ ╥╩ ш╩ ъ╩ ╦ "╦ x╦ z╦ М╦ О╦ Ъ╦ ░╦ ╛╦ Ё╦ Є╦ Ї╦ ,╠ <╠ ╝╠ ╛╠ └╠ Ў╠ °╠ ═ ═ ═ ═ єш▌ш▌єш╧ш╧ш╧ш┴ш╧шпапаСаСапашИГИx╧ш▌єш╧ш▌єш▌ш▌єш CJ OJ QJ ^J aJ CJ aJ CJ OJ QJ aJ B*CJ OJ QJ ^J aJ ph B*CJ OJ QJ ^J aJ ph #5БB*CJ OJ QJ \Б^J aJ ph 6БCJ OJ QJ ]Б^J aJ 5БCJ OJ QJ \Б^J aJ CJ OJ QJ ^J aJ CJ OJ QJ ^J aJ CJ H*OJ QJ ^J aJ /E╔ В╔ ╛╔ ╦ z╦ М╦ О╦ Ъ╦ ░╦ ,╠ ═ ┤═ W╬ ∙ ∙ ∙ ∙ ∙ vT m ∙ ∙ ∙ ∙ ∙ $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ $If ═ "═ ┤═ ─═ W╬ [╬ c╬ i╬ k╬ Ц╬ Ч╬ д╬ з╬ ┤╬ ╢╬ └╬ ╤╬ ▌╬ ╧ ╧ -╧ 9╧ [╧ |╧ Ь╧ о╧ ╤╧ ╥╧ █╧ ▄╧ т╧ ъ╧ ╨ ╨ T╨ d╨ м╨ о╨ ░╨ ф╥ ц╥ ш╥ H╙ P╙ &╘ .╘ Щ╘ ЄчЄчЄчЄ┘чЄ╟╕╟╕ж╕ж╕ж╕ж╕ж╕╟╕чЭШЭНЄВчЄчВvчВvчЄчЄч CJ H*OJ QJ ^J aJ CJ OJ QJ ^J aJ CJ OJ QJ ^J aJ CJ aJ CJ OJ QJ aJ #6БB*CJ OJ QJ ]Б^J aJ ph B*CJ OJ QJ ^J aJ ph #5БB*CJ OJ QJ \Б^J aJ ph 6БCJ OJ QJ ]Б^J aJ CJ OJ QJ ^J aJ 5БCJ OJ QJ \Б^J aJ .W╬ c╬ Ч╬ и╬ Ь╧ ╥╧ █╧ ▄╧ т╧ ъ╧ T╨ H╙ &╘ ∙ ∙ ∙ ∙ ∙ ∙ vl m ∙ ∙ ∙ ∙ $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ $If Щ╘ Ы╘ И╒ М╒ ╤╒ ┘╒ ┌╒ ▄╒ с╒ у╒ >╓ X╓ ╫ ╫ ^╫ `╫ ╬╪ р╪ :┘ ;┘ E┘ F┘ L┘ ┌ ┌ 0┌ 2┌ Z┌ j┌ █ █ И▄ Р▄ Б▌ Е▌ У▌ Ю▌ а▌ ▀▌ с▌ э▌ ю▌ Ў▌ ▐ ▐ #▐ %▐ i▐ єш┌ш┌шєшєш╚╣╚╣к╣╚╣шбЬбС┌шЖш┌ш┌ш┌ш┌шxшxшxш┌шєшєш 6БCJ OJ QJ ]Б^J aJ CJ OJ QJ ^J aJ CJ OJ QJ ^J aJ CJ aJ CJ OJ QJ aJ B*CJ OJ QJ ^J aJ ph B*CJ OJ QJ ^J aJ ph #5БB*CJ OJ QJ \Б^J aJ ph 5БCJ OJ QJ \Б^J aJ CJ OJ QJ ^J aJ CJ H*OJ QJ ^J aJ /&╘ И╒ ╤╒ >╓ ╫ ╬╪ ;┘ E┘ F┘ L┘ ┌ Z┌ █ ∙ ∙ ∙ ∙ ∙ ∙ ∙ vШ m ∙ ∙ ∙ $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ $If █ И▄ Б▌ ю▌ i▐ у▐ Вр #с +с ,с 2с :с _с ∙ ∙ ∙ ∙ ∙ ∙ ∙ ∙ v╘ m ∙ ∙ $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ $If i▐ v▐ у▐ я▐ ё▐ ·▐ ▀ 3▀ O▀ \▀ С▀ и▀ р р #р 4р [р pр Вр Фр "с #с +с ,с 2с 9с Aс _с gс ╒с ┘с Цт Ют у
у lу tу ф )ф 4ф @ф Ух ех ^ц _ц `ц aц gц qц rц yц Чц Яц
ч ч Tч э▐э▐╠▐╠▐╠▐╠▐╠▐╠▐╠▐э▐┴╕│╕иЪ┴Ъ┴Ъ┴Ъ┴Ъ┴Ъ┴э▐э▐э▐┴╕│╕иМЪ┴Ъ┴Ъ┴ 5БCJ OJ QJ \Б^J aJ 5БCJ OJ QJ \Б^J aJ CJ OJ QJ ^J aJ CJ aJ CJ OJ QJ aJ CJ OJ QJ ^J aJ #6БB*CJ OJ QJ ]Б^J aJ ph B*CJ OJ QJ ^J aJ ph #5БB*CJ OJ QJ \Б^J aJ ph 7_с ╒с Цт у lу ф 4ф Ух _ц `ц aц gц rц ∙ ∙ ∙ ∙ ∙ ∙ ∙ ∙ ∙ vШ m ∙ $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ $If rц Чц
ч Tч Эч ╪ч tш єш ущ >ъ Fъ Gъ Mъ ∙ ∙ ∙ ∙ ∙ ∙ ∙ ∙ ∙ ∙ vd m $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ $If Tч \ч qч rч Эч бч ╫ч ╪ч рч tш Бш єш ш Ащ нщ ущ їщ =ъ >ъ Fъ Gъ Mъ Vъ Нъ Оъ Пъ Юъ Яъ аъ жъ │ъ >ы ?ы @ы Fы Rы ь ь 6ь 7ь =ь Hь ▀ь рь Їь їь √ь э :э ;э ЄчЄчЄ┘чЄч╟╕╟╕ж╕╟╕чЭШЭЙ~чЄ~ЭШЭЙ~ЭШЭЙ~ЄЭШЭЙ~ЄЭШЭЙ~Є CJ OJ QJ ^J aJ B*CJ OJ QJ ^J aJ ph CJ aJ CJ OJ QJ aJ #6БB*CJ OJ QJ ]Б^J aJ ph B*CJ OJ QJ ^J aJ ph #5БB*CJ OJ QJ \Б^J aJ ph 6БCJ OJ QJ ]Б^J aJ CJ OJ QJ ^J aJ 5БCJ OJ QJ \Б^J aJ 1Mъ Оъ Пъ Яъ аъ жъ 0ы ?ы @ы Fы ь 6ь 7ь ∙ ∙ ∙ vА m ∙ ∙ v▄ m ∙ ∙ v° $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ $If 7ь =ь рь Їь їь √ь ;э Cэ Dэ Jэ ╝э ╤э ╥э Ў Ё Ё m< Ў Ё Ё m8 Ў Ё Ё mШ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ $If $$If a$ ;э Cэ Dэ Jэ Sэ ╗э ╝э ╤э ╥э ╪э рэ сэ щэ ъэ юэ ёэ ∙э ·э ■э э ю !ю $ю 5ю 6ю 7ю 8ю >ю Fю Gю Oю Pю Tю Wю _ю `ю dю eю mю Зю Кю Ыю Ью дю мю ню ╡ю ╢ю ║ю ╜ю ┼ю ╞ю ╩ю ╦ю ╙ю эю Ёю я я
я я я я ўЄўу╪уўЄў╩┐╩┐╩┐╩┐╩┐╩нЮн╩ўЄў╩┐╩┐╩┐╩┐╩┐╩нЮн╩ў╩┐╩┐╩┐╩┐╩┐╩нЮн╩ў╩┐╩ B*CJ OJ QJ ^J aJ ph #5БB*CJ OJ QJ \Б^J aJ ph CJ OJ QJ ^J aJ 5БCJ OJ QJ \Б^J aJ CJ OJ QJ ^J aJ B*CJ OJ QJ ^J aJ ph CJ aJ CJ OJ QJ aJ >╥э ╪э ┘э сэ ъэ ёэ ·э э ю ю $ю 6ю 7ю Ў Ё Ё Ё Ё Ё Ё Ё Ё Ё Ё Ё $If $$If a$ 7ю 8ю >ю ?ю Gю Pю Wю `ю eю mю {ю Кю Ью |Ш s m m m m m m m m m m $If $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ Ью Эю Юю дю ею ню ╢ю ╜ю ╞ю ╦ю ╙ю сю Ёю ∙ vШ m ∙ ∙ ∙ ∙ ∙ ∙ ∙ ∙ ∙ $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ $If Ёю я я я
я я я я #я ,я 1я 9я Gя ∙ ∙ vШ m ∙ ∙ ∙ ∙ ∙ ∙ ∙ ∙ $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ $If я я я #я +я ,я 0я 1я 9я Sя Vя gя hя pя xя yя Бя Вя Жя Йя Ся Тя Ця Чя Яя ╣я ╝я ═я ╬я ╓я ▐я ▀я чя шя ья яя ўя °я №я ¤я Ё Ё "Ё 3Ё 4Ё <Ё DЁ EЁ MЁ NЁ RЁ UЁ ]Ё ^Ё bЁ cЁ kЁ ЕЁ ИЁ ЩЁ ЪЁ ЬЁ ЭЁ їчїчїчїч╒╞╒ч╜чїчїчїчїчїч╒╞╒ч╜чїчїчїчїчїч╒╞╒ч╜чїчїчїчїчїч╒╞╒ч╜ CJ OJ QJ aJ B*CJ OJ QJ ^J aJ ph #5БB*CJ OJ QJ \Б^J aJ ph 5БCJ OJ QJ \Б^J aJ CJ OJ QJ ^J aJ >Gя Vя hя iя jя pя qя yя Вя Йя Тя Чя Яя ∙ ∙ ∙ vШ m ∙ ∙ ∙ ∙ ∙ ∙ ∙ $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ $If Яя ня ╝я ╬я ╧я ╨я ╓я ╫я ▀я шя яя °я ¤я ∙ ∙ ∙ ∙ vШ m ∙ ∙ ∙ ∙ ∙ ∙ $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ $If ¤я Ё Ё "Ё 4Ё 5Ё 6Ё <Ё =Ё EЁ NЁ UЁ ^Ё ∙ ∙ ∙ ∙ ∙ vШ m ∙ ∙ ∙ ∙ ∙ $$If a$ В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ $If ^Ё cЁ kЁ yЁ ИЁ ЪЁ ЫЁ ЬЁ ЭЁ ∙ ∙ ∙ ∙ ∙ ∙ v t В $$If Ц$ ╓F Я ╣#%с*Аэ АL АС ╓ ╓ яяя яяя яяя ЎИ6╓ ╓ ╓ ╓ 2╓ $ 2╓ Ё 2╓$ 2╓Ё 3╓ 4╓ $ aЎЁ $If 1Рh ░╨/ ░р=!░╨"░`#Р╨$Р╨%░ M D ╨╔ъy∙║╬МВ к Kй 6 h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / р╔ъy∙║╬МВ к Kй l h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D ╨╔ъy∙║╬МВ к Kй р╔ъy∙║╬МВ к Kй м h t t p : / / w w w . a m a z o n . c o m / e x e c / o b i d o s / t g / d e t a i l / - / 0 7 8 1 7 3 2 0 3 4 / 1 0 4 - 8 3 9 8 4 0 5 - 0 6 9 5 9 0 1 ? v = g l a n c e o D ╨╔ъy∙║╬МВ к Kй р╔ъy∙║╬МВ к Kй ■ h t t p : / / w w w . a m a z o n . c o m / e x e c / o b i d o s / t g / d e t a i l / - / 0 9 6 3 6 2 1 9 8 X / q i d = 1 0 9 0 5 2 6 8 1 9 / s r = 1 - 1 / r e f = s r _ 1 _ 1 / 1 0 4 - 8 3 9 8 4 0 5 - 0 6 9 5 9 0 1 ? v = g l a n c e & s = b o o k s з D ╨╔ъy∙║╬МВ к Kй р╔ъy∙║╬МВ к Kй 6 h t t p : / / w w w . d o l a s e t r o n . c o m / ч D ╨╔ъy∙║╬МВ к Kй р╔ъy∙║╬МВ к Kй v h t t p : / / w w w . m s c o n t i n . c o m / h t m l / O u r _ p r o d u c t s / O u r _ p r o d u c t s . h t m ∙ D ╨╔ъy∙║╬МВ к Kй р╔ъy∙║╬МВ к Kй И h t t p : / / w w w . g o o g l e . c o m / s e a r c h ? h l = e n & i e = U T F - 8 & q = a c e t a m i n o p h e n & s p e l l = 1 э D ╨╔ъy∙║╬МВ к Kй р╔ъy∙║╬МВ к Kй | h t t p : / / w w w . n l m . n i h . g o v / m e d l i n e p l u s / d r u g i n f o / u s p d i / 2 0 2 3 1 8 . h t m l ў D ╨╔ъy∙║╬МВ к Kй р╔ъy∙║╬МВ к Kй Ж h t t p : / / w w w . n l m . n i h . g o v / m e d l i n e p l u s / d r u g i n f o / m e d m a s t e r / a 6 0 1 2 0 9 . h t m l э D ╨╔ъy∙║╬МВ к Kй р╔ъy∙║╬МВ к Kй | h t t p : / / w w w . n l m . n i h . g o v / m e d l i n e p l u s / d r u g i n f o / u s p d i / 2 0 2 2 7 8 . h t m l э D ╨╔ъy∙║╬МВ к Kй р╔ъy∙║╬МВ к Kй | h t t p : / / w w w . n l m . n i h . g o v / m e d l i n e p l u s / d r u g i n f o / u s p d i / 2 0 2 3 7 2 . h t m l
i 8 @ё 8 N o r m a l CJ _HaJ mH sH tH B ` B H e a d i n g 1 $@& 5БOJ QJ \Б^J aJ F ` F H e a d i n g 2 $@& 5БCJ OJ QJ \Б^J aJ H ` H H e a d i n g 3 $$@&a$ 5БCJ OJ QJ \БaJ < A@Є б < D e f a u l t P a r a g r a p h F o n t > V@в ё > F o l l o w e d H y p e r l i n k >*B* phА А . U@в . H y p e r l i n k >*B*ph 6 B` 6 B o d y T e x t CJ OJ QJ aJ °╪ ] | \ " # $ Д х ц э ┬ o ш G Е ┬
= Ф о r д ¤ H ▌ я l № 7
Ц
ж
з
й
! p ╠ / L Ї є
} ~ А ф √ ╕ Т | ╠ : ╒ 5 6 8 Ч ╒ Ъ ё ╡ ╚ % Н Щ 7 Я а в 5 ╓ ╞! v" └" s# м# $ !$ #$ Ч$ ▒$ C% с% Р' T( ┴( Т) ╡* + + + Е+ ▓+ , q, j. П/ э/ :0 Ї0 ░1 2 2 2 y2 к2 х2 Ў3 14 ┴4 5 J5 у5 '6 Е6 Ж6 И6 Ё6 /7 .8 ╜8 ; B; з; Z< с= ▀> =? >? A? в? ╥? ,@ g@ ъA BB ЫB ╞B ДD D dE eE hE ╥E F zF яF ЦG ФH ╔H *I ╛J K ЙK КK НK юK
L tL zM мM QN bN ЬN P ╖P Q Q Q yQ ХQ ыQ >R ЮT нT U `V ╫V 3W 4W 7W бW ╦W 6X RX ОX GY YY ЁY ╟Z [ v[ w[ z[ ▌[ ¤[ Х\ Е] п_ ` c` ╬` b пb c c c zc нc ?d Me Jf _f Нf ╙f (g Оg Пg Тg Їg 'h vh (i Ri oi j ╒j 0k Мk Нk Рk єk *l эl wm `o бo -p ╚p 'q (q +q Лq ╓q Nr ├r t vt Юt №t 0w кw x x x x ╕x y y y Вy │y
z :z Тz { [{ Ф{ l| м| } } } Е} у} ф} ч} q~ ╪~ ┘~ ▄~ ] ╗ ╝ ┐ УА ёА ЄА їА `Б ЙБ .В йВ ¤Г ┘Д 5Е мЕ √Ж 5З аЗ бЗ дЗ GИ еИ жИ йИ ?Й ЬЙ ЭЙ аЙ ;К ЪК ЫК ЮК К DЛ ОЛ ╦Л чМ +П AП ЧП №Р [С ┴С ┬С ┼С &Т NТ ▄Т JУ HФ +Х eХ ┴Х ┬Х ┼Х %Ц uЦ TЧ rЧ ╕Ч ┘Ч FШ ├Ш эШ JЩ KЩ NЩ ЇЩ QЪ RЪ UЪ ╔Ъ (Ы 3Ы 4Ы 7Ы ЧЫ ЄЫ AЬ ┤Ь ШЮ Я ^Я РЯ Zа эа Sб Tб Wб шб Fв Gв Jв кв ╛в г ╫г Oд ╠д щд ╦ж з _з `з cз ∙з Xи Yи \и ╙и 0й 1й 4й жй к к к Юк л л л Ьл м м м tм ╘м ╒м ╪м Lн uн ╖н wо зп ╙п ░ Ч▒ ь▒ W▓ X▓ [▓ ═▓ -│ .│ 1│ G┤ е┤ ж┤ й┤
╡ (╡ ┤╡ №╡ p╢ ╗╢ √╢ ╗╕ ь╕ ]╣ ^╣ a╣ х╣ F║ G║ J║ ╡║ ╗ ╗ ╗ Й╗ щ╗ ъ╗ э╗ s╝ ╙╝ ╘╝ ╫╝ ]╜ ║╜ ╗╜ ╛╜ P╛ └╛ ┴╛ ─╛ &┐ W┐ ю┐ Д└ ┴ A┴ И┴ y┬ ▓┬ ├ ├ ├ О├ э├ ю├ ё├ y─ Є─ ╞ М╞ й╞ *╚ Q╚ н╚ о╚ ▒╚ ;╔ о╔ п╔ ▓╔ I╩ ╖╩ ╕╩ ╗╩ $╦ L╦ ┐╦ L╠ °╠ j═ ▒═ 1╬ С╬ я╬ Ё╬ є╬ Д╧ т╧ у╧ ц╧ w╨ ▀╨ р╨ у╨ V╤ ╡╤ ╢╤ ╣╤ O╥ ╢╥ ╖╥ ║╥ ╙ .╙ з╙ √╙ q╘ ╪╘ б╒ ╣╒ ■┌ o█ ╫█ ╪█ ██ ?▄ e▄ ╩▄ D▌ ╡▌ h▐ Б▐ %р @р Яр ар гр Рс Ўс ўс ·с jт ╔т ╩т ═т iу ╠у ═у ╨у jф ╟ф ╚ф ╦ф 6х Ух Фх Чх ·х &ц щц Sч ш 4ш хш Mщ мщ нщ ░щ ?ъ дъ еъ иъ jы ╬ы ╧ы ╥ы tь сь ть хь Вэ ¤э ■э ю Зю хю цю щю Бя ▐я ▀я тя xЁ ╒Ё ╓Ё ┘Ё vё ╙ё ╘ё ╫ё zЄ шЄ щЄ ьЄ dє ╧є ╨є ╙є DЇ лЇ мЇ пЇ ї 9ї Уї aЎ їЎ ў лў ,° y° с° т° х° C∙ Ж∙ Y· т· -№ Z№ ╗№ 2¤ ╙ M л м п 6 Ф Х Ш { ю я Є Х Ї ї ° j ╥ ╙ ╓ O о п ▓ 2 Р С Ф I ▒ ▓ ╡ ` ╜ ╛ ┴ D
в
г
ж
D в г ж
$ к Ў P
ю
9 х J и й м A Э Ю б z { ~ g h k ы O P T х C D H " Ц Ч Ы ^ ╝ ╜ ┴ ^ ╝ ╜ ┴ \ ║ ╗ ┐ d ─ ┼ ╔ 1 П Р Ф ] ─ ┼ ╔ Й ц ч ы ~ ▄ ▌ с y ┌ █ ▀ I │ ┤ ╕ H ░ ▒ ╡ ~! ч! ш! ь! Ъ" ∙" ·" ■" б# ■# # $ б$ %
% % Ш% ∙% ·% ■% Н& ъ& ы& я& З' ь' э' ё' S( й( ) B* f* Ы* + *, g, ╫, ╪, ▄, U- ╗- ╝- └- 0. Х. Ц. Ъ. ?/ Э/ Ю/ в/ h0 ╚0 ╔0 ═0 f1 ─1 ┼1 ╔1 a2 ╩2 ╦2 ╧2 Q3 о3 п3 │3 A4 и4 й4 н4 5 K6 │6 ▀6 ▒9 ш9 H: I: M: │: ╥: ═; Г< = p= !> Ю> ? ? ? v? ╫? ╪? ▄? V@ ╡@ ╢@ ║@ MA лA мA ░A GB нB оB ▓B "C C АC ДC юC OD PD TD ├D !E "E &E РE ЎE ўE √E oF ╬F ╧F ╙F `G ├G ─G ╚G жH I I I жI J J J yJ ╓J ╫J █J SK ╣K ║K ╛K 4L ЧL ШL ЬL 4M ТM УM ЧM %N МN НN СN 'O ПO РO ФO P КP ЛP ПP 2Q СQ ТQ ЦQ 0R ПR РR ФR (S РS СS ХS T }T ~T ВT U yU zU ~U V qV rV vV сV >W ?W CW ╦W 2X 3X 7X ┼X "Y #Y 'Y ╢Y Z Z $Z ▒Z [ [ [ Й[ ш[ щ[ э[ f\ ╬\ ╧\ ╙\ p] ╫] ╪] ▄] p^ ╙^ ╘^ ╪^ B_ и_ й_ н_ 6` Э` ╜a mb ╤b c d ═d 5e 6e :e ╨e 1f 2f 6f еf g g g Хg Ўg ўg √g ih ╨h ╤h ╒h Вi тi уi чi [j ╣j ║j ╛j 6k Цk Чk Ыk Дl цl чl ыl \m ─m ┼m ╔m ^n ╗n ╝n └n Wo │o ┤o ╕o Bp жp зp лp 7q Юq Яq гq 8r Эr Юr вr s ps qs us їs et ft jt ъt Hu Iu Mu ╦u 2v 3v 7v ╛v w dw Ex \x xx Xy еy z z z Ыz ·z √z z М{ ъ{ ы{ я{ a| ┐| └| ─| ^} ╝} ╜} ┴} D~ в~ г~ з~ _ А ╤А ┼В ОГ Д аД │З cИ ┴И ┬И ╞И gЙ ╟Й ╚Й ╠Й XК ╕К ╣К ╜К NЛ мЛ нЛ ▒Л DМ │М ┤М ╕М EН гН дН иН О yО zО ~О @П аП бП еП >Р ЬР ЭР бР С БС ВС ЖС Т zТ {Т Т Т \У ]У cУ ЪУ мУ Ф iФ NХ БХ ЄХ Ц Ц Ц Ц kЦ РЦ ўЦ Ч ЬЧ ·Ч CШ ┤Ш ыЩ єЪ ¤Ъ ■Ъ Ы hЫ ПЫ uЬ ╖Ь шЭ SЮ ЛЮ ъЯ Mа Uа Vа \а ╡а яа =б Рб ┬б 5в qв ┴в рд Tе \е ]е cе ├е ╒е Aж Аж ▌з Си ми и й й
й hй Кй Ък Тл #м Dн о 8о ╬п 1░ 8░ 9░ ?░ Ш░ ▌░ }▒ р▒ l▓ ┘▓ │ c│ ╨┤ q╡ x╡ y╡ ╡ И╡ й╡ Б╢ п╢ B╖ п╖ ь╖ (╕ ъ╕ '╣ 0╣ 1╣ 7╣ B╣ А╣ ў╣ D║ ┴║ ═║ ╗ ╗ ╝ <╝ E╝ F╝ L╝ T╝ Е╝ ╜ Б╛ у┐ ,└ z└ ▀└ )┬ Ц┬ а┬ б┬ з┬ c├ И├ х├ у─ ▄┼ I╞ ─╞ >╟ ▌╚ ~╔ Ж╔ З╔ Н╔ Х╔ ║╔ 0╩ ё╩ d╦ ╟╦ w╠ П╠ ю═ ║╬ ╗╬ ╝╬ ┬╬ ═╬ Є╬ h╧ п╧ °╧ 3╨ ╧╨ N╤ >╥ Щ╥ б╥ в╥ и╥ щ╥ ъ╥ ·╥ √╥ ╙ Л╙ Ъ╙ Ы╙ б╙ z╘ С╘ Т╘ Ш╘ ;╒ O╒ P╒ V╒ Ц╒ Ю╒ Я╒ е╒ ╓ ,╓ -╓ 3╓ 4╓ <╓ E╓ L╓ U╓ Z╓ b╓ p╓ ╓ С╓ Т╓ У╓ Щ╓ Ъ╓ в╓ л╓ ▓╓ ╗╓ └╓ ╚╓ ╓╓ х╓ ў╓ °╓ ∙╓ ╓ ╫ ╫ ╫ ╫ !╫ &╫ .╫ <╫ K╫ ]╫ ^╫ _╫ e╫ f╫ n╫ w╫ ~╫ З╫ М╫ Ф╫ в╫ ▒╫ ├╫ ─╫ ┼╫ ╦╫ ╠╫ ╘╫ ▌╫ ф╫ э╫ Є╫ ·╫ ╪ ╪ )╪ *╪ +╪ 1╪ 2╪ :╪ C╪ J╪ S╪ X╪ `╪ n╪ }╪ П╪ Р╪ С╪ Ч╪ Ш╪ а╪ й╪ ░╪ ╣╪ ╛╪ ╞╪ ╘╪ у╪ ї╪ Ў╪ ў╪ ·╪ й 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ал 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ал 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А АЫ 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А АЫ 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А АЫ 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А АЫ 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А АЫ 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А Ал 0 А АЫ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А Ай 0 А АЩ 0 А АЪ 0 А А ▀
! Ц ╩" F) Ї/ W7 В< ,G ├M CV Ч\ `c k ╨o x ~Г (З wО Т нШ HЯ @д ╘к р░ Й┤ b╣ ▓╛ у┬ @╟ а╠ 3╥ ∙╓ Р█ I▀ Тч gы zя Pї ╚∙ к■ ├
. . ╔ :$ ▌) °. Ж4 Y: ¤> ╘D ЩM R KV [ ╟_ e i [m tr +w | ╠А OЕ юИ ЇМ DФ эЪ Я єг мж Ил є░ ∙╡ ё╣ ╬└ ╥╞ ═ Щ╘ i▐ Tч ;э я ЭЁ " $ ' ) + / 2 4 8 ; > A C I L P R X [ ^ a f h j l r u z А Г Е К Р У Щ Ю д й п ▒ ╖ ╝ ╛ ─ ╩ ╨ ╓ █ с ц ъ ю Ї ·
! # % ' ) + . 1 4 9 ш д й А 8 ▐" _) [0 S7 e; ЦE ░J │P ;V И\ x` oe )l `p ╫t нz Б ЦД ═Е ┬Ж еЗ █И ╖Р 'Т У Ф ▌Ъ CЯ ╠в ╙г ╡д oк ╚л с░ ┌▒ ▓▓ Е│ Ж┤ Д╡ V╢ ┘╗ п╝ '╛ ▀┬ ╚├ Х─ k┼ U╞ <╟ B╚ Ь╠ o═ /╥ 0╙ 9╘ q╪ d┘ a┌ 7█ 8▄ ёф ┬щ xы Kь Nэ Iю я .є LЇ PЎ cў ° g∙ `· W√ U№ j¤ Q■ - c ╧
p v T 0 3 ? $ $ ╠ № щ ╤ ┼ >! >" <# F$ % И' ц( ▄) ┌* │+ ░, ч- ∙. (1 Я2 П3 А4 В5 m: Q; +< 3= ^> Z? `@ DA >B ▐H ЪM mN KO AP CQ R хR ╖S МT dU YV жW ЪX lY OZ -[ (\ "] %^ _ N` %b &c d e f ╘f ╚g ╕h ╡i йj ~k dl mm in >o ╦t ╟u Щv Мw fx xy Oz ,{ || Z} Q~ I <А 4Б 3В Г √Г ▐Д ╚Е ЩЙ РК АЛ UМ RН 8О ∙Ш ]Ъ NЫ BЬ IЭ 9Ю Я 6а 2б в г Єг жж Ул ы░ v╡ Х╣ d└ ∙├ E╔ W╬ &╘ █ _с rц Mъ 7ь ╥э 7ю Ью Ёю Gя Яя ¤я ^Ё ЭЁ
! # % & ( * , - . 0 1 3 5 6 7 9 : < = ? @ B D E F G H J K M N O Q S T U V W Y Z \ ] _ ` b c d e g i k m n o p q s t v w x y { | } ~ Б В Д Ж З И Й Л М Н О П С Т Ф Х Ц Ч Ш Ъ Ы Ь Э Я а б в г е ж з и к л м н о ░ ▓ │ ┤ ╡ ╢ ╕ ╣ ║ ╗ ╜ ┐ └ ┴ ┬ ├ ┼ ╞ ╟ ╚ ╔ ╦ ╠ ═ ╬ ╧ ╤ ╥ ╙ ╘ ╒ ╫ ╪ ┘ ┌ ▄ ▌ ▐ ▀ р т у ф х ч ш щ ы ь э я Ё ё Є є ї Ў ў ° ∙ √ № ¤ ■ " $ & ( * , - / 0 2 3 5 6 7 8 : ; < = ЭЁ $ p В Д ╤ у
R И ▐ C b x $ о √ _ p 7
Л
У
й
¤
s { А ╘ т ╒ ) 3 8 М Х 7 Л У в Ў м# $ $ #$ w$ Х$ ╡* + + + s+ Г+ ░1 2 2 2 l2 w2 '6 {6 Г6 И6 ▄6 ю6 ▀> 3? ;? A? Х? а? D SE [E hE ╝E ╨E K rK zK НK сK ьK ╖P Q Q Q lQ wQ ╫V +W 1W 7W ЛW ЯW [ d[ l[ z[ ╬[ █[ пb c c c mc xc (g |g Дg Тg цg Єg 0k Дk Кk Рk фk ёk ╚p q %q +q q Йq кw ■w x x px zx ╕x y y y oy Аy м| } } } l} z} Е} ┘} с} ч} ;~ Z~ q~ ┼~ ╓~ ▄~ 0 = ] ▒ ╣ ┐ А #А УА чА яА їА IБ ^Б 5З ЙЗ УЗ дЗ °З И GИ ЫИ гИ йИ ¤И Й ?Й УЙ ЪЙ аЙ ЇЙ Й ;К ПК ШК ЮК ЄК ¤К [С пС ╖С ┼С Т #Т eХ ╣Х ┐Х ┼Х Ц "Ц эШ AЩ HЩ NЩ вЩ нЩ ЇЩ HЪ OЪ UЪ йЪ ╜Ъ ╔Ъ Ы %Ы 7Ы ЛЫ ХЫ эа Aб Iб Wб лб ╖б шб <в Dв Jв Юв ив з Uз ]з cз ╖з ┬з ∙з Mи Vи \и ░и ╝и ╙и 'й .й 4й Ий Уй жй ·й к к [к fк Юк Єк ·к л \л jл Ьл Ёл °л м Zм rм tм ╚м ╥м ╪м ,н Iн ь▒ @▓ N▓ [▓ п▓ ║▓ ═▓ !│ +│ 1│ Е│ ▒│ G┤ Ы┤ г┤ й┤ ¤┤ ╡ ь╕ @╣ H╣ a╣ ╡╣ ╥╣ х╣ 9║ D║ J║ Ю║ й║ ╡║ ╗ ╗ ╗ k╗ w╗ Й╗ ▌╗ ч╗ э╗ A╝ M╝ s╝ ╟╝ ╤╝ ╫╝ +╜ 8╜ ]╜ ▒╜ ╕╜ ╛╜ ╛ 0╛ P╛ д╛ м╛ ─╛ ┐ #┐ ▓┬ ├ ├ ├ r├ |├ О├ т├ ы├ ё├ E─ S─ Q╚ е╚ л╚ ▒╚ ╔ ╔ ;╔ П╔ Ч╔ ▓╔ ╩ ╩ I╩ Э╩ е╩ ╗╩ ╦ "╦ С╬ х╬ э╬ є╬ G╧ S╧ Д╧ ╪╧ р╧ ц╧ :╨ J╨ w╨ ╦╨ ╙╨ у╨ 7╤ J╤ V╤ к╤ │╤ ╣╤
╥ ╥ O╥ г╥ л╥ ║╥ ╙ ╙ o█ ├█ ╦█ ██ /▄ <▄ @р Фр Эр гр ўр с Рс фс ьс ·с Nт Zт jт ╛т ╟т ═т !у <у iу ╜у ╩у ╨у $ф 0ф jф ╛ф ┼ф ╦ф х +х 6х Кх Сх Чх ых °х Mщ бщ кщ ░щ ъ ъ ?ъ Уъ Ыъ иъ №ъ ы jы ╛ы ╠ы ╥ы &ь 3ь tь ╚ь ╨ь хь 9э Cэ Вэ ╓э ▐э ю Uю aю Зю █ю ую щю =я Fя Бя ╒я ▄я тя 6Ё @Ё xЁ ╠Ё ╙Ё ┘Ё -ё Cё vё ╩ё ╤ё ╫ё +Є BЄ zЄ ╬Є ╓Є ьЄ @є Xє dє ╕є ═є ╙є 'Ї 8Ї DЇ ШЇ йЇ пЇ ї ї y° ═° ╒° х° 9∙ A∙ M б й п 6 К Т Ш ь { ╧ ╫ Є F T Х щ Є ° L X j ╛ ╞ ╓ * 5 O г м ▓ 2 Ж О Ф ш Є I Э е ╡ ` ┤ ╗ ┴
#
D
Ш
а
ж
·
D Ш а ж · J Ю ж м
A Х Ы б ї f o ~ ╥ ▐ [ e k ┐ ┌ ы ? M T и ┤ х 9 A H Ь ╖ " v ~ Ы я · ^ ▓ ║ ┴ ^ ▓ ║ ┴ ! \ ░ ╕ ┐ 0 d ╕ ┬ ╔ % 1 Е Н Ф ш Є ] ▒ ╣ ╔ ( Й ▌ ф ы ? K ~ ╥ ┌ с 5 D y ═ ╪ ▀ 3 = I Э з ╕ H Ь е ╡ ! ! ~! ╥! ┌! ь! @" K" Ъ" ю" ў" ■" R# ]# б# ї# №# $ W$ a$ б$ ї$ ¤$ % b% v% Ш% ь% ў% ■% R& [& Н& с& ш& я& C' Q' З' █' т' ё' E( Q( g, ╗, ├, ▄, 0- C- U- й- ▒- └- . . 0. Д. М. Ъ. ю. °. ?/ У/ Ы/ в/ Ў/ 0 h0 ╝0 ╞0 ═0 !1 A1 f1 ║1 ┬1 ╔1 2 ,2 a2 ╡2 ╜2 ╧2 #3 /3 Q3 е3 м3 │3 4 "4 A4 Х4 ж4 н4 5 5 ш9 <: F: M: б: ░: Ю> Є> ·> ? ]? k? v? ╩? ╒? ▄? 0@ ;@ V@ к@ │@ ║@ A A MA бA йA ░A B B GB ЫB гB ▓B C C "C vC }C ДC ╪C тC юC BD MD TD иD ╡D ├D E E &E zE ДE РE фE ьE √E OF ZF oF ├F ╠F ╙F 'G 8G `G ┤G ┴G ╚G H 1H жH ·H I I iI tI жI ·I J J ]J hJ yJ ═J ╘J █J /K 9K SK зK пK ╛K L #L 4L ИL ХL ЬL ЁL №L 4M ИM РM ЧM ыM №M %N yN БN СN хN ■N 'O {O ГO ФO шO ЄO P tP ~P ПP уP Q 2Q ЖQ ПQ ЦQ ъQ їQ 0R ДR НR ФR шR S (S |S ОS ХS щS T T sT {T ВT ╓T уT U eU mU ~U ╥U ▄U V \V dV vV ╩V ╒V сV 5W n ^n ▓n ╣n └n o o Wo лo ▒o ╕o p 5p Bp Цp дp лp p q 7q Лq Тq гq ўq r 8r Мr Ыr вr Ўr s s fs ns us ╔s ╫s їs It Qt jt ╛t ╩t ъt >u Fu Mu бu ╣u ╦u v 0v 7v Лv Шv еy ∙y z z \z zz Ыz яz °z z S{ n{ М{ р{ ш{ я{ C| N| a| ╡| ╜| ─| } $} ^} ▓} ║} ┴} ~ ~ D~ Ш~ а~ з~ √~ cИ ╖И ┐И ╞И Й :Й gЙ ╗Й ┼Й ╠Й К -К XК мК ╢К ╜К Л Л NЛ вЛ кЛ ▒Л М М DМ ШМ аМ ╕М Н Н EН ЩН бН иН №Н О О lО wО ~О ╥О ёО @П ФП ЮП еП ∙П Р >Р ТР ЪР бР їР С С rС С ЖС ┌С ъС Т fТ nТ Т ╙Т тТ Т SУ ZУ cУ НУ ШУ Ц `Ц iЦ Ы WЫ eЫ \а йа │а cе ╡е ┴е
й Zй fй ?░ М░ Ц░ °╪ X МX МX АX АX АX МXМX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МXМX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МXМX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МXМX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МX МXМX МX МX МX МX МXМX МX АX АX МX ДXАX ДX А Ё8 Ё @ ё ААА ў ЁТ Ё Ё0 Ё( Ё
Ё ЁB
Ё S Ё ┐ ╦ ? Ё °╪ _ H l t 7 9 1 6 2 1 5 8 _ H l t 7 9 1 6 2 1 5 9 _ H l t 7 8 2 7 9 7 4 4 _ H l t 7 8 2 7 9 7 4 5 _ H l t 7 8 8 7 8 8 2 3 _ H l t 7 8 8 7 8 8 2 4 _ H l t 7 8 8 7 8 3 3 6 _ H l t 7 8 8 7 8 3 3 7 _ H l t 7 8 8 9 4 7 7 0 _ H l t 7 8 8 9 4 7 7 1 _ H l t 7 8 8 9 4 9 5 0 _ H l t 7 8 8 9 4 9 5 1 _ H l t 7 9 1 2 1 0 6 8 _ H l t 7 9 1 2 1 0 6 9 _ H l t 7 9 1 2 1 1 8 2 _ H l t 7 9 1 2 1 1 8 3 _ H l t 7 9 1 2 2 1 7 1 _ H l t 7 9 1 2 2 1 7 2 _ H l t 7 9 1 2 0 1 2 8 _ H l t 7 9 1 2 0 1 2 9 _ H l t 7 9 1 3 6 8 5 1 _ H l t 7 9 1 3 6 8 5 2 i i Т
Т
П│ П│ P╧ P╧ F F б б RF RF єN єN mg mg №П №П ╝е ╝е ·╪ @ @ @ @ @ @ @ @ @ @
@ @ @
@ @ @ @ @ @ @ @ @j j У
У
Р│ Р│ Q╧ Q╧ G G в в SF SF ЇN ЇN ng ng ¤П ¤П ╜е ╜е ·╪ ! q u w z { Г ц ы э Є є ў ° √ №
Л М С Т Ф Х Щ Ъ Я а д е й к │ ┤ ╢ ╖ └ ┬ ─ ┼ ╩ ╦ ╨ ╤ ╙ ╘ ╓ ╫ ▀ с х ц ь э я Ё є Ї ° ∙ # $ . / 3 4 8 : = > ? @ D E I J O P R S V W [ \ h i m o q r v М Т У Ц Ч Щ Ъ Ю Я ж з о п │ ┤ ╜ ┐ ╞ ╟ ╠ Ї ° ∙
" # $ % * R \ ^ f h o q t w ~ Г Д К Л Р С У Ф Ч Ш Ь Э б в д е н о ▓ │ ╢ ╖ └ ┴ ─ ┼ ╬ ╧ ╒ ╓ ╫ ╪ ▌ ▐ I J L M V W X Y c d h i s x % & * + 5 : E G I J Q
% ' ) * , - 4 5 < = ? @ C N Y Z ] ^ i j l m t в з й м №
` q y Д Е Л ! Ф Ы ▒ ┐ ё √ №
Ц
Э
Я
е
■
6 9 : C . Ъ а
#
%
1
I
T
V
`
i
p
Ч
г
│
┐
═
╒
╫
▀
t { ╒ т H K m p ╫ ▀ 2 : Н С ┴ ╠ ф Ё - ; и ░ ) 6 8 F H R В Т Ф Ю н ║ _ a К М * 3 Н Х Ю е з ▓ ї а й - J x Г Ў ∙ 4 7 9 E ┬ ╚ ╩ ╒ ў ¤ } Е П Ю а ░ ▓ ╣ ╗ ╟ ╨ █ Э г е ░ ▓ ╗ ╜ ╚ ╩ ╘ ╓ ▐ р я ё ° · $ - S ` u Е ╗ ╜ └ ─ Ц Ю ў # % 4 Х а ▄ ▐ . 2 к н ╟ ╩ N W X c К Ц ! ! (! 6! _! i! t! В! Э! а! к! ╢! ╝! ┐! т! Є! " " g" o" Ч" ж" ╨" ╘" ▄" ц" (# /# 1# 9# [# _# И# К# $ $ $ $ ═$ ╧$ % % T% V% r% {% Я% л% V& _& a& d& Щ& в& ╣& ╝& ╒& ╪& e' q' ' В' Ю' н' ╫' т' ■'
( A( L( k( y( с( ы( c) e) ╡) ╛) ╨) ▄) ▐) ш) * * * #* [* i* k* s* А* П*
+ + t+ ~+ ├+ ╧+ , , d, k, к- ╢- ю- - Д. П. С. Ь. Ю. л. ╖. ┼. ╟. ╘. ╓. т. ф. Ё. / / "/ 2/ 4/ C/ E/ O/ Q/ \/ l/ t/ ╣/ ┐/ ┴/ ╠/ 20 90 ]0 l0 Х0 а0 л0 ▓0 └0 ╦0 ═0 ▄0 ▐0 ч0 щ0 є0 1 1 K1 M1 b1 g1 2 2 m2 w2 А2 Л2 Н2 Ф2 ·4 5 5 !5 #5 )5 y5 5 К5 Т5 Ф5 Э5 Я5 ж5 ▓5 ┐5 ╠5 ╙5 ■5 6 ▌6 ц6 ў6 7 7 7 7 .7 77 F7 ░7 ┐7 ш7 Ё7 8 -8 a8 m8 Ж8 Ф8 ╓8 т8 /9 39 s9 z9 П9 Х9 ╞9 ═9 т9 щ9 : : .: 1: <: C: b: i: t: {: ├: ╠: 5; A; ^; n; p; Б; ч; Ё; 0< << |< Л< Ш< б< г< м< ╛< ─< ╠< ╫< = = )= /= 1= := <= Q= _= j= v= А= Р= Ч= ╛= ┼= ;> >> ]> _> Ф> Ц> ╜> ┐> Ц? а? й? ┤? ╢? ─? ф? я? d@ f@ П@ Т@ A A @A IA cA fA B B B B &B 1B ^B mB рB щB эB ўB C
C C C &C 0C 2C ;C =C IC KC UC WC cC eC oC qC yC гC лC 5D 9D UD ]D жD иD ^E cE ╜E ╨E ┘E сE ьE єE HF MF МF ФF дF ▓F ╡G ┐G H (H *H 2H MH WH YH gH iH yH {H ЖH ИH УH ЬH вH кH ╕H ║H ╚H ╓H сH
I I I I OI ^I ВI МI ЫI иI ║I ├I ┼I ╙I ╒I ▀I J J "J .J qJ uJ J ЖJ ЬJ бJ ▐J рJ }K ИK тK ьK L $L AL IL eL sL N N ╔N ╙N рN ъN ьN ЇN ЎN O O O &O ,O 0O :O CO MO OO WO ЬO жO ╔O ╒O ▀O шO ■O P 5P 7P mQ wQ ╗Q ─Q ╨Q ▐Q QR UR T "T $T .T 0T ET GT ЬT жT мT ╒T ╫T рT тT U (U -U 3U QU [U ^U hU ЗU СU УU ЯU дU лU нU ╖U фU юU їU №U V V V (V 3V a Ja La Ya [a ga ia ra ta Бa Гa Мa Юa зa кa ╢a ╕a ┬a яa √a 0b 2b Jb Lb Tb Xb c
c nc xc Бc Оc Яc мc ёc №c Pd Td ╦d ╫d e e |e Мe Цe дe ╡e ┐e ┴e ╤e ╙e тe фe яe ёe ■e f f f f Аf Еf зf ╢f ╚f ╥f хf чf Зg Нg чg Єg №g h h h h h ┬ O┬ X┬ y┬ Й┬ О┬ Р┬ ├ ├ s├ |├ у├ ы├ F─ S─ k─ x─ с─ ч─ ·─ ─ 3┼ 8┼ y┼ }┼ ▒┼ ┤┼ ╤┼ ╘┼ F╞ V╞ ╟╞ ╥╞ ╟ ╟ ╟ ╟ -╟ 8╟ :╟ F╟ [╟ `╟ b╟ l╟ С╟ Э╟ Я╟ з╟ ▒╟ ┤╟ ╪╟ ▌╟ ╚ ╚ *╚ :╚ ?╚ A╚ ж╚ л╚ ╔ ╔ )╔ 9╔ Ъ╔ б╔ г╔ н╔ ╩ ╩ ;╩ G╩ п╩ ╢╩ С╦ Ф╦ Ь╦ Ю╦ х╦ ь╦ +╠ .╠ d╠ p╠ #═ ,═ .═ :═ У═ Э═ ▒═ ╩═ 1╬ A╬ w╬ {╬ H╧ S╧ V╧ d╧ z╧ В╧ ┘╧ р╧ ;╨ J╨ ╓╨ ▐╨ л╤ п╤ ╥ ╥ 8╥ ;╥ H╥ M╥ о╥ ╡╥ ╙ ╙ C╙ F╙ В╙ Е╙ ╚╙ ╬╙ ╧╙ █╙ ▌╙ ш╙ %╘ -╘ 1╘ <╘ I╘ K╘ a╘ i╘ К╘ У╘ о╘ ╜╘ ┐╘ ╔╘ ╦╘ ╫╘ ╒ ╒ ╒ '╒ )╒ /╒ E╒ M╒ X╒ d╒ }╒ З╒ Й╒ Т╒ Ф╒ а╒ ╙╒ █╒ ▌╒ ш╒ ъ╒ ∙╒ √╒ ╓ ╓ ╓ &╓ 0╓ 2╓ <╓ R╓ _╓ a╓ j╓ l╓ t╓ v╓ Г╓ У╓ Э╓ Я╓ к╓ м╓ ╢╓ ╛╓ ╩╓ ╠╓ ╒╓ ▄╓ ь╓ ю╓ √╓ ¤╓ ╫ ╫ (╫ 8╫ A╫ B╫ P╫ R╫ [╫ ]╫ i╫ r╫ |╫ Л╫ У╫ г╫ п╫ ▒╫ ╛╫ └╫ ═╫ ╧╫ ╫╫ ю╫ ў╫ ╪ ╪ ╪ ╪ ╪ *╪ ,╪ :╪ <╪ F╪ H╪ K╪ U╪ X╪ x╪ Е╪ З╪ Р╪ ┼╪ ═╪ ы╪ Ї╪ ┘ ┘ ┘ #┘ ,┘ 2┘ U┘ [┘ Ж┘ Л┘ ¤┘ ┌ m┌ t┌ Ш┌ Э┌ ъ┌ Є┌ ■┌ █ █ "█ ╬█ ╓█ 0▄ <▄ ?▄ D▄ F▄ S▄ U▄ d▄ e▄ k▄ m▄ w▄ x▄ y▄ z▄ Д▄ Е▄ З▄ И▄ Ф▄ Х▄ Ш▄ Щ▄ в▄ г▄ з▄ и▄ ╣▄ ║▄ ╜▄ ╛▄ └▄ ┴▄ ╔▄ ╩▄ ╬▄ ╨▄ ╫▄ ┘▄ т▄ ф▄ ю▄ Ё▄ ∙▄ ·▄ ▌ ▌ ▌ ▌ ▌ ▌ ▌ ▌ )▌ *▌ -▌ /▌ =▌ ?▌ B▌ D▌ J▌ L▌ N▌ O▌ R▌ S▌ X▌ Y▌ [▌ \▌ `▌ a▌ d▌ e▌ i▌ j▌ l▌ m▌ q▌ r▌ s▌ t▌ y▌ z▌ Г▌ Д▌ Ж▌ З▌ Л▌ Н▌ П▌ Р▌ Х▌ Ц▌ Ъ▌ Ы▌ Ь▌ Э▌ в▌ г▌ м▌ н▌ п▌ ░▌ ┤▌ ╡▌ ╖▌ ╣▌ ─▌ ╞▌ ╤▌ ╥▌ ╫▌ ╪▌ ▀▌ с▌ щ▌ ы▌ є▌ ї▌ ¤▌ ▌ ▐ ▐ ▐ ▐ ▐ ▐ !▐ #▐ 3▐ 4▐ ;▐ =▐ M▐ O▐ ^▐ _▐ g▐ h▐ n▐ p▐ А▐ Б▐ Н▐ П▐ Ъ▐ Ь▐ и▐ л▐ м▐ н▐ ╖▐ ╕▐ ║▐ ╗▐ ╟▐ ╔▐ ╤▐ ╥▐ ▄▐ ▌▐ х▐ ч▐ Ё▐ Є▐ №▐ ■▐ ▀ ▀ ▀
▀ ▀ ▀ ▀ ▀ ▀ ▀ '▀ (▀ .▀ 0▀ <▀ =▀ C▀ F▀ G▀ H▀ K▀ L▀ W▀ Y▀ a▀ c▀ i▀ k▀ t▀ w▀ z▀ {▀ |▀ }▀ Ж▀ З▀ Й▀ Л▀ Ч▀ Щ▀ б▀ в▀ е▀ ж▀ м▀ п▀ ░▀ ▒▀ ╡▀ ╢▀ ╕▀ ╣▀ ┴▀ ├▀ ╦▀ ╬▀ ╨▀ ╤▀ ╘▀ ╒▀ ╪▀ ┘▀ ┌▀ █▀ ф▀ х▀ ч▀ ш▀ ы▀ ь▀ Ё▀ ё▀ є▀ Ї▀ °▀ √▀ №▀ ¤▀ р
р р р р р #р %р 5р 7р 8р 9р :р ;р ?р Хр Юр ар вр с с Jс Xс Гс Ис Oт Zт ^т hт ┐т ╟т "у +у ?у Kу \у gу ╛у ╟у %ф 0ф <ф Gф ┐ф ┼ф х +х Лх Сх ьх °х ц %ц ^ц dц ч ч ч *ч 7ч @ч hч jч Пч Ъч дч жч ╕ч ║ч ╬ч ▄ч Xш dш pш yш {ш Еш Зш Рш Тш аш ╕ш └ш ┘ш уш хш їш ўш ∙ш 1щ 9щ вщ кщ ъ ъ )ъ 0ъ 2ъ =ъ Юъ гъ ¤ъ ы (ы 2ы <ы Jы `ы hы ┐ы ┼ы ╞ы ╠ы 'ь 3ь ┘ь рь :э Cэ Fэ Rэ cэ oэ сэ шэ ъэ ёэ єэ №э Vю aю xю Ею >я Fя ╓я ▄я 7Ё @Ё CЁ JЁ LЁ WЁ ═Ё ╙Ё .ё Cё Fё Pё ╦ё ╤ё ,Є 6Є 7Є BЄ EЄ \Є nЄ xЄ ┘Є ▐Є рЄ чЄ Aє Mє ╣є ┬є (Ї 0Ї ЩЇ бЇ ї ї ╢ї ╗ї ╜ї ─ї ╞ї ═ї >ў Jў фў ыў ° ° ,° <° Q° S° g° n° ╪° р° :∙ A∙ \∙ e∙ g∙ u∙ в∙ и∙ · · -· 9· d· j· p· v· А· Ж· З· М· О· Щ· м· ▓· │· ╕· ;№ G№ I№ O№ № Г№ ъ№ ю№ &¤ 1¤ k¤ x¤ z¤ И¤ Ю¤ з¤ й¤ │¤ ╣¤ ─¤ х¤ ё¤ ї¤ ■ ■ ■ ■ ■ @■ N■ P■ Z■ \■ j■ o■ v■ w■ z■ Г■ Р■ Т■ Ы■ Э■ ж■ и■ ▓■ ┤■ ─■ ╞■ ╧■ ╤■ █■ ▀■ ъ■ ю■ °■ J Q З М ╘ ┌ ▌ щ ы Є Ї / 6 N U b j o z г к ╟ ╠ ╙ у Ї Ў ! # в й
' 0 э
┌ х G T ъ Є M X [ c ╔ ╤ + 5 д м " З О щ Є ї № и ░
) ╡ ╗ 5
B
√
√ x ~ Ъ й ╥ ▐ р щ
,
.
╪ у х ї Я ж
! " . Ц Ы Ў g o r y ╙ ▐ с ю є √ \ e └ ╔ ▌ щ @ J й ┤ ╖ ┼ █ у : A Э п ╟ ╤ ∙ Б И К Х ¤ 0 9 # 0 2 = │ ║ ! $ - ▒ ╕ 0 A K ╣ └ % Ж Н щ Є 9 ; F O P [ ╝ ├ ( 0 : ▐ ф @ K ╙ ┌ ; D G N P [ ╬ ╘ 4 = Ю з к ▓ Э е
! ! A! I! m! s! ▌! ц! A" K" я" ў" S# ]# x# В# К# У# Ф# Я# Ў# №# X$ a$ w$ Е$ % % c% v% y% Е% э% ў% S& [& т& ш& I' Q' T' [' ]' h' y' |' ~' Б' В' Ж' ▄' т' х' ы' F( Q( Z( e( З( С( У( Э( ╗( ╞( 1) 8) ]) d) f) n) ─) ╨) * * * * * (* Р* Ъ* ▒* ╜* ь* ї* 7+ >+ W+ f+ p+ ~+ А+ Й+ Л+ Ч+ ─+ ╧+ ы+ є+ *, :, ╞, ╠, ╬, ╓, 1- >- F- S- ┤- ║- . . #. .. П. Ф. я. °. √. / / %/ */ 8/ ў/ 0 0 0 @0 O0 ╜0 ╞0 "1 /1 01 91 2 ,2 :2 B2 └2 ╔2 $3 /3 23 >3 ж3 м3 4 "4
5 5 ?5 K5 ў5 5 o6 z6 ╖6 ─6 ╞6 ╥6 ╘6 ▐6 ¤6 7 17 =7 ?7 M7 O7 ]7 _7 k7 r7 7 Б7 З7 Ч7 а7 в7 к7 л7 │7 ╒7 ┌7 █7 у7 &8 -8 T8 V8 g8 i8 Е8 Л8 Ц8 Ь8 Ю8 е8 о8 ╢8 ╕8 ╛8 ╨8 ┘8 9 9 9 (9 f9 m9 r9 w9 ▒9 ┴9 =: D: в: ░: ║: ┼: ╟: ╤: я: №: '; *; л; ╕; u< x< ┴< ╔< ╦< ╙< ш< є< ї< < = = ,= <= >= G= К= Ш= Ъ= к= Є= ¤= =
> > > !> 1> ¤> ? ^? k? ╦? ╒? 1@ ;@ >@ E@ л@ │@ A A >A KA B B B B жB мB C C C C wC }C ┘C тC CD MD йD ╡D ╖D ┬D E E "E %E {E ДE ЗE ОE яE їE PF ZF ─F ╠F (G 2G MG UG ╡G ╗G H )H lH tH ХH ЫH I I jI tI ^J hJ ╬J ╘J 0K 9K n │n ╣n o o "o )o 6o @o мo ▒o p p Чp Юp q q Мq Тq Хq Эq °q r r r r r 'r .r Нr Цr r s gs ns ╩s ╫s ъs єs Tt [t ]t dt ┐t ╩t ▌t шt ?u Fu вu ╣u ╝u ╔u v )v ░v ╜v хv єv w w hw tw vw Бw Гw Уw Хw бw ╤w ▀w Ўw ■w "x -x :x Dx чx ёx ¤x y y y y "y 9y Gy Iy Wy Xy hy my oy ]z pz qz zz Ёz °z T{ n{ q{ К{ D| N| ╢| ╜| } $} ,} 8} G} N} │} ║} ~ ~ "~ 0~ % E Q S ] ╦ ╫ GА UА WА eА {А ГА ЮА дА ╣А ┴А ZБ ^Б mБ pБ СБ ХБ ╛Б ┴Б В В 5В CВ qВ yВ ЛВ ОВ ШВ ЫВ ╔В ┘В █В ъВ ьВ ЎВ °В Г FГ NГ ЦГ аГ ЄГ ∙Г ·Г №Г ■Г Д wД {Д ыД їД ўД Е &Е 0Е 2Е =Е ?Е LЕ NЕ YЕ [Е fЕ hЕ qЕ sЕ Е ОЕ ЦЕ бЕ нЕ пЕ ╗Е ─Е ╔Е ╦Е ╘Е ╓Е ▐Е ъЕ ўЕ Ж Ж CЖ MЖ ]Ж gЖ iЖ wЖ yЖ ЗЖ ЙЖ ЧЖ ┴Ж ╙Ж З З iЗ nЗ │З ├З юЗ ЁЗ *И ,И CИ GИ Й )Й =Й JЙ LЙ UЙ WЙ eЙ ╝Й ┬Й !К -К 0К =К ?К MК нК ╢К Л Л ,Л 9Л IЛ LЛ гЛ кЛ М М М М !М *М гМ лМ мМ ▓М Н (Н О О О О mО wО ╙О чО шО ёО ХП ЫП ·П Р УР ЪР ЎР ¤Р ■Р С wС С █С ъС эС ЎС qТ yТ ╘Т тТ хТ ЄТ ЇТ ¤Т TУ ZУ cУ ЩУ бУ лУ ╬У ╤У █У фУ фФ ъФ fХ rХ tХ АХ ПХ ЫХ ЭХ нХ ▓Х ╜Х ╞Х ╨Х ╒Х ▀Х шХ ЁХ ЄХ Ц Ц Ц Ц jЦ rЦ xЦ цЦ ьЦ "Ч %Ч 6Ч 9Ч ?Ч BЧ KЧ OЧ \Ч _Ч аЧ ░Ч ▓Ч ╜Ч ╓Ч ┌Ч чЧ ыЧ -Ш 9Ш ЗШ ЛШ цШ ьШ 7Щ EЩ lЩ tЩ ыЩ √Щ Ъ Ъ >Ъ @Ъ jЪ lЪ КЪ МЪ ХЪ ЩЪ ЪЪ ЬЪ ╢Ъ ┴Ъ ЎЪ №Ъ oЫ wЫ ЄЫ ·Ы 9Ь GЬ ОЬ СЬ ╗Ь ┼Ь ╟Ь ╥Ь ЎЬ Э Э Э Э !Э LЭ WЭ cЭ oЭ Э Ю еЮ ░Ю ╔Ю ╓Ю ╪Ю тЮ фЮ ьЮ юЮ ўЮ ∙Ю Я Я Я Я Я !Я 4Я 6Я >Я wЯ ГЯ ЕЯ ПЯ аЯ кЯ мЯ ║Я ▌Я шЯ ъЯ ·Я ╝а ╚а █а фа б б 1б <б lб zб ░б │б ьб ·б №б в в в в в в "в *в 4в │в ╢в █в чв Єв ■в %г 0г 2г >г @г Iг Kг Vг Xг dг fг pг rг }г г Кг Мг Хг Чг дг жг ог ┴г ╩г д д д 'д Sд Yд ид мд ┘д ▐д рд Ёд їд ўд е е Tе [е cе ┬е ╩е ╘е ж ж ░ж ▓ж Kз Oз {з }з (и 4и =и Lи ми ╝и и й oй |й ~й Йй Aк Kк Mк \к |к Йк ╝к ╞к ╘к ╓к л л мл пл м !м 'м 3м 5м 9м Kм ]м _м hм jм rм tм {м |м Жм им │м н н н н !н ,н >н Cн Rн \н Fо Rо ─о ╠о п п п +п ;п Fп Hп Uп Wп dп ─п ╠п ╬п ▐п Єп Їп ░ ░ 1░ 7░ ?░ Ч░ │░ ╛░ └░ ╬░ я░ ·░ =▒ G▒ d▒ r▒ ╩▒ ╙▒ ╒▒ ▀▒ Л▓ Ч▓ Щ▓ е▓ з▓ л▓ {│ │ ├│ ╠│ ╬│ ╫│ ┘│ т│ ф│ я│ №│ ┤ ┤ ,┤ a┤ j┤ ╨┤ р┤ Є┤ Ї┤ П╡ Щ╡ Ы╡ и╡ ╢ ╢ 4╢ @╢ Z╢ c╢ г╢ о╢ ё╢ °╢ P╖ [╖ ]╖ b╖ i╖ p╖ ╚╖ ┘╖ █╖ ы╖ Q╕ W╕ Y╕ b╕ d╕ o╕ Д╕ Р╕ ъ╕ ·╕ '╣ /╣ 7╣ A╣ I╣ S╣ л╣ о╣ ║ ║ ╝║ └║ ╒║ р║ с║ э║ ю║ ў║ °║ ╗ ,╗ 8╗ ;╗ G╗ ^╗ g╗ v╗ А╗ Ч╗ г╗ е╗ о╗ ╟╗ ╬╗ ┌╗ ц╗ ш╗ Є╗ Ї╗ ·╗ №╗ ╝ ╝ ╝ )╝ +╝ <╝ D╝ L╝ S╝ ]╝ g╝ q╝ А╝ ю╝ ·╝ №╝ ╜ Т╜ п╜ ╛ ╛ ╛ !╛ #╛ 2╛ 9╛ >╛ L╛ Z╛ m╛ x╛ ┐ ┐ k┐ n┐ Ч┐ Ю┐ ч┐ ё┐ └ └ └ #└ S└ ]└ З└ Т└ ╔└ ╫└ я└ Ў└ └ ┴ ┴ ┴ I┴ W┴ Y┴ f┴ h┴ w┴ е┴ м┴ ╚┴ ╬┴ ┬ ┬ ┬ ┬ )┬ 9┬ з┬ ▓┬ j├ q├ u├ ├ ╡├ ╛├ └├ ╠├ ╬├ ┘├ ─ ─ ─ $─ A─ Q─ |─ И─ Й─ Т─ У─ Ы─ Э─ ж─ к─ ░─ ▓─ ╛─ ╟─ ╒─ ы─ ў─ ┼ ┼ t┼ v┼ |┼ ┼ й┼ м┼ ╬┼ ╨┼ ╓┼ ┘┼ р┼ ь┼ ю┼ ∙┼ ╞ ╞ ╞ ╞ ╞ (╞ *╞ :╞ <╞ H╞ c╞ n╞ Х╞ г╞ │╞ ╛╞ 2╟ 8╟ a╟ k╟ y╟ |╟ }╟ Ж╟ Р╟ Щ╟ Ы╟ з╟ ╖╟ └╟ ╚ ╚ ╚ "╚ 2╚ :╚ F╚ P╚ s╚ ~╚ Г╚ О╚ Р╚ Щ╚ Ы╚ ж╚ и╚ │╚ ╕╚ ├╚ ▌╚ э╚ ╚ ╔ !╔ #╔ F╔ H╔ ~╔ Е╔ л╔ ╣╔ ф╔ я╔ ╩ +╩ e╩ k╩ r╩ ~╩ ┼╩ ╠╩ █╩ ч╩ ╦ #╦ Д╦ Н╦ Ы╦ л╦ ў╦ ╠ ╠ ╠ *╠ -╠ .╠ 8╠ F╠ N╠ Y╠ e╠ й╠ ╕╠ Ё╠ ¤╠ 9═ D═ F═ M═ Y═ _═ Н═ Ц═ ╛═ ┬═ ч═ ь═ ю═ ■═ ╬ ╬ ┬╬ ╠╬ у╬ ё╬ ·╬ ╧ ╧
╧ ╧ ╧ ╧ ╧ ╧ ╧ ╧ '╧ (╧ *╧ +╧ 3╧ 4╧ 6╧ 7╧ @╧ A╧ K╧ L╧ S╧ T╧ V╧ W╧ c╧ d╧ g╧ n╧ x╧ y╧ {╧ |╧ ╧ Б╧ К╧ Л╧ С╧ Т╧ Ф╧ Х╧ Ш╧ Щ╧ Ь╧ Э╧ б╧ в╧ о╧ ╖╧ ┐╧ └╧ ╦╧ ═╧ ╧╧ ╨╧ ╘╧ ╒╧ ╪╧ ┘╧ ▐╧ ▀╧ х╧ ц╧ ь╧ э╧ Ё╧ ё╧ Ў╧ №╧ ╨ ╨ ╨ ╨ ╨ "╨ )╨ *╨ 2╨ 3╨ 9╨ ;╨ K╨ L╨ N╨ O╨ S╨ T╨ X╨ Z╨ a╨ b╨ d╨ e╨ i╨ k╨ u╨ w╨ ╨ А╨ Б╨ В╨ К╨ М╨ С╨ У╨ г╨ д╨ л╨ н╨ ┤╨ ╡╨ ╝╨ ╜╨ ═╨ ▄╨ ц╨ ш╨ ю╨ я╨ Ї╨ ї╨ ў╨ °╨ ╨ ╤ ╤ ╤ ╤ ╤ ╤ ╤ ╤ ╤ %╤ &╤ /╤ 0╤ <╤ >╤ C╤ D╤ M╤ \╤ ]╤ ^╤ d╤ e╤ g╤ h╤ r╤ t╤ В╤ Д╤ П╤ С╤ Ч╤ Щ╤ ж╤ и╤ й╤ к╤ ╜╤ ┐╤ ╔╤ ╦╤ ╙╤ ╘╤ ╪╤ █╤ ▌╤ ▐╤ с╤ т╤ х╤ ц╤ ч╤ ш╤ э╤ ю╤ є╤ Ї╤ Ў╤ ў╤ ╤ ╥ ╥ ╥ ╥ ╥ ╥ ╥ ╥ ╥ ╥ ╥ "╥ $╥ -╥ /╥ 7╥ 8╥ <╥ >╥ N╥ P╥ R╥ S╥ V╥ W╥ _╥ a╥ d╥ e╥ q╥ r╥ z╥ {╥ В╥ Д╥ П╥ Р╥ С╥ Т╥ У╥ Ф╥ Ш╥ Щ╥ а╥ в╥ з╥ и╥ ░╥ ▒╥ ╝╥ ╛╥ ╩╥ ╦╥ ╬╥ ╧╥ ╘╥ ╒╥ р╥ т╥ ш╥ ъ╥ ∙╥ √╥ ╙ ╙ ╙ ╙ ╙ ╙ )╙ +╙ 6╙ 8╙ B╙ C╙ S╙ T╙ _╙ a╙ f╙ h╙ p╙ q╙ s╙ t╙ w╙ x╙ ~╙ ╙ К╙ Л╙ Щ╙ Ы╙ а╙ б╙ м╙ н╙ ╝╙ ╜╙ ╔╙ ╩╙ ╘╙ ╒╙ ▄╙ ▐╙ щ╙ ы╙ ў╙ °╙ √╙ №╙ ╘ ╘ ╘ ╘ ╘ ╘ ╘ ╘ )╘ +╘ 6╘ 8╘ @╘ A╘ J╘ L╘ S╘ T╘ Z╘ \╘ c╘ d╘ f╘ g╘ q╘ s╘ y╘ z╘ А╘ В╘ Л╘ М╘ Р╘ Т╘ Ч╘ Ш╘ в╘ г╘ │╘ ┤╘ ╖╘ ╕╘ ╛╘ ┐╘ ╩╘ ╦╘ ╨╘ ╥╘ т╘ у╘ ш╘ ъ╘ Ё╘ ё╘ Ї╘ Ў╘ ╒ ╒ ╒ ╒ ╒
╒ ╒ ╒ ╒ ╒ "╒ #╒ )╒ +╒ 2╒ 3╒ :╒ ;╒ D╒ F╒ N╒ P╒ U╒ V╒ a╒ b╒ m╒ n╒ u╒ w╒ В╒ Д╒ Х╒ Ц╒ Э╒ Я╒ д╒ е╒ н╒ о╒ ╢╒ ╖╒ ┴╒ ┬╒ ┼╒ ╞╒ ╧╒ ╨╒ ╥╒ ╙╒ ▐╒ ▀╒ с╒ т╒ ь╒ ю╒ Ў╒ ў╒ ∙╒ ·╒ ╓ ╓ ╓ ╓ ╓ ╓ ╓ !╓ +╓ -╓ 2╓ 4╓ 9╓ <╓ B╓ E╓ I╓ L╓ R╓ U╓ W╓ Z╓ `╓ b╓ m╓ p╓ |╓ ╓ П╓ У╓ Ш╓ Ъ╓ Я╓ в╓ и╓ л╓ п╓ ▓╓ ╕╓ ╗╓ ╜╓ └╓ ╞╓ ╚╓ ╙╓ ╓╓ т╓ х╓ ї╓ ∙╓ ■╓ ╫ ╫ ╫ ╫ ╫ ╫ ╫ ╫ !╫ #╫ &╫ ,╫ .╫ 9╫ <╫ H╫ K╫ [╫ _╫ d╫ f╫ k╫ n╫ t╫ w╫ {╫ ~╫ Д╫ З╫ Й╫ М╫ Т╫ Ф╫ Я╫ в╫ о╫ ▒╫ ┴╫ ┼╫ ╩╫ ╠╫ ╤╫ ╘╫ ┌╫ ▌╫ с╫ ф╫ ъ╫ э╫ я╫ Є╫ °╫ ·╫ ╪ ╪ ╪ ╪ '╪ +╪ 0╪ 2╪ 7╪ :╪ @╪ C╪ G╪ J╪ P╪ S╪ U╪ X╪ ^╪ `╪ k╪ n╪ z╪ }╪ Н╪ С╪ Ц╪ Ш╪ Э╪ а╪ ж╪ й╪ н╪ ░╪ ╢╪ ╣╪ ╗╪ ╛╪ ─╪ ╞╪ ╤╪ ╘╪ р╪ у╪ є╪ ·╪ ц ь @ C ▄ ▀ u Ж Ю# г# $ $ - - ю2 ї2 [4 a4 5 !5 ї5 №5 X7 k7 ц9 ъ9 D: E: D= Q= Г= О= эB ўB KD QD aD eD ▄D чD РI ЧI мI ╢I уI чI ЬJ бJ пJ ╡J O O 0O :O UR VR S S zU ГU V V ╝V ┬V ╥X ▀X Т\ Ф\ є` ·` Сa Ъa сa ыa ╨h ╒h 9j @j ╛j ├j sn {n 9u Bu Vu Zu ╞u ╤u v
v Оv Ъv ╝v └v ц{ Є{ A| F| EА WА Г Г %Ж 3Ж GЖ SЖ ПЖ ЦЖ ░Ж ╖Ж ┐М ┬М ╗П ┴П ╥П ▄П Р Р XР ]Р ▌Р цР ыР ёР
У У СФ ЩФ ╞Ф ╠Ф ▌Ф хФ Х
Х ╣Ш ┴Ш ▓Ы ╜Ы dЭ eЭ ╔Э ╩Э ЬЯ ЮЯ ╞Я ═Я sд vд Yе cе hе tе д░ м░ ║░ ├░ █░ ф░ %▒ .▒ ╔│ F┤ ╢ ╢ e╖ j╖ А╖ З╖ *╕ :╕ d╕ i╕ ┴┐ ╟┐ ┬ ┬ ┬ '┬ K╟ P╟ Ж╟ М╟ ╚ ╚ ╜═ ╩═ )╒ 0╒ Б╫ З╫ i╪ q╪ ▓┘ ┴┘ ▄┌ ц┌ ╫▄ ╪▄ н▐ ╖▐ ▒▀ ╡▀ ¤▀ р oч rч Тш аш PЄ \Є ° ° ц√ ъ√ К¤ У¤ ■ ■ %■ (■ o■ v■ ▀■ ъ■ N U o z s
~
# В# L+ S+ W+ f+ °+ ■+ 1/ 8/ 0 '0 t6 z6 ┬8 ╬8 М9 О9 m< x< ╕= └= х= щ= Лc Рc Щc аc Od Wd Дx Жx їx √x y y ]Г fГ ўД Е
Е Е ГЕ КЕ Ж Ж RЖ YЖ aЗ iЗ ┼З ╥З HИ RИ √О ?П ▓Х ╜Х ╒Х ▀Х ЁШ ўШ ┐Щ ╟Щ АЬ НЬ !Э +Э 1Ю :Ю Я Я ФЯ ЮЯ Єв ■в г г ╕г ┐г ┌г ▀г г д tо о ╤о ╪о п п 0п 7п ф│ я│ ;┤ >┤ ╞┤ ╬┤ ╛╕ ─╕ ▌╣ ▐╣ c║ d║ 8╗ :╗ l╗ r╗ ╟╗ ╬╗ └ └ |┴ В┴ Ы┴ б┴ ┼ ┼ y╟ |╟ м╟ │╟ ю╟ Є╟ ]╚ a╚ Г╚ О╚ ╕╚ ├╚ ╦ ╦ ╝╠ ┬╠ ╥╠ ╪╠ ═ ═ ╬
╬ к╤ ╜╤ ·╪ 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 T e d < C : \ M y D o c u m e n t s \ N u r s i n g \ C o m m o n l y u s e d d r u g s i n c l i n i c a l 1 . d o c T e d < C : \ M y D o c u m e n t s \ N u r s i n g \ C o m m o n l y u s e d d r u g s i n c l i n i c a l 1 . d o c T e d d C : \ W I N D O W S \ A p p l i c a t i o n D a t a \ M i c r o s o f t \ W o r d \ A u t o R e c o v e r y s a v e o f C o m m o n l y u s e d d r u g s i n c l i n i c a l 1 . a s d T e d < C : \ M y D o c u m e n t s \ N u r s i n g \ C o m m o n l y u s e d d r u g s i n c l i n i c a l 1 . d o c T e d d C : \ W I N D O W S \ A p p l i c a t i o n D a t a \ M i c r o s o f t \ W o r d \ A u t o R e c o v e r y s a v e o f C o m m o n l y u s e d d r u g s i n c l i n i c a l 1 . a s d T e d d C : \ W I N D O W S \ A p p l i c a t i o n D a t a \ M i c r o s o f t \ W o r d \ A u t o R e c o v e r y s a v e o f C o m m o n l y u s e d d r u g s i n c l i n i c a l 1 . a s d T e d d C : \ W I N D O W S \ A p p l i c a t i o n D a t a \ M i c r o s o f t \ W o r d \ A u t o R e c o v e r y s a v e o f C o m m o n l y u s e d d r u g s i n c l i n i c a l 1 . a s d T e d d C : \ W I N D O W S \ A p p l i c a t i o n D a t a \ M i c r o s o f t \ W o r d \ A u t o R e c o v e r y s a v e o f C o m m o n l y u s e d d r u g s i n c l i n i c a l 1 . a s d T e d d C : \ W I N D O W S \ A p p l i c a t i o n D a t a \ M i c r o s o f t \ W o r d \ A u t o R e c o v e r y s a v e o f C o m m o n l y u s e d d r u g s i n c l i n i c a l 1 . a s d T e d d C : \ W I N D O W S \ A p p l i c a t i o n D a t a \ M i c r o s o f t \ W o r d \ A u t o R e c o v e r y s a v e o f C o m m o n l y u s e d d r u g s i n c l i n i c a l 1 . a s d дP\{DЪJ╬ Д╨ДШ■╞ ╨^Д╨`ДШ■CJ OJ QJ o( ╖Ё А ДаДШ■╞ а^Да`ДШ■CJ OJ QJ o( o А ДpДШ■╞ p^Дp`ДШ■CJ OJ QJ o( зЁ А Д@ ДШ■╞ @ ^Д@ `ДШ■CJ OJ QJ o( зЁ А ДДШ■╞ ^Д`ДШ■CJ OJ QJ o( зЁ А ДрДШ■╞ р^Др`ДШ■CJ OJ QJ o( зЁ А Д░ДШ■╞ ░^Д░`ДШ■CJ OJ QJ o( зЁ А ДАДШ■╞ А^ДА`ДШ■CJ OJ QJ o( зЁ А ДPДШ■╞ P^ДP`ДШ■CJ OJ QJ o( зЁ дP\{ ВєPЮъРPь}▓D№t^\tUl9xЙlз:xЪxb╛╧*i " # $ Д о 7
ж
з
й
} ~ А ╒ 5 6 8 7 Я а в м# $ !$ #$ ╡* + + + ░1 2 2 2 '6 Е6 Ж6 И6 ▀> =? >? A? D dE eE hE K ЙK КK НK ╖P Q Q Q ╫V 3W 4W 7W [ v[ w[ z[ пb c c c (g Оg Пg Тg 0k Мk Нk Рk ╚p 'q (q +q кw x x x ╕x y y y м| } } } Е} у} ф} ч} q~ ╪~ ┘~ ▄~ ] ╗ ╝ ┐ УА ёА ЄА їА 5З аЗ бЗ дЗ GИ еИ жИ йИ ?Й ЬЙ ЭЙ аЙ ;К ЪК ЫК ЮК [С ┴С ┬С ┼С eХ ┴Х ┬Х ┼Х эШ JЩ KЩ NЩ ЇЩ QЪ RЪ UЪ ╔Ъ 3Ы 4Ы 7Ы эа Sб Tб Wб шб Fв Gв Jв з _з `з cз ∙з Xи Yи \и ╙и 0й 1й 4й жй к к к Юк л л л Ьл м м м tм ╘м ╒м ╪м ь▒ W▓ X▓ [▓ ═▓ -│ .│ 1│ G┤ е┤ ж┤ й┤ ь╕ ]╣ ^╣ a╣ х╣ F║ G║ J║ ╡║ ╗ ╗ ╗ Й╗ щ╗ ъ╗ э╗ s╝ ╙╝ ╘╝ ╫╝ ]╜ ║╜ ╗╜ ╛╜ P╛ └╛ ┴╛ ─╛ ▓┬ ├ ├ ├ О├ э├ ю├ ё├ Q╚ н╚ о╚ ▒╚ ;╔ о╔ п╔ ▓╔ I╩ ╖╩ ╕╩ ╗╩ С╬ я╬ Ё╬ є╬ Д╧ т╧ у╧ ц╧ w╨ ▀╨ р╨ у╨ V╤ ╡╤ ╢╤ ╣╤ O╥ ╢╥ ╖╥ ║╥ o█ ╫█ ╪█ ██ @р Яр ар гр Рс Ўс ўс ·с jт ╔т ╩т ═т iу ╠у ═у ╨у jф ╟ф ╚ф ╦ф 6х Ух Фх Чх Mщ мщ нщ ░щ ?ъ дъ еъ иъ jы ╬ы ╧ы ╥ы tь сь ть хь Вэ ¤э ■э ю Зю хю цю щю Бя ▐я ▀я тя xЁ ╒Ё ╓Ё ┘Ё vё ╙ё ╘ё ╫ё zЄ шЄ щЄ ьЄ dє ╧є ╨є ╙є DЇ лЇ мЇ пЇ y° с° т° х° M л м п 6 Ф Х Ш { ю я Є Х Ї ї ° j ╥ ╙ ╓ O о п ▓ 2 Р С Ф I ▒ ▓ ╡ ` ╜ ╛ ┴ D
в
г
ж
D в г ж J и й м A Э Ю б z { ~ g h k ы O P T х C D H " Ц Ч Ы ^ ╝ ╜ ┴ ^ ╝ ╜ ┴ \ ║ ╗ ┐ d ─ ┼ ╔ 1 П Р Ф ] ─ ┼ ╔ Й ц ч ы ~ ▄ ▌ с y ┌ █ ▀ I │ ┤ ╕ H ░ ▒ ╡ ~! ч! ш! ь! Ъ" ∙" ·" ■" б# ■# # $ б$ %
% % Ш% ∙% ·% ■% Н& ъ& ы& я& З' ь' э' ё' g, ╫, ╪, ▄, U- ╗- ╝- └- 0. Х. Ц. Ъ. ?/ Э/ Ю/ в/ h0 ╚0 ╔0 ═0 f1 ─1 ┼1 ╔1 a2 ╩2 ╦2 ╧2 Q3 о3 п3 │3 A4 и4 й4 н4 ш9 H: I: M: Ю> ? ? ? v? ╫? ╪? ▄? V@ ╡@ ╢@ ║@ MA лA мA ░A GB нB оB ▓B "C C АC ДC юC OD PD TD ├D !E "E &E РE ЎE ўE √E oF ╬F ╧F ╙F `G ├G ─G ╚G жH I I I жI J J J yJ ╓J ╫J █J SK ╣K ║K ╛K 4L ЧL ШL ЬL 4M ТM УM ЧM %N МN НN СN 'O ПO РO ФO P КP ЛP ПP 2Q СQ ТQ ЦQ 0R ПR РR ФR (S РS СS ХS T }T ~T ВT U yU zU ~U V qV rV vV сV >W ?W CW ╦W 2X 3X 7X ┼X "Y #Y 'Y ╢Y Z Z $Z ▒Z [ [ [ Й[ ш[ щ[ э[ f\ ╬\ ╧\ ╙\ p] ╫] ╪] ▄] p^ ╙^ ╘^ ╪^ B_ и_ й_ н_ ═d 5e 6e :e ╨e 1f 2f 6f еf g g g Хg Ўg ўg √g ih ╨h ╤h ╒h Вi тi уi чi [j ╣j ║j ╛j 6k Цk Чk Ыk Дl цl чl ыl \m ─m ┼m ╔m ^n ╗n ╝n └n Wo │o ┤o ╕o Bp жp зp лp 7q Юq Яq гq 8r Эr Юr вr s ps qs us їs et ft jt ъt Hu Iu Mu ╦u 2v 3v 7v еy z z z Ыz ·z √z z М{ ъ{ ы{ я{ a| ┐| └| ─| ^} ╝} ╜} ┴} D~ в~ г~ з~ cИ ┴И ┬И ╞И gЙ ╟Й ╚Й ╠Й XК ╕К ╣К ╜К NЛ мЛ нЛ ▒Л DМ │М ┤М ╕М EН гН дН иН О yО zО ~О @П аП бП еП >Р ЬР ЭР бР С БС ВС ЖС Т zТ {Т Т Т \У ]У cУ Ц Ц Ц Ц єЪ ¤Ъ ■Ъ Ы Mа Uа Vа \а Tе \е ]е cе и й й
й 1░ 8░ 9░ ?░ q╡ x╡ y╡ ╡ '╣ 0╣ 1╣ 7╣ <╝ E╝ F╝ L╝ Ц┬ а┬ б┬ з┬ ~╔ Ж╔ З╔ Н╔ ║╬ ╗╬ ╝╬ ┬╬ Щ╥ б╥ в╥ и╥ ъ╥ ·╥ √╥ ╙ Л╙ Ъ╙ Ы╙ б╙ z╘ С╘ Т╘ Ш╘ ;╒ O╒ P╒ V╒ Ц╒ Ю╒ Я╒ е╒ ╓ ,╓ -╓ 3╓ С╓ Т╓ У╓ Щ╓ ў╓ °╓ ∙╓ ╓ ]╫ ^╫ _╫ e╫ ├╫ ─╫ ┼╫ ╦╫ )╪ *╪ +╪ 1╪ П╪ Р╪ С╪ Ч╪ ї╪ Ў╪ ў╪ ·╪ Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ю Ц @
А ш ш X ш ш @Д└{Р ┬ ┬ ┬6 ┬7 = > ~Б ~В ~ъ ~ы j# j$ j6 j7 jQ jR jЖ jЗ j╡ j╢ j╕ j╣ j║ [╝ [╜ [╛ [└ [┴ [├ [─ °╪ ╨ @ ╨ ╨ 8 @ ╨ < ╨ | @ ╨ D ╨ М @ ╨ К ╨ @ ╨ Ї ╨ ь@ ╨ & ╨ P@ ╨ 0 ╨ d@ ╨ D ╨ М@ ╨ ` ╨ ─@ ╨ Ц ╨ 0@ ╨ ╞ ╨ Р@ ╨ ╩ ╨ ╠ ╨ Ь@ ╨ ╨ ╨ ╥ ╨ и@ ╨ ╓ ╨ ░@ ╨ ┌ ╨ ╕@ U n k n o w n GР З: T i m e s N e w R o m a n 5Р А S y m b o l 3&Р З: A r i a l 7&Р З Я V e r d a n a A"Р G e n e v a A r i a l ?5Р З: C o u r i e r N e w ;Р А W i n g d i n g s " 1 И Ё╨фh t
И╣
Ин
И kD ■Е ╟ ? ! Ё ╨╨x ┤ ВВ20 d Ё▐ 2ГQ Ё ! C o m m o n l y u s e d d r u g s i n c l i n i c a l s : T e d T e d Ш°Каг┬╤╛# └Oг From: "toe"
Subject: Commonly used drugs in clinicals.doc
Date: Thu, 29 Jul 2004 20:27:26 -0400
MIME-Version: 1.0
Content-Type: text/plain;
charset="iso-8859-1"
Content-Transfer-Encoding: 7bit
X-Priority: 3
X-MSMail-Priority: Normal
X-MimeOLE: Produced By Microsoft MimeOLE V6.00.2800.1106
Д CU~1рE ■ Z рЕЯЄ∙OhлС +'│┘0 Ф Ш а ╠ ╪ ф Ё № (
D P \
h t | Д М ф " Commonly used drugs in clinicals: os omm Ted ed ed Normal.dot e Ted 17 Microsoft Word 9.0 @ ╛я @ Ю4┤:x─@ ╟L3x─@ ц[a h t t p : / / w w w . n l m . n i h . g o v / m e d l i n e p l u s / d r u g i n f o / u s p d i / 2 0 2 3 7 2 . h t m l M ▌ > h t t p : / / w w w . n l m . n i h . g o v / m e d l i n e p l u s / d r u g i n f o / u s p d i / 2 0 2 2 7 8 . h t m l } $ ┌ C h t t p : / / w w w . n l m . n i h . g o v / m e d l i n e p l u s / d r u g i n f o / m e d m a s t e r / a 6 0 1 2 0 9 . h t m l K ╫ > h t t p : / / w w w . n l m . n i h . g o v / m e d l i n e p l u s / d r u g i n f o / u s p d i / 2 0 2 3 1 8 . h t m l r u ╘ D h t t p : / / w w w . g o o g l e . c o m / s e a r c h ? h l = e n & i e = U T F - 8 & q = a c e t a m i n o p h e n & s p e l l = 1 Q ╤ ; h t t p : / / w w w . m s c o n t i n . c o m / h t m l / O u r _ p r o d u c t s / O u r _ p r o d u c t s . h t m ) % ╬ h t t p : / / w w w . d o l a s e t r o n . c o m / % N ╦ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 0 6 8 . h t m l % N ╚ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 0 6 8 . h t m l ( J ┼ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 9 9 5 . h t m l ( J ┬ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 9 9 5 . h t m l # F ┐ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 2 2 2 . h t m l # F ╝ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 2 2 2 . h t m l " B ╣ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 3 1 7 . h t m l " B ╢ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 3 1 7 . h t m l ! @ │ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 5 2 3 . h t m l ! @ ░ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 5 2 3 . h t m l $ J н F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 4 5 8 . h t m l $ J к F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 4 5 8 . h t m l & A з F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 2 7 5 . h t m l & A д F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 2 7 5 . h t m l $ D б F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 4 4 6 . h t m l $ D Ю F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 4 4 6 . h t m l % C Ы F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 3 6 6 . h t m l % C Ш F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 3 6 6 . h t m l % @ Х F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 0 6 6 . h t m l % @ Т F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 0 6 6 . h t m l % N П F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 0 6 8 . h t m l % N М F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 0 6 8 . h t m l ) M Й F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 2 9 9 . h t m l ) M Ж F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 2 9 9 . h t m l " C Г F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 2 3 0 6 . h t m l " C А F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 2 3 0 6 . h t m l + B } F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 3 8 7 . h t m l + B z F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 3 8 7 . h t m l " G w F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 3 1 2 . h t m l " G t F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 3 1 2 . h t m l & D q F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 4 6 6 . h t m l & D n F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 4 6 6 . h t m l ' D k F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 1 4 3 . h t m l ' D h F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 1 4 3 . h t m l C e F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 2 3 2 6 . h t m l C b F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 2 3 2 6 . h t m l # F _ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 2 3 2 . h t m l # F \ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 2 3 2 . h t m l $ @ Y F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 7 4 . h t m l $ @ V F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 7 4 . h t m l ! L S F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 9 0 3 . h t m l ! L P F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 9 0 3 . h t m l * G M F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 9 3 . h t m l * G J F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 9 3 . h t m l # E G F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 0 1 . h t m l # E D F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 0 1 . h t m l ' O A F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 0 6 9 . h t m l ' O > F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 0 6 9 . h t m l % A ; F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 5 4 2 . h t m l % A 8 F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 5 4 2 . h t m l % C 5 F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 6 7 . h t m l % C 2 F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 6 7 . h t m l M / F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 2 1 9 . h t m l M , F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 2 1 9 . h t m l B ) F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 3 6 . h t m l B & F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 3 6 . h t m l % D # F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 2 3 7 1 . h t m l % D F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 2 3 7 1 . h t m l % M F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 8 4 3 . h t m l % M F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 8 4 3 . h t m l & N F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 9 7 1 . h t m l & N F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 9 7 1 . h t m l # L F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 3 0 9 . h t m l # L F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 3 0 9 . h t m l ! K F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 5 2 8 . h t m l ! K F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 5 2 8 . h t m l $ D F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 7 0 . h t m l $ D F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 7 0 . h t m l ' D F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 0 7 2 . h t m l ' D № F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 0 7 2 . h t m l M ∙ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 2 1 9 . h t m l M Ў F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 2 1 9 . h t m l O є F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 2 0 2 9 . h t m l O Ё F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 2 0 2 9 . h t m l & A э F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 5 5 . h t m l & A ъ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 5 5 . h t m l $ D ч F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 7 0 . h t m l $ D ф F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 7 0 . h t m l B с F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 3 6 . h t m l B ▐ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 3 6 . h t m l $ B █ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 6 4 2 . h t m l $ B ╪ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 6 4 2 . h t m l & L ╒ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 3 5 9 . h t m l & L ╥ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 3 5 9 . h t m l + M ╧ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 8 9 . h t m l + M ╠ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 8 9 . h t m l ) H ╔ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 8 8 6 . h t m l ) H ╞ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 8 8 6 . h t m l # E ├ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 1 0 2 . h t m l # E └ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 1 0 2 . h t m l B ╜ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 1 0 5 . h t m l B ║ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 1 0 5 . h t m l & C ╖ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 3 5 6 . h t m l & C ┤ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 3 5 6 . h t m l $ B ▒ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 3 5 7 . h t m l $ B о F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 3 5 7 . h t m l ' O л F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 0 6 9 . h t m l ' O и F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 0 6 9 . h t m l # F е F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 2 3 2 . h t m l # F в F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 2 3 2 . h t m l # D Я F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 2 2 0 . h t m l # D Ь F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 2 2 0 . h t m l & A Щ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 1 5 6 . h t m l & A Ц F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 1 5 6 . h t m l " G У F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 1 1 0 . h t m l " G Р F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 1 1 0 . h t m l ' O Н F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 0 6 9 . h t m l ' O К F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 0 6 9 . h t m l " G З F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 0 2 1 . h t m l " G Д F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 0 2 1 . h t m l # F Б F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 8 3 8 . h t m l # F ~ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 8 3 8 . h t m l ! B { F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 2 1 3 5 . h t m l ! B x F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 2 1 3 5 . h t m l * F u F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 0 9 0 . h t m l * F r F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 0 9 0 . h t m l % B o F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 5 5 1 . h t m l % B l F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 5 5 1 . h t m l ' B i F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 5 4 1 . h t m l ' B f F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 5 4 1 . h t m l % B c F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 2 4 6 . h t m l % B ` F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 2 4 6 . h t m l ' H ] F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 8 7 6 . h t m l ' H Z F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 8 7 6 . h t m l % E W F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 1 6 2 . h t m l % E T F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 1 6 2 . h t m l % H Q F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 7 4 9 . h t m l % H N F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 7 4 9 . h t m l # D K F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 2 3 1 1 . h t m l # D H F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 2 3 1 1 . h t m l % A E F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 6 5 . h t m l % A B F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 6 5 . h t m l ' D ? F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 4 0 . h t m l ' D < F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 4 0 . h t m l * C 9 F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 1 9 4 . h t m l * C 6 F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 1 9 4 . h t m l % @ 3 F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 1 6 7 . h t m l % @ 0 F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 1 6 7 . h t m l F - F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 8 1 8 . h t m l F * F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 8 1 8 . h t m l & D ' F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 0 5 2 . h t m l & D $ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 0 5 2 . h t m l B ! F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 6 1 2 . h t m l B F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 6 1 2 . h t m l ( I F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 7 9 8 . h t m l ( I F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 7 9 8 . h t m l % B F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 5 4 1 . h t m l % B F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 5 4 1 . h t m l B F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 3 6 . h t m l B F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 3 6 . h t m l $ M F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 7 9 . h t m l $ M F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 7 9 . h t m l $ M F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 2 2 6 9 . h t m l $ M F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 2 2 6 9 . h t m l % D ¤ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 2 3 7 1 . h t m l % D · F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 2 3 7 1 . h t m l " @ ў F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 1 4 . h t m l " @ Ї F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 1 4 . h t m l ! I ё F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 7 0 8 . h t m l ! I ю F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 7 0 8 . h t m l $ D ы F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 3 5 1 . h t m l $ D ш F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 3 5 1 . h t m l ! M х F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 8 0 3 . h t m l ! M т F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 8 0 3 . h t m l @ ▀ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 5 1 3 . h t m l @ ▄ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 5 1 3 . h t m l % D ┘ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 6 0 . h t m l % D ╓ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 6 0 . h t m l & A ╙ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 5 5 . h t m l & A ╨ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 5 5 . h t m l # B ═ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 5 0 1 . h t m l # B ╩ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 5 0 1 . h t m l # E ╟ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 2 3 1 0 . h t m l # E ─ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 2 3 1 0 . h t m l M ┴ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 3 3 8 . h t m l M ╛ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 3 3 8 . h t m l ( @ ╗ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 0 9 6 . h t m l ( @ ╕ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 0 9 6 . h t m l B ╡ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 2 1 2 5 . h t m l B ▓ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 2 1 2 5 . h t m l ( A п F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 7 9 0 . h t m l ( A м F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 7 9 0 . h t m l " M й F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 9 3 2 . h t m l " M ж F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 9 3 2 . h t m l ! C г F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 5 2 0 . h t m l ! C а F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 5 2 0 . h t m l * M Э F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 9 9 . h t m l * M Ъ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 9 9 . h t m l $ E Ч F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 3 7 0 . h t m l $ E Ф F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 3 7 0 . h t m l # A С F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 0 0 7 . h t m l # A О F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 0 0 7 . h t m l ' G Л F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 0 6 1 . h t m l ' G И F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 0 6 1 . h t m l + M Е F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 3 8 8 . h t m l + M В F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 3 8 8 . h t m l ' @ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 4 4 2 . h t m l ' @ | F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 4 4 2 . h t m l # D y F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 3 0 1 . h t m l # D v F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 3 0 1 . h t m l " D s F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 3 3 1 . h t m l " D p F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 3 3 1 . h t m l C m F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 7 1 2 . h t m l C j F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 7 1 2 . h t m l " G g F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 0 1 1 . h t m l " G d F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 0 1 1 . h t m l ' D a F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 4 0 . h t m l ' D ^ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 4 0 . h t m l % B [ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 1 6 5 . h t m l % B X F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 1 6 5 . h t m l % G U F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 6 4 7 . h t m l % G R F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 6 4 7 . h t m l ' C O F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 4 4 1 . h t m l ' C L F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 4 4 1 . h t m l E I F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 4 3 7 . h t m l E F F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 4 3 7 . h t m l ) O C F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 1 8 8 . h t m l ) O @ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 1 8 8 . h t m l & N = F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 9 7 1 . h t m l & N : F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 9 7 1 . h t m l E 7 F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 3 1 . h t m l E 4 F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 3 1 . h t m l $ H 1 F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 8 4 6 . h t m l $ H . F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 8 4 6 . h t m l # F + F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 8 2 8 . h t m l # F ( F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 8 2 8 . h t m l & E % F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 0 5 3 . h t m l & E " F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 0 5 3 . h t m l # D F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 1 3 3 . h t m l # D F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 1 3 3 . h t m l ' @ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 5 4 3 . h t m l ' @ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 5 4 3 . h t m l ( @ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 7 9 1 . h t m l ( @ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 7 9 1 . h t m l ! B
F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 1 1 5 . h t m l ! B
F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 1 1 5 . h t m l ' G F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 0 6 1 . h t m l ' G F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 0 6 1 . h t m l ' D F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 0 7 2 . h t m l ' D ■ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 0 7 2 . h t m l & F √ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 2 4 4 4 . h t m l & F ° F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 2 4 4 4 . h t m l % @ ї F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 0 6 6 . h t m l % @ Є F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 0 6 6 . h t m l # A я F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 1 0 6 . h t m l # A ь F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 1 0 6 . h t m l " F щ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 1 2 . h t m l " F ц F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 1 2 . h t m l ! E у F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 3 2 0 . h t m l ! E р F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 3 2 0 . h t m l D ▌ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 0 3 2 . h t m l D ┌ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 0 3 2 . h t m l D ╫ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 1 1 3 . h t m l D ╘ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 1 1 3 . h t m l ' M ╤ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 3 6 8 . h t m l ' M ╬ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 3 6 8 . h t m l & D ╦ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 6 6 4 . h t m l & D ╚ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 6 6 4 . h t m l # @ ┼ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 5 0 3 . h t m l # @ ┬ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 5 0 3 . h t m l G ┐ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 2 4 2 5 . h t m l G ╝ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 2 4 2 5 . h t m l % E ╣ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 4 6 7 . h t m l % E ╢ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 4 6 7 . h t m l # E │ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 2 3 1 . h t m l # E ░ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 2 3 1 . h t m l + E н F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 3 8 0 . h t m l + E к F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 3 8 0 . h t m l $ B з F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 3 5 7 . h t m l $ B д F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 3 5 7 . h t m l ! D б F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 3 0 1 . h t m l ! D Ю F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 3 0 1 . h t m l " E Ы F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 0 3 3 . h t m l " E Ш F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 0 3 3 . h t m l " F Х F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 3 1 3 . h t m l " F Т F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 3 1 3 . h t m l & F П F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 2 4 4 4 . h t m l & F М F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 2 4 4 4 . h t m l " O Й F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 1 3 8 . h t m l " O Ж F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 1 3 8 . h t m l * G Г F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 2 0 8 1 . h t m l * G А F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 2 0 8 1 . h t m l " I } F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 9 2 6 . h t m l " I z F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 9 2 6 . h t m l " G w F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 0 1 1 . h t m l " G t F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 0 1 1 . h t m l * G q F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 2 0 8 1 . h t m l * G n F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 2 0 8 1 . h t m l ' J k F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 8 6 4 . h t m l ' J h F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 8 6 4 . h t m l $ B e F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 2 3 6 7 . h t m l $ B b F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 2 3 6 7 . h t m l " M _ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 8 2 3 . h t m l " M \ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 8 2 3 . h t m l % O Y F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 0 6 9 . h t m l % O V F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 0 6 9 . h t m l $ K S F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 8 4 5 . h t m l $ K P F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 8 4 5 . h t m l * M M F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 2 2 8 9 . h t m l * M J F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 2 2 8 9 . h t m l ) B G F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 6 9 2 . h t m l ) B D F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 6 9 2 . h t m l + F A F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 3 8 3 . h t m l + F > F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 3 8 3 . h t m l % B ; F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 0 6 4 . h t m l % B 8 F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 0 6 4 . h t m l % G 5 F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 6 4 7 . h t m l % G 2 F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 6 4 7 . h t m l % A / F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 1 6 6 . h t m l % A , F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 1 6 6 . h t m l % G ) F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 6 4 7 . h t m l % G & F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 6 4 7 . h t m l M # F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 3 9 . h t m l M F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 3 9 . h t m l $ B F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 1 7 5 . h t m l $ B F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 1 7 5 . h t m l % C F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 5 5 0 . h t m l % C F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 5 5 0 . h t m l # F F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 2 3 2 . h t m l # F F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 2 3 2 . h t m l ! G F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 2 1 3 . h t m l ! G F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 2 1 3 . h t m l % C F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 2 1 7 4 . h t m l % C F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 2 1 7 4 . h t m l # B F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 4 0 0 . h t m l # B № F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 4 0 0 . h t m l # E ∙ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 2 3 1 . h t m l # E Ў F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 2 3 1 . h t m l % F є F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 1 6 1 . h t m l % F Ё F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 1 6 1 . h t m l # @ э F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 0 4 . h t m l # @ ъ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 0 4 . h t m l F ч F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 3 2 . h t m l F ф F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 3 2 . h t m l ' B с F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 6 6 2 . h t m l ' B ▐ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 6 6 2 . h t m l ! O █ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 8 0 1 . h t m l ! O ╪ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 8 0 1 . h t m l % E ╒ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 1 6 2 . h t m l % E ╥ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 1 6 2 . h t m l ' B ╧ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 1 4 5 . h t m l ' B ╠ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 1 4 5 . h t m l G ╔ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 4 3 5 . h t m l G ╞ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 4 3 5 . h t m l # E ├ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 3 2 0 . h t m l # E └ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 3 2 0 . h t m l I ╜ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 9 1 6 . h t m l I ║ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 9 1 6 . h t m l # J ╖ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 4 0 8 . h t m l # J ┤ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 4 0 8 . h t m l % G ▒ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 0 5 1 . h t m l % G о F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 0 5 1 . h t m l ! O л F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 8 0 1 . h t m l ! O и F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 8 0 1 . h t m l " N е F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 2 1 0 9 . h t m l " N в F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 2 1 0 9 . h t m l * @ Я F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 9 4 . h t m l * @ Ь F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 9 4 . h t m l $ D Щ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 7 0 . h t m l $ D Ц F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 7 0 . h t m l B У F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 6 1 2 . h t m l B Р F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 6 1 2 . h t m l ' G Н F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 4 6 5 . h t m l ' G К F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 4 6 5 . h t m l ! E З F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 4 2 7 . h t m l ! E Д F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 4 2 7 . h t m l # C Б F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 5 2 0 . h t m l # C ~ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 5 2 0 . h t m l D { F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 3 0 . h t m l D x F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 2 3 0 . h t m l + N u F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 0 8 8 . h t m l + N r F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 0 8 8 . h t m l ) H o F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 6 9 8 . h t m l ) H l F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 6 9 8 . h t m l % @ i F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 0 6 6 . h t m l % @ f F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 0 6 6 . h t m l ( G c F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 0 8 1 . h t m l ( G ` F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 0 8 1 . h t m l G ] F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 1 3 0 . h t m l G Z F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 1 3 0 . h t m l + A W F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 0 8 7 . h t m l + A T F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 0 8 7 . h t m l $ D Q F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 4 5 6 . h t m l $ D N F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 4 5 6 . h t m l $ G K F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 1 4 0 . h t m l $ G H F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 1 4 0 . h t m l ! B E F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 1 1 5 . h t m l ! B B F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 1 1 5 . h t m l $ D ? F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 0 7 2 . h t m l $ D < F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 0 7 2 . h t m l % G 9 F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 3 4 2 . h t m l % G 6 F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 3 4 2 . h t m l ( @ 3 F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 1 9 7 . h t m l ( @ 0 F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 1 9 7 . h t m l # E - F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 2 3 1 . h t m l # E * F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 2 3 1 . h t m l # F ' F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 3 3 3 . h t m l # F $ F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 3 3 3 . h t m l B ! F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 6 1 2 . h t m l B F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 1 6 1 2 . h t m l " M F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 3 1 8 . h t m l " M F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 3 3 1 8 . h t m l ' F F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 0 7 0 . h t m l ' F F h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / D r u g s / e 0 0 7 0 . h t m l [ 0 ? h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / ? o r d e r = B a | z h t t p : / / w w w . a m a z o n . c o m / e x e c / o b i d o s / t g / d e t a i l / - / 0 9 6 3 6 2 1 9 8 X / q i d = 1 0 9 0 5 2 6 8 1 9 / s r = 1 - 1 / r e f = s r _ 1 _ 1 / 1 0 4 - 8 3 9 8 4 0 5 - 0 6 9 5 9 0 1 ? v = g l a n c e & s = b o o k s J O V h t t p : / / w w w . a m a z o n . c o m / e x e c / o b i d o s / t g / d e t a i l / - / 0 7 8 1 7 3 2 0 3 4 / 1 0 4 - 8 3 9 8 4 0 5 - 0 6 9 5 9 0 1 ? v = g l a n c e o D 6 h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / ^ 0 ? h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / ? o r d e r = G a 9 Q > h t t p : / / w w w . m o s b y s d r u g c o n s u l t . c o m / D r u g C o n s u l t / T o p _ 2 0 0 / ? o r d e r = 9
! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w x y z { | } ~ А Б В Г Д Е Ж З И Й К Л М Н О П Р С Т У Ф Х Ц Ч Ш Щ Ъ Ы Ь Э Ю Я а б в г д е ж з и й к л м н о п ░ ▒ ▓ │ ┤ ╡ ╢ ╖ ╕ ╣ ║ ╗ ╝ ╜ ╛ ┐ └ ┴ ┬ ├ ─ ┼ ╞ ╟ ╚ ╔ ╩ ╦ ╠ ═ ╬ ╧ ╨ ╤ ╥ ╙ ╘ ╒ ╓ ╫ ╪ ┘ ┌ █ ▄ ▌ ▐ ▀ р с т у ф х ц ч ш щ ъ ы ь э ю я Ё ё Є є Ї ї Ў ў ° ∙ · √ № ¤ ■
! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w x y z { | } ~ А Б В Г Д Е Ж З И Й К Л М Н О П Р С Т У Ф Х Ц Ч Ш Щ Ъ Ы Ь Э Ю Я а б в г д е ж з и й к л м н о п ░ ▒ ▓ │ ┤ ╡ ╢ ╖ ╕ ╣ ║ ╗ ╝ ╜ ╛ ┐ └ ┴ ┬ ├ ─ ┼ ╞ ╟ ╚ ╔ ╩ ╦ ╠ ═ ╬ ╧ ╨ ╤ ╥ ╙ ╘ ╒ ╓ ╫ ╪ ┘ ┌ █ ▄ ▌ ▐ ▀ р с т у ф х ц ч ш щ ъ ы ь э ю я Ё ё Є є Ї ї Ў ў ° ∙ · √ № ¤ ■
! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ■ @ A B C D E F ■ H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w x y z { | } ~ А Б В Г Д Е Ж З И Й К Л М Н О П Р С Т У Ф Х Ц Ч Ш Щ Ъ Ы Ь Э Ю Я а б в г д е ж з и й к л м н о п ░ ▒ ▓ │ ┤ ╡ ╢ ╖ ╕ ╣ ║ ╗ ╝ ╜ ╛ ┐ └ ┴ ┬ ├ ─ ┼ ╞ ╟ ╚ ╔ ╩ ╦ ╠ ═ ╬ ╧ ╨ ╤ ╥ ╙ ╘ ╒ ╓ ╫ ╪ ┘ ┌ █ ▄ ▌ ▐ ▀ р с т у ф х ц ч ш щ ъ ы ь э ю я Ё ё Є ■ Ї ї Ў ў ° ∙ · ■ № ¤ ■
! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w x y z { | } ~ А Б В Г Д Е Ж З И Й К Л М Н О П Р С Т У Ф Х Ц Ч Ш ■ ¤ ¤ ¤ ¤ ¤ ¤ ¤ ¤ в ■ ■ ■ R o o t E n t r y └ F └/4Д